Handbook of Patient Safety 2022
Handbook of Patient Safety 2022
ALGRAWANY
Oxford Professional Practice
Handbook of
Patient Safety
EDITED BY
Peter Lachman
ASSOCIATE EDITORS
John Brennan
John Fitzsimons
Anita Jayadev
Jane Runnacles
Great Clarendon Street, Oxford, OX2 6DP,
United Kingdom
Oxford University Press is a department of the University of Oxford. It furthers the University’s objective of excellence in
research, scholarship, and education by publishing worldwide. Oxford is a registered trade mark of Oxford University Press in the
UK and in certain other countries
© Oxford University Press 2022
The moral rights of the authors have been asserted
First Edition published in 2022
Impression: 1
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by
any means, without the prior permission in writing of Oxford University Press, or as expressly permitted by law, by licence or
under terms agreed with the appropriate reprographics rights organization. Enquiries concerning reproduction outside the scope
of the above should be sent to the Rights Department, Oxford University Press, at the address above
You must not circulate this work in any other form and you must impose this same condition on any acquirer
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America
British Library Cataloguing in Publication Data
Data available
Library of Congress Control Number: 2021945574
ISBN 978-0-19-284687-7
eISBN 978-0-19-266232-3
DOI: 10.1093/med/9780192846877.001.0001
Printed in Great Britain by
Ashford Colour Press Ltd, Gosport, Hampshire
Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must
therefore always check the product information and clinical procedures with the most up-to-date published product information
and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the
publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in
this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breast-
feeding
Links to third party websites are provided by Oxford in good faith and for information only. Oxford disclaims any responsibility
for the materials contained in any third party website referenced in this work.
ALGRAWANY
Foreword
ALGRAWANY
Contents
Contributors
Index
ALGRAWANY
Contributors
Ahmeda Ali
General Practitioner and Assistant
Director of Dublin Northeast ICGP Training Scheme
Irish College of General Practitioners
Dublin, Ireland
Chapter 2: The culture and system of patient safety
Jay Banerjee
Consultant in Geriatric Emergency Medicine
University Hospitals of Leicester NHS Trust
Leceister, England
Chapter 27: Safety in the emergency department
Rob Bethune
Consultant Surgeon
Royal Devon and Exeter NHS Foundation Trust
Exeter, England
Chapter 29: Safety in the operating theatre
Pallavi Bradshaw
Deputy Chief Medical Officer
AXA Health
London, England
Chapter 17: Open disclosure
Jeffrey Braithwaite
Professor and Founding Director
Australian Institute of Health Innovation, Macquarie University
Sydney, NSW, Australia
Chapter 11: Resilience theory, complexity science, and Safety-II
John Brennan
General Practitioner and Quality Improvement Faculty
Royal College of Physicians of Ireland
Dublin, Ireland
Chapter 4: Person-centred safety; Chapter 14 Practical approaches to safety improvement; and
Chapter 26: Safety in primary care and general practice
Karen Britton
Lead Nurse Deteriorating Patient and Resuscitation
Frimley Health Foundation Trust
Frimley, England
Chapter 24: Preventing and limiting deterioration on the medical wards
Kate Churruca
Postdoctoral Research Fellow
Australian Institute of Health Innovation, Macquarie University
Sydney, NSW, Australia
Chapter 11: Resilience theory, complexity science, and Safety-II
Robyn Clay-Williams
Associate Professor
Australian Institute of Health Innovation, Macquarie University
Sydney, NSW, Australia
Chapter 11: Resilience theory, complexity science, and Safety-II
Chris Cornue
Founder & President
sláinte global partners (sgp)
Chicago, IL, USA
Chapter 19: Patient safety and information technology
David Crosby
Consultant Obstetrician and Gynaecologist, Subspecialist in Reproductive Medicine & Surgery
and Perinatal & Reproductive Genetics
The National Maternity Hospital
Dublin, Ireland
Chapter 7: Communicating to be safe and Chapter 31: Safety in maternity care
Rob Cunney
Consultant Microbiologist
Children Hospital Ireland, Temple Street
Dublin, Ireland
Chapter 22: Prevention of healthcare-associated infections and Chapter 23: Sepsis and
antimicrobial stewardship
Louise A. Ellis
Research Fellow
Australian Institute of Health Innovation, Macquarie University
Sydney, NSW, Australia
Chapter 11: Resilience theory, complexity science, and Safety-II
Sibylle Erdmann
Patient Carer
London, England
Chapter 4: Person-centred safety
Eoin Fitzgerald
Paediatric Registrar
Children Hospital Ireland
ALGRAWANY
Dublin, Ireland
Chapter 8: Situation awareness and patient safety
John Fitzsimons
Consultant Paediatrician
Children Hospital Ireland, Temple Street
Dublin, Ireland
Chapter 2: The culture and system of patient safety and Chapter 13: Measuring patient safety on
the front line
Frank Frederico
Vice President
Institute for Healthcare Improvement
Boston, MA, USA
Chapter 20: Enabling medication safety
Sean Harding
Consultant Nurse Acute Care & Trust Lead for Advanced Clinical Practice
Frimley Health NHS Foundation Trust
London, England
Chapter 28: Safety in ambulatory care
Helen Haskell
President at Mothers Against Medical Error
WHO Patients for Patient Safety
Lexington County, SC, USA
Preface
Daniel Hayes
Senior Research Fellow, Evidence Based Practice Unit
University College London and the Anna Freud National Centre for Children and Families
London, England
Chapter 32: Safety issues in mental health
Sue Hignett
Professor of Healthcare Ergonomics & Patient Safety
Loughborough Design School, Loughborough University
Loughborough, England
Chapter 9: Practical application of human factors and ergonomics to improve safety
James Hoffman
Chief Patient Safety Officer
St Judes Childrens Research Hospital
Memphis, TN, USA
Chapter 21: Safe prescribing in paediatrics
Kristen Hughes
Clinical Pharmacist, Medication Safety and Informatics
St Judes Childrens Research Hospital
Memphis, TN, USA
Chapter 21: Safe prescribing in paediatrics
Hussein Jaffrey
Patient Advocate World Patient Alliance
WHO Patients for Patient Safety
Pakistan
Preface
Kirstyn James
Consultant Geriatrician
Cork University Hospital
Cork, Ireland
Chapter 34: Safety in patients with frailty and complex long-term conditions
Anita Jayadev
Consultant Respiratory Physician
Wexham Park Foundation NHS Trust
London, England
Chapter 24: Preventing and limiting deterioration on the medical wards; Chapter 28: Safety in
ambulatory care; and Chapter 37: Patient safety in a pandemic
Thomas Jun
Reader in Socio-technical System Design
Loughborough University
Loughborough, England
Chapter 9: Practical application of human factors and ergonomics to improve safety
Uma Kotagal
Emerirus Professor
Cincinnati Children Hospital Medical Centre
Cinncinati, OH, USA
Chapter 10: Reliability in healthcare
Peter Lachman
Lead Faculty Quality Improvement Programme
Royal College of Physicians of Ireland
Dublin, Ireland
Chapter 1: Introduction to patient safety; Chapter 3: Transparent leadership for safety; Chapter
7: Communicating to be safe; Chapter 8: Situation awareness and patient safety; Chapter 10:
Reliability in healthcare; Chapter 14: Practical approaches to safety improvement; and Chapter
37: Patient safety in a pandemic
Thomas Lamont
Senior Lecturer and Honorary Consultant in Restorative Dentistry
University of Dundee
Dundee, Scotland
Chapter 12: Measuring patient safety at a national, organization, and system level
ALGRAWANY
Michaela LaRegina
Clinical Risk Manager, Azienda Sociosanitaria Ligure 5, La Spezia, Italy
Chapter 37: Patient safety in a pandemic
Jason Leitch
Professor and National Clinical Director
Scottish Government
Edinburgh, Scotland
Chapter 12: Measuring patient safety at a national, organization, and system level
Janet C. Long
Senior Research Fellow
Australian Institute of Health Innovation, Macquarie University
Sydney, NSW, Australia
Chapter 11: Resilience theory, complexity science, and Safety-II
Michael Marx
Professor for International Public Health, Institute of Public Health
Universität Heidelberg
Heidelberg, Germany
Chapter 14: Practical approaches to safety improvement and Chapter 35: Safety in a
multidisciplinary team
Margaret Murphy
Mother and Patient Advocate
WHO Patients for Patient Safety
Cork, Ireland
Preface and Chapter 4: Person-centred safety
Kieran Murray
Consultant Rheumatologist
University Hospital Limerick
Limerick Ireland
Chapter 35: Safety in a multidisciplinary team
Eugene Nelson
Professor
The Dartmouth Institute of Health Policy & Clinical Practice
Dartmouth, NH, USA
Chapter 4: Person-centred safety
Gail Nielsen
Consultant in Advancing Healthcare Transformation
Des Moines, Iowa, USA
Chapter 25: Preventing and limiting diagnostic error
Mark O’Brien
Associate Fellow Programme Director, Oxford Healthcare Leadership Programme
Saïd Business School, University of Oxford
Oxford, England
Chapter 17: Open disclosure
Patricia O’Connor
Honorary Professor
University of Stirling, Faculty of Healthcare Sciences and Sport
Dundee, Scotland
Chapter 6: Developing a safe clinical team
Kevin O’Hare
Consultant Histopathologist
Tallaght Hospital
Dublin, Ireland
Chapter 36: Safety in the laboratory
James F O’Mahony
Health Economist
Centre for Health Policy & Management, Trinity College
Dublin, Ireland
Chapter 5: The economics of patient safety
Susanne O’Reilly
Consultant Gastroenterologist
St Vincent’s University Hospital
Dublin, Ireland
Chapter 14: Practical approaches to safety improvement
Suying Ong
Anaesthetics Registrar
Anaesthetic Department Royal Alexandra Hospital
Paisley, Scotland
Chapter 33: Patient safety in critical care
Shefal Patel
Acute Medical Consultant
Wexham Park Hospital
London, England
Chapter 24: Preventing and limiting deterioration on the medical wards
Adrian Plunkett
Consultant Paediatrician Intensive Care
Birmingham Childrens Hospital
Birmingham, England
Chapter 15: Learning from success to become safer
Rachel Pool
Intelligence Analyst
Healthcare Safety Investigation Branch (HSIB)
Farnborough, England
Chapter 16: Investigating and learning from adverse events
Damian Roland
Professor and Consultant in Paediatric Emergency Medicine
University Hospital of Leicester NHS Trust
Leceister, England
Chapter 27: Safety in the emergency department
Kevin Rooney
Clinical Director for Critical Care, Clyde Sector
Consultant in Anaesthesia and Intensive Care Medicine
Royal Alexandra Hospital
Paisley, Scotland
Chapter 33: Patient safety in critical care
Jane Runnacles
Consultant Paediatrician
St Georges University Hospital NHS Trust
London, England
Chapter 13: Measuring patient safety on the front line and Chapter 30: Safety in paediatrics and
child health
Blair L. Sadler
Senior Fellow
Institute for Healthcare Improvement
San Diego, CA, USA
Chapter 3: Transparent leadership for safety
Kevin Stewart
Medical Director
Healthcare Safety Investigation Branch (HSIB)
Farnborough, England
Chapter 16: Investigating and learning from adverse events
Riccardo Tartaglia
Professor in Risk Management, Marconi University, Italy
Chapter 37: Patient safety in a pandemic
Kris Vanhaecht
Professor
KU Leuven Institute for Healthcare Policy
Leuven, Belgium
Chapter 18: Caring for the caregivers: The second victim
Tricia Woodhead
Associate Director for Patient Safety
West of England Academic Health Science Network (AHSN)
Bristol, England
Chapter 25: Preventing and limiting diagnostic error
Part 1
Introduction to the science and theory of patient safety
ALGRAWANY
Chapter 1
Introduction to patient safety
Key points
Patient safety is a framework of organized activities that creates cultures, processes,
procedures, behaviours, technologies, and environments in healthcare that consistently
and sustainably lower risks, reduce the occurrence of avoidable harm, make error less
likely and reduce its impact when it does occur.
World Health Organisation, Global Patient Safety Action Plan 2021–2030
Every day clinicians are faced with the challenge of keeping the people they treat safe and free
from harm, while, delivering the care they need. This task has become more difficult as a result
of the increasing complexity of healthcare, especially in relation to chronic illness, and a
continuously aging population.
Patient safety is a relatively new field of study and traditionally has not been part of the
medical curriculum. The concept of patient safety, however, is not new; the maxim ‘First do no
harm’, attributed to Hippocrates, goes back about two and a half thousand years.
Throughout the history of medicine patient safety has passed many milestones, such as
Semmelweis’s recommendations for handwashing in 1847 and Florence Nightingale’s reports on
infection rates in military hospitals in 1855.
In the 1960s, the harm caused by thalidomide led to a greater understanding of drug-related
adverse events. Many consider that the modern patient safety movement started after a
publication of the Harvard Medical Practice Study in 1991. This study revealed a significant and
measurable problem with patient safety in US hospitals and in the following years was replicated
around the world, with similar findings. This led to the development of what can now be
considered as the science of patient safety.
The extent of the problem was highlighted in the Institute of Medicine’s 1999 publication of
To Err Is Human, which detailed the extent of the problem in the USA, estimating that up to
100,000 patients die each year from adverse events. Concurrently, in the UK, the NHS was
responding to the emerging awareness of patient safety concerns through the development of
clinical risk management and clinical governance strategies.
In 2000 an NHS review, Organisation with a Memory, estimated that there were over 850,000
adverse events in UK hospitals each year. Despite this awareness, serious events still occurred,
and detailed enquiries revealed systematic deficits in patient safety. These deficits included the
lack of a culture of safety, a blame environment, and a poor understanding of how to be safe.
The 2013 Berwick report, a response to the safety culture crisis at Mid Staffordshire NHS
Foundation Trust, stated that ‘mastery of quality and patient safety sciences and practices should
be part of initial preparation and lifelong education of all healthcare professionals, including
managers and executives’.
This handbook aims to provide frontline clinicians with an easy-to-read reference work that
can address this challenge. The handbook brings the principles of patient safety to frontline
health professionals such as doctors, nurses, and other health professionals. Patient safety is often
seen as a complex topic. We aim to offer simple interventions to protect patients and staff from
potential adverse events and harm.
Quality of care has always been a feature of healthcare. The modern quality in healthcare
movement commenced with the publication of Crossing the Quality Chasm by the Institute of
Medicine in the USA in 2001. Previously, standards in healthcare had been developed and
services had been evaluated against the standards in the accreditation or external evaluation
process. Donabedian postulated that one can achieve quality outcomes only if one has the
structures or systems in place and if there are processes by which those outcomes are to be
achieved. The past twenty years have registered the growth of improvement and implementation
science, which has developed theories and methods to improve care.
One can view quality of care as being a system made up of different components or domains.
If one wants to achieve good quality care, all elements of the system need to be fully operational,
working together to ensure desired outcomes are achieved.
Figure 1.1 indicates how all the domains of quality are interrelated.
ALGRAWANY
Figure 1.1 The quality system.
The quality system will function well when there is a culture that facilitates the development
of the structures and processes required to produce the desired outcome. Person- or kin-centred
care surrounds all the domains of quality and must be acknowledged as one develops safer care.
As one explores the challenge of delivering safe care, it will become apparent that every domain
of quality has a safety element. For example, one of the domains is the provision of timely care
and of good access to care. Delayed diagnosis therefore is a safety and quality issue. An
important quality challenge is the provision of equitable care to all, and this applies to how we
design the system so that it is always safe.
This system must operate in all the domains of quality to enable the achievement of high-
quality outcomes. As one learns the theories of patient safety, one will use the methods of
improvement and implementation science to test and implement the changes required to achieve
the care that is desired. The core values of kindness, compassion, respect, dignity, partnership,
and holistic care are inherent in the quality system and central to the design of safe systems.
The WHO Action Plan has several ambitious goals, and these will require the application of the
theories and methods presented in this book.
Box 1.2 Strategic objectives of the World Health Organisation Global Patient Safety
Action Plan
1. Make zero avoidable harm to patients a state of mind and a rule of engagement in the
planning and delivery of healthcare everywhere.
2. Build high-reliability health systems and health organizations that protect patients daily
from harm.
3. Assure the safety of every clinical process.
4. Engage and empower patients and families to help and support the journey to safer
healthcare.
5. Inspire, educate, skill and protect health workers to contribute to the design and delivery
of safe care systems.
6. Ensure a constant flow of information and knowledge to drive the mitigation of risk, a
reduction in levels of avoidable harm, and improvements in the safety of care.
7. Develop and sustain multisectoral and multinational synergy, solidarity, and
partnerships to improve patient safety and quality of care.
Patient safety science is an evolving field informed by research, debate, and real-world
experience. In recent years, in what should be seen as a sign of maturity, greater space for
questioning and for a critical evaluation of theories and methods has emerged. Despite
achievements in the face of advancing complexity, rates of harm have remained a stubborn
concern. Criticisms to the effect that patient safety has ceased to progress, has become overly
bureaucratic, or has deviated from the guiding influence of safety science in general need to be
addressed by examining our ability to reduce harm consistently. Many of the chapters in this
book seek to address new and emerging ideas, so that they may be blended into a systematic
approach to safety practice.
As the field has evolved, there is better understanding of what is needed in order for us to
ALGRAWANY
measure and achieve safety. The theories covered in this book are practical, so that the busy
clinician can make patient safety part of day-to-day work. To be safe, we need always to manage
risk proactively; and each theory aims to provide a way to do this.
Individual responsibility and accountability are the foundation of most safety initiatives.
However, given the complexity of healthcare, one needs to have a safe context within which
one can deliver it safely.
Risk/critical incident management has been the mainstay, and the original approach to
patient safety was limited to risk/incident management and the review of adverse events.
This included the introduction of root cause analysis and failure mode effects analysis,
which aimed to understand the causation of harm. This is insufficient to ensure a safer
system but is essential for highlighting where we need to improve.
Human factors and ergonomics (HFE) is a domain that originates in engineering and
aviation and provides the framework upon which most patient safety initiatives are based.
Safety results from the successful interaction of related parts of a complex system of
interactions between humans, the environment, and the technologies that are required to
complete complex tasks.
Reliability theory emanates from the study of ‘high reliability organizations’ (HROs) in
other industries, which are designed to have low defect rates—for example in nuclear
power, in the military, and in air traffic control, where safety is core to all operations. HFE
is central to the design of highly reliable processes. Interventions such as the standardization
of processes and care pathways have achieved considerable success, for example in the
elimination of central line-associated bloodstream infections.
Systems theory and the proactive management of risk combine how the system operates at
different levels and introduce the concept of complex adaptive systems, in which there are
no linear processes but rather a set of ever changing interactions, and therefore safety
cannot be taken as a given but needs to be planned and managed. Processes are not linear,
and therefore the complexity of the system implies that one cannot have a simple solution
that fits all. The proactive management of risk in each clinical area requires an assessment
of how the system works and how reliable can it be under varying conditions. For example,
highly predictable clinical care processes such as blood transfusion need to be highly
reliable, others may aim for the ability to adapt under changing conditions. For example,
routine surgery and some similar trauma need to be highly adaptable.
Resilience theory considers safety as occurring on a day-to-day basis, with constant
adaptation to changing conditions. Safety II looks at safety from the prism of what works
well. It studies this process and also analyses adverse events, in order to enable a process to
be safe under all conditions.
The most important component in the development of a safe system relates to a culture of safety,
where safety is embedded in everything we do. Healthcare is a high-risk industry, and therefore
safety must be central to all its strategies and policies. A safe organization has safety as its core
business, aims to ensure that all those who work in the system make safety a priority, and does
everything it can to help them achieve this goal.
There are many challenges to developing a safe culture, and the most complex of these is
offering employees psychological safety, the foundation of developing a safe system. Individuals
need to feel safe in order to challenge the status quo, report deficits, and feel empowered to
improve the process. This requires a leadership that fosters safety, protecting and supporting staff
in what is called a just culture. It involves the development of teams and the co-creation of safety
both with the team and with the people who receive care. It involves making people feel safe, so
that they may deliver safe care.
Despite our knowing why we need to be safe and what we need to do to deliver safe care,
healthcare is still not safe (see Wears and Sutcliffe 2020). This may be due to changing
definitions of safety and to the lack of agreement on what constitutes harm and how to measure
it. We have tended to measure it retrospectively, but the latest theory calls for anticipating harm
and predicting where it may occur, so that we can minimize the risk through active mitigation.
It is intended that this book will encourage the development of safer systems, in which all staff
members feel psychologically safe, work together without fear, and share expectations of
delivering safe care and minimizing all potential harm.
Summary box
ALGRAWANY
from adverse events in the NHS. London: The Stationery Office, 2000.
Donaldson, L. An organisation with a memory. Clinical Medicine 2.5 (2002): 452–7.
https://www.rcpjournals.org/content/clinmedicine/2/5/452.full.pdf.
Francis, R. (chair). Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. 2012.
London: Crown copyright, 2013.
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/279124/0947.pdf
Kohn, L. T., Corrigan, J., and Donaldson, M. (eds). To Err Is Human: Building a Safer Health
System. Washington, DC: National Academy Press, 1999.
Leape, L. L. Making Healthcare Safe: The Story of the Patient Safety Movement. Springer, 2021.
https://library.oapen.org/handle/20.500.12657/49509.
Leape, L. L. et al. The nature of adverse events in hospitalized patients: Results of the Harvard
Medical Practice Study II. New England Journal of Medicine 324.6 (1991): 377–84.
Learning from Bristol: The Report of the Public Inquiry into Children’s Heart Surgery at the
Bristol Royal Infirmary 1984–1995. London: Crown copyright, 2002.
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/273320/5363.pdf
Reason, J. Human error: Models and management. BMJ 320.7237 (2000): 768–70.
https://doi.org/10.1136/bmj.320.7237.768.
Scally, G. and Donaldson, L. J. Clinical governance and the drive for quality improvement in the
new NHS in England. BMJ 317 (1998): 61–65.
Recent theories
Bates, D. W. and Singh, H. Two decades since to err is human: An assessment of progress and
emerging priorities in patient safety. Health Affairs 37 (2018): 1736–43.
Chassin, M. R. and Loeb, J. M. High-reliability health care: Getting there from here. Milbank
Quarterly 91 (2013): 459–90.
Edmondson, A. C. The Fearless Organization: Creating Psychological Safety in the Workplace
for Learning, Innovation, and Growth. Hoboken, NJ: John Wiley & Sons, 2018.
Heifetz, R. and Linsky, M. Leadership on the Line: Staying Alive through the Dangers of
Leading. Boston, MA: Harvard Business Review Press, 2017.
Vincent, C. and Amalberti, R. Safer Healthcare: Strategies for the Real World. London:
Springer, 2016.
Wears, R. and Sutcliffe, K. Still Not Safe: Patient Safety and the Middle-Managing of American
Medicine. Oxford: Oxford University Press, 2020.
Weick, K. E. and Sutcliffe, K. M. Managing the Unexpected. Hoboken, NJ: Jossey-Bass, 2007.
Quality improvement
Lachman, P., Batalden, P., and Vanhaecht, K. A multidimensional quality model: An opportunity
for patients, their kin, healthcare providers and professionals to coproduce health.
F1000Research 9 (2021):1140 (https://doi.org/10.12688/f1000research.26368.3).
Chapter 2
The culture of patient safety
Introduction
Key components of a safe culture
How to measure safety culture and climate
How to develop a safe culture
Summary box
Key points
Safety culture is that aspect of organizational culture that reflects and influences how
safety is prioritized, resourced and practiced in a work setting.
Safety culture is the result of the interaction between individual and group beliefs,
values, and attitudes.
Safety climate refers to an employee’s perceptions of particular aspects of the
organization’s safety culture.
Introduction
Culture is the foundation of all the processes and resultant outcomes in an organization. In
healthcare, patient safety is dependent on the prevailing safety culture. When one assesses either
the success or the failure of the safety of an organization, both will be attributed to the prevailing
culture, which determines every action that is taken by every person in the organization to
achieve outcomes. This chapter introduces the concept of safety culture in healthcare.
Hospital surveys on patient safety culture: Agency for Healthcare Research and Quality
(AHRQ) in the USA
The AHRQ Surveys on Patient Safety Culture (SOPS™) enable healthcare organizations to
assess how their staff perceives various aspects of patient safety culture in multiple settings
such as hospitals, nursing homes, ambulatory outpatient medical offices, community
pharmacies, and ambulatory surgery centres. The hospital SOPS has, for example, forty survey
items covering areas such as communication, reporting and teamwork. See
www.ahrq.gov/sops/about/index.html, AHRQ Publication No. 19-0076, September 2019.
The means and effectiveness of interventions to change safety culture remain controversial.
Some components of a safety culture require structures and processes (data systems, education,
named roles) that need to be resourced and supported. These features contribute to an
organization’s governance for safety and are most effective in influencing safety culture when
combined with good leadership practices.
Six leadership practices necessary to develop and sustain a culture of safety were identified in
the report Leading a Culture of Safety:
There are many additional practices and tools that support leaders and organizations in their task
of shaping a culture. Many of these have their basis in person centredness and are an extension to
staff of concepts that are used to improve patient care (see Box 2.3).
The idea of setting out to change culture on purpose is not necessarily helpful, except in
extreme circumstances. Culture may be seen as flawed or poor, and changing it may be
considered an essential action; however, this broad brush can be overly simplistic. An
organization’s culture also tends to be a source of strength and character, and recognizing this
can yield results. Issues regarding safety governance, management, or leadership should be
considered before addressing any concerns with culture.
Another approach is to focus on behaviour and performance as the means to building culture
over time. Here shared activities (handover, huddles, debriefs) may be used to model good
behaviours and to highlight their benefits on performance. Over time, through the sincere
enacting of the behaviours that represent a safe culture, a virtuous cycle is created that can
change deeply held attitudes and beliefs. This requires leadership, psychological safety, and
patience.
It is important to recognize that any efforts to address safety culture benefit from highlighting
staff safety as a goal, in addition to patient safety. In a workplace with multiple hazards for staff
(lifting injuries, assault, contagion), the power of a staff safety culture has an important influence
on shared values.
Finally, regulators must understand the influence that safety culture has on efforts to reduce
harm. As Dr Don Berwick noted in the Berwick report, ‘culture will trump rules, standards and
control strategies every single time’. This means that regulators must not only pay attention to
compliance and critical outcomes, but also have a role in encouraging and guiding the emergence
of supportive safety cultures.
Summary box
• Safety culture refers to the way patient safety is thought about and implemented within an
organization and the structures and processes in place to support it.
• Measuring safety culture or the safety climate is important because the culture of an
organization and the attitudes of its teams have been found to influence patient safety
outcomes, and these measures can be used to monitor change over time.
• Safety tools that are short, easily repeatable over time, and adaptable to different contexts
may be the ones most practical to adopt.
• Organizations with a positive safety culture base their communication processes on
mutual trust, shared perceptions of the importance of safety, confidence in the
effectiveness of preventive measures, and support for the workforce.
Further reading
Key points
The safety of an organization is set by the culture that exists, as this culture will
determine how people act and behave.
A safety culture requires leadership that defines the expected behaviours of all and the
desired outcomes to be achieved.
A leader for safety addresses the complexity of care and does not avoid conflict. Safety
will be planned and supported at every level of the organization.
Candour with patients and support for staff will be key features of leadership.
A leader for safety addresses the complexity of care and does not avoid conflict.
A leader for safety will be compassionate and reflective and will develop a learning
organization that takes lessons from successes as well as failures.
A safe organization requires leadership at all levels, from the frontline clinical team to middle
and executive management. This chapter discusses the key leadership attributes that are needed
in order for an organization to be safe. The theme of leading for safety will be present and
evident in every subsequent chapter.
Leadership for safety and quality of healthcare should be part of a quality management system
in every part of the organization. Box 3.1 lists the essential elements.
Achieving optimal levels of safety throughout an organization requires highly visible, consistent,
and empathetic leadership. Patient safety must be a priority that is recognized, rewarded, and
supported by leadership. Failure to satify this condition will be a major barrier to success.
Without an overt commitment to safety the following may occur:
Frontline staff members will be uncertain as to whether safety really is a top priority and
will not know how to proceed if they see suboptimal care.
When harm occurs, there can be confusion and paralysis caused by fear.
Safety will become reactive to incidents rather than proactive
Leadership provides the platform of confidence in support of patient safety and is the glue that
connects individual patient safety efforts.
Effective leaders create a just culture in which team members feel safe both physically and
mentally/psychologically, so that they in turn can provide safe care to the people seeking care,
who in turn feel safe about the care they receive.
Genuine ownership of safety at the front line begins with a core belief that all patients deserve
to be free of harm. This belief is expressed in all organizational literature, in conversations
during the recruitment of new personnel, and in daily activity. Such expressions could involve
doing regular presentations with staff members who work on projects about safety, thinking
about how to implement their recommendations across the organization, appointing safety
champions among both staff and patients, and regularly discussing the business of safety.
One way to develop a culture of safety is for leaders to do the gemba (i.e. ‘real place’) walks
or the safety walkrounds. Leadership walkrounds show commitment to the concepts of safety.
They are learning opportunities, which can be used for understanding what the front line is doing
to achieve safety and to listen to patients and their families. Frontline staff has the chance to
discuss its safety achievements and improvement projects.
A team can use tools such as MaPSaF to assess the current state of its culture, so that
improvement in that culture may be assessed. There are tools available to do this and it is
important to implement them at the beginning of the assessment, so that improvement may be
measured.
Walkrounds have been shown to assist in the prevention of burnout if they are done within the
wider context of a culture that supports patient safety. That will be a just culture, which
encourages learning from mistakes and supports reporting both clinical incidents and excellence
in care (see Box 3.2).
Safe organizations will have safety management systems at every level, from the front line to the
board. This applies to executive leaders as well as to leaders of clinical teams. Juran proposed a
trilogy of actions for a quality management system that can be applied to the safety system (see
Figure 3.1).
Figure 3.1 A clinical leader for safety will apply these three interventions on a daily basis, using
improvement theories and methodologies to implement change.
As one assesses the complexity of healthcare, it is clear that we need to plan all aspects of care in
order to ensure that we can achieve its safe delivery. It cannot be assumed that professionals will
be safe. Safety needs to be the focus of the organization and of the clinical teams.
Each of the steps outlined in Box 3.3 is part of a proactive planning and continual adjustment
to changing environments.
A leader for safety will ensure that there are standards of care and measures by which one can
assess whether these standards are met. The real-time measurement of safety at each system level
allows for immediate reactions and makes safety more likely. The measures need to be regularly
reviewed and widely understood by frontline staff, as described in Chapters 12 and 13
Metrics need to be reviewed at various levels of the organization, including by the board and
by each department and clinical team. Organizations should participate in relevant quality review
systems, where their results can be compared with others. An annual outside review of the
overall safety and quality programme could be conducted, and results should be shared widely.
An example is medication harm. To prevent erroneous prescriptions and possible adverse
events from them, one should follow a standard operating procedure (SOP) that needs to be
adhered to. A leader for safety will make this a priority at both executive and clinical team level.
This will entail making accuracy in prescribing a daily measure, with the help of an associated
improvement programme. (See ch. 13)
Underpinning all safety efforts is how an organization or a clinical team learns. A safety leader at
any level of the organization will constantly ask:
A transparent leader will use tools such as failure mode and effects analysis (FMEA) to discover
potential failures within an organization and clinical teams.
A transparent organization or team is one that is willing to share what happens openly, with
duty of candour, and one that will learn from these experiences. The safety leader will actively
seek out comparator teams or organizations in order to see whether the standard of care is as safe
as it could be.
A progressive safety leader recognizes that leadership in patient safety is important at all
levels, not just at the top, and will place safety at the centre of all decisions.
Summary box
Culture
• Achieving optimal levels of safety in an organization and in clinical teams requires
visible, consistent, and empathetic leadership.
• Genuine ownership of safety begins with a core belief that all patients, however long their
stay, deserve to be free of harm.
• Effective leaders for safety are those who create a just culture, enthusiastically support
safety in their own work, and embrace transparency in communication.
Further reading
Baker, R. and Axler, R. Creating a high performing healthcare system for Ontario: Evidence
supporting strategic changes in Ontario. University of Ontario, October 2015.
http://ihpme.utoronto.ca/wp-content/uploads/2016/03/Baker-OHA_HSR-Creating-High-
Performing-Healthcare-System_policy_paper_oct…Final_.pdf.
Barson, S. et al. What initiatives do healthcare leaders agree are needed for healthcare system
improvement? Results of a modified Delphi study. Journal of Health Organization and
Management 32.8 (2018): 1002–12. https://doi.org/10.1108/jhom-08-2017-0216.
Clay-Williams, R. et al. Medical leadership, a systematic narrative review: Do hospitals and
healthcare organisations perform better when led by doctors? BMJ Open 7.9 (2017):
e014474. https://doi.org/10.1136/bmjopen-2016-014474.
Drew, J. R. and Pandit, M. Why healthcare leadership should embrace quality improvement BMJ
368 (2020): m872. https://doi.org/10.1136/bmj.m872.
Martin, G. P. and Dixon-Woods, M. After Mid Staffordshire: From acknowledgement, through
learning, to improvement. BMJ Quality and Safety 23 (2014): 706–8.
Rosenbaum, L. Cursed by knowledge: Building a culture of psychological safety. New England
Journal of Medicine 380.8 (2019, 21 Feb.): 786–90. https://doi.org/10.1056/nejmms1813429.
Regulation 20: Duty of candour. London: Quality of Care Commission, 2015.
https://app.croneri.co.uk/care-standards/cqc-fundamental-standards-england/regulation-20-
duty-candour.
Sadler, B. and Stewart, K. Leadership in a Crisis: The Power of Transparency. London: The
Health Foundation, 2015.
https://www.health.org.uk/sites/default/files/LeadingInACrisisThePowerOfTransparency.pdf.
Savage, M. et al. Effective physician leaders: An appreciative inquiry into their qualities,
capabilities and learning approaches. BMJ Leader 2 (2018): 95–102.
https://bmjleader.bmj.com/content/leader/2/3/95.full.pdf.
Vincent, C., Burnett, S., and Carthey, J. The Measuring and Monitoring of Safety. London: The
Health Foundation, 2013.
Chapter 4
Person-centred safety
Key points
• Patients, as people, are central to improving patient safety.
• There are many practical approaches to creating person-centered safety.
• These include patient-held records, co-production and co-design of services, and
sharing in the decision-making process.
• Tools such as teach back and peer-to-peer support can lead to improved safety.
• Partnership with patients can improve safety at all levels of care.
Are patients and their families … someone to whom we provide care? Or are they active
partners in managing and redesigning their care?
Don Berwick, MD
As the ultimate recipient and victim of unsafe care, the patient as a person has the greatest
interest in improving safety. Traditionally, patients have been largely excluded from efforts to
improve care. It is increasingly recognised that patients, caregivers, and family members have a
critical role to play in making healthcare safer and often notice safety issues that busy healthcare
workers may miss. Positive patient experience is associated with increased clinical effectiveness
and fewer adverse events. Everyone shares a responsibility for safe care.
Partnering with people to achieve safer care occurs across a continuum, from remote
involvement and feedback to basic care delivery to co-leadership in care redesign (see Figure
4.1).
Figure 4.1 Continuum of patient partnership for safety
Person-centred care has been defined as care that is coordinated, personalized, enabling, and
delivered with dignity, compassion, and respect. While aspiring to improve in these four areas is
laudable, true enablement of effective patient involvement in care delivery through the
facilitation of patient agency is core to co-producing safer care. Agency is the power and courage
to make change. It seems reasonable to state that patient-centred care and patient-centred safety
exist only when perceived as such by the patient.
The greatest challenge to unlocking person-centred safety lies in disrupting the traditional
hierarchy of healthcare so as to create space for patients to feel comfortable to ask questions and
to get adequately involved in their own care. This requires every effort to establish an equal
relationship between the clinician and the patient as a person, in order to generate a respectful
exchange on an equal footing. The first step is for the clinician to listen and to allow patients and
members of their families to speak up and be part of the care process. By realizing a true and
equal partnership and by fostering a sense of psychological safety between the clinician and the
patient as a person, one can generate a culture of safety in all aspects of health and care.
Paying attention to the quality of language is the foundation for successful dialogue and
everyday collaboration. Many patients and carers can describe the pain caused by a single
word they encountered while being treated. (Sibylle Erdmann, parent carer)
There are many practical approaches to enhancing this kind of relationship and ensuring that the
voice of patients can be heard; such approaches are listed in Box 4.1.
Partnership with patients and the incorporation of the patient voice facilitates patient-centred
improvements in safety at all levels of the healthcare system. In general, informed patients who
build meaningful therapeutic relationships with clinicians, relationships underpinned by
psychological safety, have a greater opportunity to take an active part in making their own care
and the care of their loved ones safer. This stems from their greater situational awareness of all
parties involved and their ability to focus on the goal of safe care, shared with their clinician and
the wider health system (see ch. 8, p. 00 (situation awareness)). For many clinicians, adopting
this approach may require some radical change to current practice and to the healthcare system
design. Achieving safer care in partnerships with patients as persons who receive care requires a
change in the power relationship. NHS England has produced a framework designed to facilitate
the co-production of services together with patients and their families (Box 4.2).
Addressing hierarchy and power differentials is a logical place to start. A patient-held medical
record addresses transparency and encourages the sharing of information about how to be safe.
While robust data about improved overall safety are lacking, anecdotal evidence suggests that,
when patients have open access to healthcare information about themselves, many of them feel
empowered to take a more active role in partnering with their clinician in order to achieve safer
care. When both the patient and the clinician view the medical record, it is more likely to have
correct information on critical facts such as prescribed medications and medical history. This
also offers patients the opportunity to track their health progress and to highlight potential safety
concerns of their own.
Safer care can be co-created and co-produced at the individual level of patient and clinician;
at group level, for patients who share a common illness or healthcare resource; and across the
wider healthcare system.
Co-production allows patients, as persons, to design how care could be delivered and what
safety measures could be included in the design from the perspective of the service user as well
as from that of the service provider (see Box 4.3).
Box 4.3 Coproduction with a single patient
A change in the way we interact with patients as persons can lead to safer clinical encounters
and safer experiences. Shared decision-making is a two-way relational process of helping people
to reflect on, and express, their preferences on the basis of their unique circumstances,
expectations, beliefs, and values (see Box 4.4)
To encourage active participation, clinicians need to address the power imbalances that may
be present in the clinician–patient dynamic. There are several tools that can assist the clinician;
and structured question tools can be used to encourage patients to ask questions of their clinician
at every healthcare interaction. These questions can relate to diagnosis, treatment options,
medications, and other aspects of care. Examples include programmes such as Ask Me 3 (IHI), 5
Moments for Medication Safety (WHO), Know Check Ask (HSE Ireland), and Take 2 (CEC,
NSW).
Often patients do not understand what is said to them; and a useful method to improve
comprehension in a non-hierarchical manner is teach back. This is an evidence-based health
literacy intervention where patients explain back to their provider, in their own words, what they
must know and do about their condition (see Box 4.5).
Structures like the one presented in Box 4.6 can facilitate a shared medical review for a group
of people with a common condition or treatment need. For example, a shared medical
appointment is arranged for a group of people newly diagnosed with asthma. They meet with the
doctor and the specialist nurse simultaneously, to learn about optimal management of asthma.
Concerns can be shared among the group, and patients may learn from each other’s questions
and experiences. Direct links between this model of care delivery and improved safety have yet
to be made; nevertheless, associated improvements in treatment effectiveness and lower rates of
hospitalization may lead to safer care for patients overall.
Possible ways to take a systems approaches to patient safety are listed in Box 4.7.
Why • Design principles and techniques are used to improve an experience from the perspective of the service user.
• Through partnership, patients and clinicians are empowered to make changes.
• The approach provides rich qualitative insights and can be tailored to a variety of care settings.
How
1. Use observation to appreciate how care happens on a daily basis.
2. Interview and record the experiences of patients, carers, families, and clinicians.
3. Edit the interviews to create a film.
4. Meet with clinicians and agree on the elements that they are happy to share with patients.
5. Show the film to patients.
6. Identify improvement areas together with patients.
7. Hold a joint meeting of patients and clinicians to share experiences and agree on improvement priorities.
8. Organize structured design groups comprised of patients and clinicians in order to drive improvement.
9. Celebrate improvements in safety together.
Finally, the most important way to achieve safety is to listen and hear and to treat the patient
as a person. This includes involving him or her in investigations.
‘You ignore at your peril the concerns of a mother’, as Mother and Patient Representative
Margaret Murphy once said.
Summary box
Top tips
• Treat a patient as a person rather than as someone with a disease.
• Appreciate patients’ ideas, expectations and contributions in creating safer care.
• Co-design solutions and co-produce safer care in partnership with patients (regarded as
persons) and with those closest to them.
• Use available tools to assist you in the way care is delivered.
• Never disregard the concerns of a patient or family member.
Additional resources
Vincent, C. and Amalberti, R. Safer Healthcare; Strategies for the Real World. Ebook, Springer
Open, 2016.
Further reading
de Iongh, Anya and Erdmann, Sibylle. Better healthcare must mean better for patients and carers.
BMJ 361 (2018): k1877. doi: https://doi.org/10.1136/bmj.k1877.
Doyle, C., Lennox, L., and Bell, D. A systematic review of evidence on the links between patient
experience and clinical safety and effectiveness. BMJ Open 3 (2013): e001570. doi:
10.1136/bmjopen-2012-001570.
Elwyn, G. et al. Shared decision making: A model for clinical practice. Journal of General
Internal Medicine 27.10 (2012), 1361–7. doi:10.1007/s11606-012-2077-6.
Griffey, R. T. et al. The impact of teach-back on comprehension of discharge instructions and
satisfaction among emergency patients with limited health literacy: A randomized, controlled
study. Journal of Community Healthcare 8.1 (2015): 10–21.
https://doi.org/10.1179/1753807615y.0000000001.
Health Foundation. Person-centred care made simple (Version 1). 2014. London.
https://www.health.org.uk/publications/person-centred-care-made-simple.
NHS England. Framework for Involving Patients in Patient Safety. 2021. NHS, June.
https://www.england.nhs.uk/wp-content/uploads/2021/06/B0435-framework-for-involving-
patients-in-patient-safety.pdf.
The Point of Care Foundation. Experience-based co-design. n.d. London.
.https://www.pointofcarefoundation.org.uk/resource/using-patient-experience-for-
improvement/improving-care/experience-based-co-design.
Teach Back Training Kit. Website. n.d. http://teachbacktraining.org/home.
Chapter 5
The economics of patient safety
Overview
What is health economics?
Definitions
Quantification of health gains
Cost-effectiveness analyses of safety
How health economics can align and conflict with patient safety
Summary box
Key points
• An understanding of health economics is essential when making clinical decisions as
well as when improving the safety of care.
• Harm to patients accounts for up to 15% of the budget of a hospital, and there is a
broader impact in terms of litigation and loss of earnings for the individual affected.
• It is far more cost-effective to deliver safe care.
• The measurement of the cost effectiveness of patient safety initiatives can be
calculated.
Abbreviations used
Overview
This chapter considers the health economics framework and its application to patient safety in
healthcare. It begins with a brief outline of cost-effectiveness analysis (CEA), then goes on to
examine some illustrative examples of published health economic analyses of safety initiatives.
The discussion section explores how the health economic perspective can be both aligned and in
conflict with the objective of patient safety.
The objective of this chapter is to equip you with an understanding of the basics of health
economics and its application to patient safety, so as to enable you to identify cost-effective
patient safety initiatives.
Health economics is a broad area of study that applies the concepts of economic analysis to the
production, maintenance, and consequences of health at both individual and population level.
Health economics contains many subdisciplines and, in the context of patient safety, the most
relevant one is cost-effectiveness analysis (CEA).
CEA is the study of the costs of providing health interventions and their resulting health
benefits; its objective is to maximize overall population health. CEA is motivated by the scarcity
of resources. To maximize the health generated by healthcare budgets, we need to make difficult
choices about which healthcare interventions to provide and which to withhold.
CEA combines both technical and ethical judgements in order to decide which interventions
ought to be funded and which not. While the technical or positive judgements are matters of fact,
the ethical or normative issues depend on matters of value and are not always supported by
consensus. Accordingly, different approaches to CEA have emerged, depending on the extent to
which central government has a role in providing healthcare and on the preferences within
society for trade-offs between equity and individual liberty.
CEA aims to appraise the total cost of an intervention, including the upfront costs of providing
the intervention and any downstream savings that may occur later and in other areas of the health
system. Whether or not CEA should also include costs and savings that accrue to other
government departments, private businesses, and the broader society depends on the prevailing
norms in each country or national setting.
CEA also attempts to appraise the total health benefits that follow from an intervention, both
now and in the future. These include the positive therapeutic outcomes, but also any harms that
may result as consequence of unavoidable side effects, misdiagnosis or adverse events.
Definitions
CEA
Cost-effectiveness analysis is the study of the costs of providing health interventions and their
resulting health benefits; its objective is to maximize overall population health.
QALY
The quality-adjusted life years (QALY) is a unidimensional metric of health gain that combines
reductions in both morbidity and mortality.
Cost-effectiveness ratios
Cost-effectiveness ratios are obtained by dividing the total net cost of an intervention by the total
net QALYs gained.
ICER
The incremental cost-effectiveness ratio estimates how many additional costs are incurred in
order to achieve this or that additional health gain, when comparing alternative intervention
strategies.
Cost-effectiveness threshold
The cost-effectiveness threshold represents an upper bound on ICERs that corresponds to a limit
on what represents good value for money.
The QALY is a unidimensional metric that combines reductions in both morbidity and
mortality.
A unidimensional metric is used deliberately to provide a measure of health gain that can be
employed to compare many different types of interventions that work on different aspects of
health improvement across different illnesses in different patients.
This compromises the resolution with which we appraise the multifaceted improvement in
health from diverse interventions, but such a simplification is required if we want to achieve
comparability across multiple candidate interventions.
CEA employs a simple decision rule to determine which interventions represent sufficiently
good value to merit funding.
This decision is based on cost-effectiveness ratios and on what is known as the cost-
effectiveness threshold.
Cost-effectiveness ratios are obtained by dividing the total net cost of an intervention by the
total net QALYs gained with its help.
Importantly, the costs and effects within the ratio are not necessarily formed by comparison
to no intervention, but are relative to the costs and effects of the next best alternative
intervention strategy. This is in order to estimate what is known as the ICER, which tells us
how many additional costs are incurred in order to achieve this or that additional health gain
when comparing alternative intervention strategies.
The cost-effectiveness threshold represents an upper bound on ICERs that corresponds to a
limit on what represents good value for money.
Health economists would recommend that all interventions with ICERs below the threshold
be accepted and all those above the threshold be rejected.
In principle, allocation according to this decision rule yields the largest health gain possible
for the corresponding number and magnitude of healthcare resources available.
The earlier description of the ICER-threshold decision rule assumes that new interventions
are both more costly and more effective than existing interventions. In some cases, new
interventions are both more effective and less costly than the previous standard of care. In
such cases, new interventions demonstrate what is known as dominance and can be
recommended without reference to a threshold.
CEA is most useful when there are clearly identifiable net total costs and QALYs that can
be appraised for a specific intervention, such as a drug. Conversely, the appraisal of the
cost-effectiveness of nursing care is a less meaningful proposition, as clearly nurses carry
out a range of tasks, some of which might be highly cost-effective while others might not.
Accordingly, CEA must be applied carefully to produce meaningful recommendations for
resource allocation.
Typically, the hierarchy for the adoption of a new intervention is to demonstrate that
Improved safety is, typically, an ongoing and explicit objective of all health services.
Furthermore, it will often be the case that what is safer will also demonstrate dominance in terms
of cost effectiveness. For example, the reduction in adverse events within a service may lead to
better health outcomes and lower additional care costs. In such cases, the objectives of safety and
cost effectiveness are aligned.
There are three scenarios to consider:
1. If it can be demonstrated that safer care is likely to be more effective and to cost less
(which demonstrates dominance), then there is little need for a comprehensive CEA. A
decision maker does not need to know how much more effective and how much less costly
a safer service improvement will be to endorse that improvement. Indeed, research that
carefully quantifies the size of the increase in effectiveness and cost savings would itself be
a waste of research effort, and therefore should be avoided.
2. Where a safety improvement leads to an increase in effectiveness, but also to an increase in
costs, the objectives of safety and cost effectiveness are potentially in tension. While
ideally we would like all services to be as safe as possible, the fact that some safety
initiatives can be net costly requires us to consider the trade-off of increased cost for
increased safety. Many safety initiatives may be good value, but others may not be worth
paying for. In other words, we choose, naturally, safer healthcare services, but not at all
costs.
3. Where there is a trade-off of increased cost for additional safety, we must carefully quantify
the improved effectiveness in terms of QALYs and the increased costs of the new
intervention or service improvement. If the ICER of the safety improvement is within the
cost-effectiveness threshold, then the objectives of safety and cost effectiveness remain
aligned. Conversely, if the ICER of the safety improvement exceeds that threshold, then the
objective of improved safety conflicts with the objective of achieving cost-effective care.
Accordingly, we may reject a safety initiative that is not within our threshold.
There are studies that attempt to estimate the overall costs to health systems of medical errors,
both in terms of damaged health and additional healthcare costs and in terms of lost employment
and wider economic damage.
For example, in the USA, estimates from 2008 appreciated medical errors to have costed
£19.5bn (from 1.5 million avoidable medical injuries).
While such estimates can be useful in demonstrating the urgency of attending to the issue of
healthcare safety and in creating an overall motivation to promote related policies, they do
not provide a useful guide to policymakers or service planners as to what specific service
improvements are worth adopting (or not). CEAs of particular service changes or
innovations are more specific.
How health economics can align and conflict with patient safety
It is tempting to assume that all initiatives that improve patient safety will necessarily enhance
the cost effectiveness of healthcare services. Indeed, in many cases they will do. Unfortunately,
reassuring statements that safer care is more efficient care are simplistic, as they are not always
true.
Safety is a desirable feature of healthcare systems and should be enhanced, but not if the
costs of doing so exceed the benefits of better uses of resources required elsewhere in the
health system.
CEA provides decision makers with a clear, consistent analytical tool for appraising the
benefits and costs of improved safety initiatives.
Moreover, CEA offers a very clear decision-making framework within which one can judge
which safety initiatives represent value for money.
In cases in which the cost-effectiveness perspective conflicts with the drive to improve
safety, decision makers must act with conviction to avoid the temptation to enhance safety
at all costs.
Insisting on prioritizing safety without regard to cost will lead to an overall reduction in the
health gains achieved by the healthcare system.
Resisting the temptation to increase safety at all costs is difficult, as the forgone additional
safety will belong in the part of the health system that the decision maker has responsibility
for, while the resources saved may purchase health benefits that are purchased elsewhere.
Accordingly, it is understandably difficult for a decision maker to knowingly prioritise the
health of patients outside of their area of management at the detriment of those within their
area of control.
Achieving cost-effective improvements in safety is, arguably, as much about the discipline
of decision makers and their resolve to make efficient choices as it is about the clinical,
technical, and cultural processes required to enhance care.
This chapter presented some examples of health-economic evaluations of safety drawn from the
existing literature. Nevertheless, the literature on the cost effectiveness of safety improvements
remains relatively thin and immature. Accordingly, those wishing to understand the health-
economic consequences of safety initiatives within their area of practice may need to generate
the cost-effectiveness evidence themselves, as there is little published evidence at present.
Summary box
Health economics provides a well-developed framework for the appraisal of safety initiatives.
In many cases there will be a happy alliance between improving safety and enhancing the
efficiency of care.
Where safety and cost effectiveness conflict, decision makers need to remember that cost-
ineffective services reduce population health.
The shortage of published evidence to date means that decision makers may need to
conduct their own analyses of safety improvements in order to make evidence-based decisions
regarding the efficient use of resources at their disposal.
References
ALGRAWANY
Further reading
Andel, C. et al. The economics of health care quality and medical errors. Journal of Health Care
Finance 39.1 (2012): 39–50
Bouvy, C. et al. The cost-effectiveness of periodic safety update reports for biologicals in
Europe. Clinical Pharmacology & Therapeutics 93.5 (2013): 433–42.
Cook, A. et al. The effect of a hospital nurse staffing mandate on patient health outcomes:
Evidence from California’s minimum staffing regulation. Journal of Health Economics 31.2
(2012): 340–8.
Etchells, E. et al. Comparative economic analyses of patient safety improvement strategies in
acute care: A systematic review. BMJ Quality & Safety 21.6 (2012): 448–56.
Pauker, S. G., Zane, E. M., and Salem, D. N. Creating a safer health care system: Finding the
constraint. JAMA 294.22 (2005): 2906–8.
OECD papers
Auraaen, A., Slawomirski, L., and Klazinga, N. The economics of patient safety in primary and
ambulatory care: Flying blind. OECD Health Working Papers, No. 106, OECD Publishing,
Paris 2018, https://doi.org/10.1787/baf425ad-en.
de Bienassis, K., Llena-Nozal, A., and Klazinga, N. The economics of patient safety, Part III:
Long-term care: Valuing safety for the long haul. OECD Health Working Papers, No. 121,
OECD Publishing, Paris 2020, https://doi.org/10.1787/be07475c-en.
de Bienassis, K., Slawomirski, L., and Klazinga N. The economics of patient safety Part IV:
Safety in the workplace: Occupational safety as the bedrock of resilient health systems.
OECD Health Working Papers, No. 130. OECD Publishing, Paris 2021,
https://doi.org/10.1787/b25b8c39-en.
Slawomirski, L., Auraaen, A., and Klazinga, N. The economics of patient safety: Strengthening a
value-based approach to reducing patient harm at national level. OECD Health Working
Papers, No. 96. OECD Publishing, Paris 2017, https://doi.org/10.1787/5a9858cd-en.
Chapter 6
Developing a safe clinical team
Key points
• The achievement of patient safety requires teamwork.
• The degree of teamwork reflects the culture of the system.
• Safe clinical teams exhibit psychological safety, where every team member feels
safe to raise concerns and always feels supported.
• In a safe clinical team there is meaning to work and a sense of belonging.
• Respect, compassion, and kindness are core values of a safe clinical team.
Harm occurs in all healthcare settings and is a concern for all healthcare staff.
Most multidisciplinary professional training offers little regarding the practical application of
how to assess risk and continuously improve safety in clinical practice.
As patients, we all assume that healthcare is safe.
Team training is not routine in healthcare, yet it is the operational norm in all healthcare settings.
All healthcare environments are currently experiencing a deficit in staff availability.
Why is it a challenge?
Many processes in healthcare are not standardized. Healthcare is complex and not considered a
highly reliable industry.
Many clinical leaders are focused on day-to-day operations and outputs rather than on a systems
approach and patient outcomes.
Clinical discussions carried out every day as a team, specifically on safety matters that occur
throughout the day, are not routinely practised.
The culture of the clinical context needs to be receptive to open and honest discussions.
Person- and family-centred approaches are not always paramount.
The technology for standardizing care can be unaffordable and poorly designed.
Team learning enables outcome improvement, task mastery, and adaptive and responsive
practices.
Adopt systems thinking: understanding the interactions and interdependencies of the whole
healthcare system is crucial for the local impact of behaviours and practices and for the patient’s
outcomes.
Practise open disclosure: the open, honest, and timely disclosure of medical errors to patients
develops a culture based on transparency (see Chapter 17, open disclosure).
Use standard measures to determine outcomes, measuring what matters to patients and staff
members.
Make measuring the system’s performance and outcomes easy tasks to do.
Understand the difference between work imagined and work done.
Analyse safety across the patient’s journey by defining individual processes and timelines from
the patient’s perspective, using process mapping (see ch. 13, measurement of safety).
Practising team safety: Tips
Encourage and create opportunities to discuss risk openly in your conversations.
Use a standard template to guide conversations, for example:
• Are we all clear about the care planning today?
• Are there any concerns?
• Where do we anticipate that there may be problems?
• What can we do to mitigate any issues identified?
• Who will be responsible for each aspect?
Summary box
• Seek to build a whole system of care where the potential harms are openly discussed and
active plans are made to avoid harm.
• Embed and practise clear communications tools, to be used on a daily basis.
• Build training opportunities to use tools and techniques that improve and maintain safe
practice.
• Measure staff compliance alongside patient outcomes.
• Practise using simulation techniques for both simple and complex tasks and use key
communication tools within the scenarios.
• Hierarchy does not necessarily correspond to knowledge. Defer to the expert, be that the
patient or a junior member of the team, if that person can deliver the tasks at hand when
safety is paramount.
• Seek to understand and create joy at work.
• Encourage your team to be the best that it can be.
Further reading
Aggarwal, R. et al. Training and simulation for patient safety. BMJ Quality & Safety 19 (2010):
i34–i43.
Edmonson, A. C. (1999). Psychological safety and learning behavior in work teams.
Administrative Science Quarterly 44: 350–83.
Gandhi, T. K. et al. Transforming concepts in patient safety: A progress report. BMJ Quality &
Safety 27 (2018): 1019–26.
Gordon, M., Darbyshire, D. and Baker, P. Non-technical skills training to enhance patient safety:
A systematic review. Medical Education 46 (2012): 1042–54.
McDowell, D. S. and McComb, S. A. Safety checklist briefings: A systematic review of the
literature. AORN Journal 99.1 (2014): 125–37, e13.
Nabhan, M. et al. What is preventable harm in healthcare? A systematic review of definitions.
BMC Health Services Research 12 (2012),
https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-12-128.
Perlo, J. et al. IHI Framework for Improving Joy in Work (IHI White Paper). Cambridge, MA:
Institute for Healthcare Improvement, 2017.
Robert, G. et al. Exploring the adoption of Schwartz Center Rounds as an organisational
innovation to improve staff well-being in England, 2009–2015. BMJ Open 7 (2017):
e014326.
Studdert, D. M., Piper, D., and Iedema, R. Legal aspects of open disclosure, II: Attitudes of
health professionals: Findings from a national survey. Medical Journal of Australia 193
(2010): 351–5.
Chapter 7
Communicating to be safe
Key points
• Communication reflects the culture of a system at every level in healthcare.
• In the course of one day there are multiple transfers of information that can lead to a
communication error.
• Most patient safety incidents and adverse events have a communication component.
• Communication methods can be implemented so as to improve communication
between people, either with the patient and his or her family or within the clinical
teams.
Effective communication among team members and between team members and patients is of
paramount importance in the provision of safe and reliable person-centred care. Effective clinical
communication is clear, explicit, respectful, collaborative, and attentive. It can lead to an
improved flow of information, effective interventions, the patient’s and the healthcare
professional’s satisfaction, and patient safety.
Ineffective communication among healthcare professionals can have serious repercussions and
may even result in harm for the patient.
Why is it a challenge?
Ineffective communication puts patient safety at risk for various reasons. These include the lack
of exchange of critical information, the misinterpretation of information, and the overlooking of
changes in the patient’s status. The sources of ineffective communication are often multifactorial
and can span the entire multidisciplinary team. Patients need an open communication system
instead of experiencing adverse events stemming from communication failures. Ineffective
communication is a common problem and may be caused by barriers to effective communication
or by human factors (see Table 7.1).
ALGRAWANY
Using a common language
Structured communication support tools such as SBAR and I-PASS have been used successfully
in clinical practice to improve patient safety (see Table 7.2).
SBAR was successfully adapted in 2002 from the US Army; the goal was to reduce
communication errors at the time of clinical handover. It was adopted by the Kaiser Permanente
organization in Colorado, USA, and is now commonly used worldwide in healthcare (see Table
7.3).
I-PASS was developed from best cited handover practices in the literature, user feedback from
a pilot study, and observations made by the handover team; and it has been shown to be highly
reliable (Clements 2007; see Table 7.4).
Table 7.4 Example of user of I-PASS handover tool
Documentation to be safe
Documentation is a vital component of safe and effective patient care. It provides a mechanism
to record and communicate data, information, and knowledge about a patient and the care
provided. It can be written or electronic. The fundamental principles of documentation to be safe
are found in Box 7.1.
Summary box
References
Aggarwal, R. et al. Technology as applied to patient safety: An overview. BMJ Quality & Safety
19 (2010): i3–i8.
Clements, K. High-reliability and the I-PASS communication tool. Nursing Management 48,3
(2017): 12–13.
Institute for Healthcare Improvement. Guidelines for communicating with physicians using the
SBAR process. n.d. Cambridge, MA.
http://www.ihi.org/resources/Pages/Tools/SBARToolkit.aspx.
Lyndon, A., Zlatnik, M. G., and Wachter, R. M. Effective physician–nurse communication: A
patient safety essential for labor and delivery. American Journal of Obstetrix and
Gynecology 205,2 (2011): 91–96. doi:10.1016/j.ajog.2011.04.021.
Starmer, A. J. et al. I-PASS, a mnemonic to standarize verbal handoffs. Pediatrics 129 (2012):
201–4.
Further reading
Key points
• Situation awareness implies that all team members have the same level of
understanding of the real-time safety challenges.
• This requires constant collection of information, comprehension and sharing of the
information, and then making decisions to mitigate risk.
• Methods to improve situation awareness include safety huddles and crew resource
management.
In its simplest sense, situation awareness means being aware of what is going on around you.
In the healthcare context, effective situation awareness begins with the collation of relevant
patient information in a systematic fashion, followed by the analyses and sharing of this
information, which allows for a unified understanding among the members of the clinical team.
This in turn allows for the early identification of potential risks, enabling appropriate mitigating
actions to be taken in a timely fashion.
Situation awareness is widely used in other high-risk industries such as aviation, nuclear energy,
construction and the military.
Interesting fact: situation awareness was recognized as an essential tool for military aircraft
crews already during the First World War.
All organizations in which people work have latent weaknesses, which are multifactorial in
nature and increase the likelihood of errors. This is particularly true of complex adaptive systems
such as healthcare organizations.
Even the most experienced professionals can be lacking in situation awareness, particularly when
performing tasks that are routine to them.
A study analysing the causative factors in airline accidents identified problems related to
situational awareness in 88% of the accidents that involved human error.
Indeed, medical error was estimated as the third leading cause of death in the USA.
Failure to recognize and treat patients whose condition is deteriorating is a cause of significant
unintended harm in healthcare environments.
Why is it a challenge?
The way in which we read situations can be influenced by a number of factors such as our level
of experience, the numbers of distractions, the amount of relevant information at our disposal,
and tiredness—to name only a few.
The science that examines the relationships between humans and the systems they interact with
is known as human factors or ergonomics.
The early detection of deteriorating patients is key to improving patient outcomes, and this is
facilitated through better situation awareness.
Improving situation awareness in the healthcare setting is a complex task, which requires
significant efforts to embed it as part of the culture.
Clinicians may initially view it as an additional pressure on top of an already busy workload,
given that the benefits are not immediately apparent.
The theory of change proposes that short meetings such as safety huddles (discussed later)
facilitate the development of situation awareness and allow for a more collaborative teamwork,
with a more efficient sharing of information. This further expedites a common understanding of
the clinical condition of patients, which in turn enables actions to be taken to mitigate any
potential harm and to respond in a timely fashion to any deterioration in these patients’
condition.
Summary box
• Situation awareness means being aware of what is going on around you. This concept is
widely used in other high-risk industries, and with proven benefits.
• Medical error was estimated as the third leading cause of death in the USA, and therefore
its mitigation requires a conscious effort.
• The early detection of deteriorating patients is key to improving patient outcomes and is
facilitated by better situational awareness.
• One of the key benefits of improving situation awareness is facilitation of a shift from a
reactive to a proactive approach to patient care.
• Huddles and CRM are very useful tools for improving situation awareness in healthcare
settings.
• The WHO Safe Surgery Checklist is an excellent clinical example of situation awareness
in action.
Further reading
ALGRAWANY
(2004): i85–i90.
Makary, M. A. and Daniel, M. Medical error: The third leading cause of death in the US. BMJ
353 (2016): i2139. https://doi.org/10.1136/bmj.i2139.
O’Dea, A., O’Connor, P., and Keogh, I. A meta-analysis of the effectiveness of crew resource
management training in acute care domains. Postgraduate Medical Journal 90 (2014): 699–
708.
Stapley, E., et al. Factors to consider in the introduction of huddles on clinical wards: perceptions
of staff on the SAFE programme. International Journal for Quality in Health care.30,1
(2018): 44–49. doi:10.1093/intqhc/mzx162
Chapter 9
Practical application of human factors and ergonomics to
improve safety
Introduction
Human factors and ergonomics
Domains of HFE
Physical
Cognitive
Organizational HFE
Applications of HFE
Design for people
Design by or with people
Incident analysis
HFE principles
Systems orientation
Person centredness
Design-driven improvements
Summary box
Key points
• Human factors and ergonomics (HFE) aims to understand the complexity of the
interaction between humans and the other elements of an increasingly complex
system.
• HFE integrates and applies theories from psychology, anatomy and physiology as
well as organization management to design safe clinical systems.
• The design of all healthcare systems and processes should apply HFE theory and
methods.
Introduction
Healthcare has developed, borrowed and applied various tools and approaches from other
industrial sectors in order to improve safety. It has often done so dogmatically, without
understanding how different tools and approaches would address different types of risk in
healthcare.
Despite efforts over the past two decades to improve patient safety in various areas of
healthcare, it is very hard to find clear evidence of widespread and sustained improvement.
Calls to integrate HFE into healthcare and patient safety have been growing, but there is a risk
of misunderstanding what HFE is and how it should be applied. This chapter aims to present the
definition, core principles, models and methods of HFE and their applications to healthcare.
HFE is a unique academic transdisciplinary subject that brings together knowledge from
disciplines such as psychology (attention, motivation, memory, cognition, perception, decision-
making, and situation awareness), anatomy and physiology (vision, hearing, strength, posture,
reach, and fit) and organization management (teamwork and organizational culture).
This multi-, inter- and cross-disciplinary subject aims to better understand the nature of
interactions at multiple levels (= social science) and seeks to create a system or to change the
existing one (= design and engineering) so as to suit people’s needs rather than expecting people
to adapt to designed interactions.
At the same time, HFE understands that complexity, uncertainty, and ambiguity from
continuously changing work situations and conditions inevitably create the need for a flexible
adaptation of people as they interact with a system. The ‘system’ here can be a technology, a
software, a medical device, a team, a procedure, a policy, or a guideline and has the physical,
cognitive, and organizational dimensions with which people interact.
Domains of HFE
HFE has the following three domains of specialization, as defined by the International
Ergonomics Association:
Physical
Physical HFE focuses primarily on the physical characteristics and activities of a person.
Relevant topics in healthcare include design of workplace layout (e.g. intensive care
environments and emergency room), work-related musculoskeletal disorder (e.g. patient-
handling activities and surgeons performing minimally invasive surgery) and impact of
environmental factors (e.g. noise, alarm, temperature, humidity, airflow, and lighting).
Cognitive
Cognitive HFE focuses primarily on the cognitive characteristics and activities of a person
(perception, memory, decision-making and human error). Relevant topics in healthcare include
usability analysis and design of medical devices (e.g. inhalers), medical equipment (e.g.
anaesthesia machines) and information technologies (e.g. electronic patient records). Human
error is a cognitive ergonomic issue that has been studied in order to better understand
underlying causal factors and reduce patient safety incidents.
Organizational HFE
Organizational HFE, which is also called macro ergonomics, focuses primarily on psychosocial
characteristics of people and on organization-level structures, policies, and processes. Relevant
topics in healthcare include work schedule, job stress and burnout of healthcare workers,
teamwork, work system, and organizational culture.
As used in this chapter, the acronym HFE combines two distinct terms, ‘human factors’ and
‘ergonomics’, in a kind of shorthand designed to indicate that they can be used interchangeably,
to designate the same thing. Human factors specialists (also known as ergonomists) are
professionals who applies theory, principles, data and methods to optimize human well-being
holistically and to improve overall system performance. Human factors professionals usually
avoid focusing on short-term or local outcomes and aim to understand trade-offs between system
performance and human well-being.
HFE is the relevant purposive human behaviour in ‘designed’ human technology
organizational systems. People in healthcare integrate their physical, cognitive and social skills
while having multiple goals and the means to carry out a vast variety of tasks through
interactions with a wide range of devices and systems. Besides, the individuals’ increasing
ability to customize, adapt, and design their own work tasks and workplace setup means that we
are unable to predict the way in which people complete their work tasks.
Therefore HFE applies methods in order to consider the variety of ways in which work tasks
might be completed and ensures that systems are designed for use in a range of contexts.
In simple terms, the core question that HFE aims to address is: Can this person, with this
training and information, using these tools and technologies, perform these tasks to these
standards, under these conditions?
Applications of HFE
The HFE applications to design (both ‘design for people’ and ‘design by or with people’) are
relevant at all stages in the lifecycle of equipment, environment and services: planning,
prototyping, implementing, operating, training, evaluating, maintaining and recycling.
Incident analysis
HFE has been applied to improve learning from healthcare safety incidents and near misses as
well as successes. It provides tools such as the Human Factors Analysis and Classification
System (HFACS), which is based on the Swiss cheese model (Box 9.2).
1. organizational influences;
2. unsafe supervision;
3. precondition for unsafe acts and twenty-one subcategories;
4. HFE also provides various accident analysis methods that help to identify patient safety
incidents and to understand the underlying causal factors systematically (rather than
attributing blame to individuals). HFE-based incident analysis encourages both systems
thinking and resilience thinking.
Systems thinking highlights that incidents are not usually caused by a single catastrophic
decision or maladaptive action, but by dynamic interactions between people, tasks, technology,
and working conditions—including management, regulation, and policy. Resilience thinking
acknowledges that human adaptations are essential, yet no particular adaptation is ‘right’ or
‘wrong’ in itself but depends on its own context, which is always slightly different from any
other.
HFE principles
1. systems orientation;
2. person centredness;
3. design-driven improvements, which are very relevant to healthcare.
Systems orientation
Performance results from the interactions of a sociotechnical system in which the person is but
one embedded component. This principle has motivated healthcare to replace a ‘blame the
person’ culture with a more holistic, system-based approach.
Person centredness
The person or the group of people is central in a healthcare work system. This means that efforts
must be made to support people by designing work systems that fit their capabilities, limitations,
performance needs, and other characteristics—and not the other way around.
Design-driven improvements
A person-centred design of work structures and processes, when grounded in robust HFE science
and practice, can improve myriads of important patient, provider, and organization outcomes.
One of the most widely used healthcare HFE system models depicting the three HFE
principles is the Systems Engineering Initiative for Patient Safety (SEIPS). This model was
initially introduced in 2006 and an extended version, SEIPS 2.0, was introduced in 2013 (see
Figure 9.1).
The SEIPS 2.0 model has been used in many areas, including
• quality and safety improvement research and practice;
• health technology evaluation;
• patient safety education.
The SEIPS 2.0 model facilitates systems thinking and resilience thinking in order to deal with
the complexity of designing, evaluating, monitoring and auditing systems, services, and
processes as well as of investigating incidents.
In Chapters 29 and 35 the model will be used to demonstrate how one can design safe work
systems and processes of care.
There are systems frameworks and a variety of HFE approaches and methods that can help
us to understand complex interacting systems and subsystems involving people. HFE aims to
take the right approach, and this almost always involves collaboration with other specialities
and disciplines. There are advantages to integrating HFE with quality improvement science
and with implementation science, as discussed in Chapter 14.
HFE approaches can have greater impact when HFE expertise is embedded in the
healthcare system and HFE awareness is extended to a wider range of healthcare professionals
by instilling HFE education into the medical and healthcare curriculum.
Summary box
Reference
Holden, R. J. et al. SEIPS 2.0: A human factors framework for studying and improving the work
of healthcare professionals and patients. Ergonomics 56.11 (2013): 1669–86.
https://doi.org/10.1080/00140139.2013.838643.
Further reading
Carayon, P. et al. Work system design for patient safety: The SEIPS model. Quality & Safety in
Health Care 15 (Suppl 1) ((2006): i50–8. http://dx.doi.org/10.1136/qshc.2005.015842.
Chartered Institute of Ergonomics and Human Factors. Human Factors for Health & Social Care
(White Paper). Birmingham: CIEHF, 2018. https://www.ergonomics.org.uk/Healthcare.
Cohen, T. N. et al. Using HFACS–Healthcare to identify systemic vulnerabilities during surgery.
American Journal of Medical Quality 33.6 (2018); 614–22.
https://doi.org/10.1177%2F1062860618764316.
Dul, J. et al. A strategy for human factors/ergonomics: Developing the discipline and profession.
Ergonomics 55.4 (2012): 377–95. doi: 10.1080/00140139.2012.661087.
Hignett, S. et al. Human factors and ergonomics and quality improvement science: Integrating
approaches for safety in healthcare. BMJ Quality & Safety 24.4 (2015): 250–4.
http://dx.doi.org/10.1136/bmjqs-2014-003623.
International Ergonomics Association. Definition and Domains of Ergonomics. 2019.
https://www.iea.cc/whats/index.html.
International Journal Quality in Healthcare Supplement on Human Factors 33.1 (2021).
https://academic.oup.com/intqhc/issue.
Holden RJ, Carayon P. SEIPS 101 and seven simple SEIPS tools. BMJ Quality & Safety
2021;30:901-910. http://dx.doi.org/10.1136/bmjqs-2020-012538
Jun, G. T. et al. A participatory systems approach to design for safer integrated medicine
management. Ergonomics 61.1 (2018): 48–68.
https://doi.org/10.1080/00140139.2017.1329939.
Jun, G. T. and Waterson, P. Systems thinking: A new direction in healthcare incident
investigation (4 min-long animation). 2017. https://youtu.be/5oYV3Dqe0A8.
Wilson, J. and Sharples, S. Methods in the understanding of human factors. In J. Wilson and S.
Sharples (eds), Evaluation of Human Work (4th edn). Boca Raton, FL: CRC Press, 2015, pp.
1–32.
ALGRAWANY
Chapter 10
Reliability in healthcare
Key points
• Healthcare is unreliable in many of its operations. This is unsafe and inefficient.
• High reliability aims to produce error-free operations under various conditions.
• Reliability in healthcare implies that the patient receives the right care and that the
processes deliver care in a standardized way.
• Reliability theory offers interventions such as care bundles standardization and
process redesign, which can improve the reliability of care and its outcomes.
• The key features of a reliable team are a capacity for anticipation, frontline
ownership of the process, and learning.
Reliability theory is a scientific approach designed to achieve the elimination of error rates in a
process. High-reliability organizations (HROs) are characterized by the high potential to
eliminate error through processes that are organized in a systematic and scientific way, and
thereby to reduce risk and deliver unprecedented outcomes. Examples of HROs are firefighters,
rescue services and the nuclear industry.
Reliability is a concept that derives from everyday life. We normally expect a process to
produce the same result every time we use it. These processes can vary between being relatively
simple—for example opening a carton of milk, or washing one’s clothes in the washing machine
—and being extremely complex—for example launching a rocket. If the outcome of a process is
inconsistent or unpredictable, the process will be recognized as unfit for purpose. What use
would a car be that does not start when the key is turned in the ignition, or a lamp that fails to
light when one turns the switch on?
Why is it important?
Much of what we do in healthcare achieves the desired outcome most of the time. However,
there are many processes that are not reliable. For example:
the time when the operating list or outpatient clinic will start;
whether the correct medication is prescribed, and whether it will be given on time;
whether a clinical protocol is adhered to all the time.
To achieve the best possible outcomes for patients and to enhance the overall healthcare provider
experience, it is essential to aim for high reliability in healthcare systems and processes.
Definitions of reliability
Reliability is defined as the capability of an object or process to perform its intended function
over time, under specified conditions. It can be measured as the amount of failure-free operations
over time.
The translation of this definition into healthcare is as follows: reliability is a situation in which
every single time the correct patient receives the correct treatment, in the correct place, at the
correct time, from the correct person. The aim is to decrease potential error, that is to enhance
the number of failure-free operations.
If one measures human behaviour, there are nominal errors that occur, and these increase with
stress. In healthcare the chances of error increase with the complexity of a task and the levels of
stress under which the corresponding action is taken. Stressful clinical processes in the
emergency department (ED), in the operating room, or in the intensive care unit (ICU) are prone
to error.
A study of high reliability organizations undertaken by Weick and Sutcliffe (2011) has identified
five key characteristics of HROs (see Figure 10.1).
Characteristic Example
Anticipation Preoccupation Making sure that every prescription is 100% correct every
with failure time
Sensitivity to Using the SEIPS M model to assess the work system in real
operations time
Reluctance to Understanding the complexity of clinical processes and that
simplify good and poor outcomes are not due to linear action
Containment Commitment Applying learning to any event and working within a just
to resilience culture
Deference to Asking the patient, house officer, or nurse what the solution
expertise could be rather than coming up with solutions
Measures of reliability
Reliability can be measured using the following formula:
reliability = the number of actions that achieve the intended result, out of the total number of
actions taken
The defect rate of a process is 1 minus reliability.
Reliability is measured as a defect rate or as an index, and is expressed as an order of
magnitude:
10-2 means that 1 time in 100 the action fails to achieve its intended result;
10-3 means that 1 time in 1,000 the action fails to achieve its intended result;
10-4 means that 1 time in 10,000 the action fails to achieve its intended result.
One can also use a related measure of reliability, for example time or counts between failures:
transplant cases between organ rejection;
days between unplanned admissions to ICU;
days between pressure ulcer, falls, and line infections;
employee work hours worked between lost-time injuries.
Using these measures, we can classify the degree of reliability, as indicated in Table 10.2.
Recognizing the human element in care provision is essential if we want to move towards a more
reliable system-based care. Practical ways to improve reliability include the use of human factors
theory (see Chapter 9) and simple tools designed to act as enforcers of reliable processes. With
these we can achieve a high degree of reliability. Examples are:
The introduction of decision aids and reminders that are built into systems. These need to be
reviewed and revised regularly, as the brain learns to ignore them in time.
The development of evidence-based processes that ensure that the desired action is the default
action. This guarantees that there is no other way to complete a certain task or process.
The implementation of redundant processes that ensure that a given action is reliable. A good
example is the double-checking of a prescription by another person, independent of the
prescriber, to ensure that the prescription is correct.
The careful examination of the process flow and the subsequent redesign around the habits of
providers.
This implies that we need to design the processes of care to achieve reliability. In Figure 10.2 the
conceptual approach is shown and in Table 10.3 examples of actions to take at each level are
indicated.
Standardization
The most important way to improve the reliability of a facet of care is to standardize the care
process. Standardization:
is based on the clear specification and articulation of the desired process;
should be agreed by all those who will use the process; and
must be subject to scrutiny and study to be assessed for variability.
Care bundles
Top tips
Practical steps to improve reliability:
Study the process carefully.
Draw a detailed process map of what happens.
Compare it to what is supposed to happen.
Measure whether the steps in the process deliver the desired outcome (e.g. medications on time
every time).
If something is not reliable, ask why.
Redesign and test a new process with one patient at a time.
Measure against the old process.
Spread the new process gradually, as reliability is achieved.
Summary box
Reference
Further reading
Chassin, M. R. and Loeb, J. M. High-reliability health care: Getting there from here. Milbank
Quarterly 91.3 (2013): 459–90.
Health Foundation. Evidence Scan: High Reliability Organisations. 2011, November.
https://www.health.org.uk/sites/default/files/HighReliabilityOrganisations.pdf.
Pronovost, P. et al. Creating high reliability in health care organizations. Health Services
Research, 41 (2006): 1599–617.
Chapter 11
Resilience theory, complexity science, and Safety-II
Safety in healthcare
The challenge: ensuring safety in complex systems
Safety-II and resilience
Applying resilience and Safety-II thinking
Summary box
Key points
• Traditionally, safety in healthcare relied on linear assumptions and solutions—such
as restructuring processes to minimize human error, constraining behaviours, or
standardizing procedures.
• The approach is challenged by the recognition that healthcare behaves as a complex
adaptive system.
• In line with this, resilience engineering suggests that humans, with their ability to
adapt their own behaviour to changing conditions, are an important resource for
maintaining safety in the system.
• The application of resilience ideas to healthcare includes the disjuncture between
work-as-imagined and work-as-done and Safety-II, an approach that focuses on how
and why things go right, rather than paying attention exclusively to the occasions
where things go wrong (Safety-I).
• Two methods for examining resilience in healthcare are considered here, namely the
resilient assessment grid and the functional resonance analysis method.
Safety in healthcare
Safety, as approached by most healthcare systems worldwide, has traditionally relied on beliefs
that adverse outcomes can be explained by linear cause–effect chains, as originally proposed by
the domino effect and later, by Reason’s Swiss cheese model.
This approach is underpinned by the assumption that adverse outcomes, whether mild or
serious, have causes that can be found and fixed, and that these differ from the causes of
ordinary, successful care. This assumption has had consequences for how adverse events have
been investigated. The focus has been on identifying specific components that failed, for instance
via root cause analysis (RCA); and a consequent regime of reactive safety management
ALGRAWANY
procedures followed—such as enforcing compliance with policies and processes. From this
perspective, humans, acting alone or collectively, appear predominantly as a liability or hazard.
However, healthcare is much more complex than this approach to safety suggests and few
ultimate sources of problems are amenable to simplistic fixes.
More recently, there has been a shift towards complexity-based safety thinking, where safety
is no longer viewed as a static product or service but as an emergent property in a complex
adaptive system (CAS). Healthcare is increasingly being recognized as a CAS, which functions
in a non-linear fashion and is composed of interdependent and interacting parts (e.g. clinicians,
patients, equipment). This means that cause and effect are not always linked in a predictable
manner; they are mediated through all the complexities.
There are many challenges to maintaining safety within a complex system. Traditional responses
to safety focus retrospectively, addressing adverse events or restructuring systems or processes
so as to minimize human error, or by attempting to constrain behaviours and standardize
procedures.
But this traditional approach does not align with what actually happens in clinical practice,
which represents the dynamic, ever-changing nature of health settings; nor does it take into
account the inherent interdependencies and connections between various parts of the system.
Health professionals constantly adjust their practices to changing conditions; they do not realize
safer care by slavishly following guidelines or policies. For example, many areas in health are
chronically understaffed and people must work within the constraints imposed by this situation,
which sometimes means fluctuating numbers of staff with differing skill sets.
Changing service demands also introduce unanticipated challenges: for example, multiple
trauma patients arriving en masse at an emergency department, or increased demand for isolation
beds during a difficult Clostridium difficile outbreak can seriously stretch the resources. The
intricacies of the context add so many variables to the equation that simple directives or
procedures (e.g. standard operating procedures) with instructions to follow them faithfully are
not sufficient for managing safety effectively.
A related challenge is how the work of safety is conceptualized. The complexity of the health
system means that the way in which the work of keeping patients safe is imagined to occur rarely
comes close to the reality of its occurring. The concepts of work-as-imagined (WAI) and work-
as-done (WAD) seek to highlight this discrepancy and provide a useful framework for
addressing it. WAI refers to how work is planned and thought through before acting, while WAD
refers to the actual carrying out of that work. Those who develop policies and directives distant
from the clinical “coal face” are sometimes derogatively thought of as producing WAI, but even
work planned by those at the bedside may not adequately account for the unpredictable variables
and for the web of interactions within a complex health system. And it is a truism that no one
doing WAI can predict all the things that can happen on the front lines of care. No one could
write a policy manual to cover so many contingencies—and no clinician would have the time to
consult it, anyway.
When applying any tool, whether it be based on Safety-I or Safety-II thinking, we need to ensure
that it is the right tool for the job. Process-oriented tools—such as RCA, standardization of
procedures, or checklists—are very effective in a Safety-I space, where problems are well
characterized and outcomes predictable. By mandating that workers follow the prescribed
guidance, we can minimize variation in work and achieve consistent performance. But these
approaches do not work in a Safety-II environment, where both the required objectives and the
context of the work can and do change rapidly and unexpectedly. To develop effective solutions
in a complex system that is dynamic and unpredictable, we need new tools and a goal-oriented
approach rather than a process-oriented one. Allowing healthcare professionals to operate within
broad goals but not overprescribing their work will give them space to flex and adjust, so as to
meet unexpected challenges and achieve the desired aims.
This brings us to a key question. Can we measure the resilient potentialities or properties of a
system? It is not possible to measure resilience prospectively, but we do have methods for
obtaining proximal measures that assess team or organizational behaviour in a way that will
predict their tendency to exhibit resilient behaviours when challenged. Two methods that have
shown promise in this regard are the resilient assessment grid (RAG) (see Box 11.1) and the
functional resonance analysis method (FRAM) (see Box 11.2).
Within the four abilities and subvariables are nested a series of probing or diagnostic
questions, which should be developed specifically for the organization to be studied, and are
answered on a six-point Likert scale (‘excellent’, ‘satisfactory’, ‘acceptable’, ‘unacceptable’,
‘deficient’, ‘missing’).
The answers to the probing questions can be quantified, and the results aggregated to derive
an overall resilience rating. The answers can also be used to construct a resilience profile
(usually presented as a web chart), in which a high aggregated score and a balanced web chart
(i.e. scores for all elements towards the perimeter of the chart) indicate that the organization is
likely to be resilient if challenged.
Example, taken from the work of Damen et al. (2021), shows how the FRAM can be used to
understand the differences between WAI and WAD in a clinical department. This understanding
can then be used to better align procedures so as to enable clinicians to flex and adjust to
changing circumstances in ways that are safe for patients.
The study was conducted at two cardiothoracic surgery departments, one in Australia and one
in Europe, around patient anticoagulation procedures associated with surgery. The WAI FRAM
was developed from international guidelines. The FRAM was modified to show pathways for
WAD using data derived from semi-structured interviews with eighteen healthcare professionals
who were involved in anticoagulation processes.
The analysis provided a clinical view of preoperative anticoagulation management overlaid on
the institutional view, and highlighted some of the everyday practical considerations that led to
variability in relation to the guidelines. While the implementation of the modelling tool revealed
a number of places where clinicians did not follow processes that aligned with international
guidelines, it provided insights into why this might be the case and offered some suggestions as
to what to do about it.
Summary box
• Healthcare is a complex adaptive system; this makes the control, prediction, and
understanding of cause and effect difficult.
• Resilience is a system’s capacity to maintain performance in response to variable
conditions. Humans are an important resource for system resilience.
• Traditional safety management (Safety-I) focuses on the few occasions where things go
wrong. This leads to an increasing disconnect between WAI (by managers, policymakers)
and WAD (by frontline staff).
• Safety-II, on the other hand, encourages us to gain a deep understanding of everyday
clinical work and system resilience by focusing on the cases, usually taken for granted,
where things go right.
• The FRAM and the RAG are two tools that assist in the study of resilience.
In the real world on the front lines of care, clinicians have always flexed and adjusted their
practices, accommodating to the demands placed upon them, whether they are stimulated by
patient needs, resource constraints, technological limitations, test delays, deficits in the team,
poor cultures, or systems that are not completely fit for purpose.
Concepts drawn from resilience engineering and complexity theory help us to understand
better how healthcare works and what keeps patients safe. Policies, guidelines, standard
operating procedures and regulations have a place, but are not ultimately definitive in
describing how clinical work is done.
The Safety-I paradigm has helped us to think how care can be delivered if everything goes
to plan and has supported efforts to reduce harm whenever it occurs in a stable, predictable
environment. The Safety-II paradigm has drawn our attention instead to the actual work that
keeps patients safe and has encouraged us to focus on what makes things go right when care is
delivered under pressures and demands.
References
Further reading
Braithwaite, J., Wears, R. L., and Hollnagel, E. (eds). Resilient Health Care: Reconciling Work-
as-Imagined and Work-as-Done. Boca Raton, FL: CRC Press, 2016.
Braithwaite, J., Wears, R. L., and Hollnagel, E. Resilient health care: Turning patient safety on
its head. International Journal for Quality in Health Care 27.5 (2015): 418–20.
Heinrich, H. W. Industrial Accident Prevention: A Scientific Approach. New York: McGraw
Hill, 1941
Hollnagel, E., Braithwaite, J., and Wears, R. L. (eds). Delivering Resilient Health Care. London:
Routledge, 2018.
Hollnagel, E, Wears, R. L., and Braithwaite, J. From Safety-I to Safety-II: A White Paper. The
Resilient Health Care Net/University of Southern Denmark, University of Florida, USA, and
Macquarie University, Australia, 2015. https://www.england.nhs.uk/signuptosafety/wp-
content/uploads/sites/16/2015/10/safety-1-safety-2-whte-papr.pdf.
Hollnagel, E. and Woods, D. D. Epilogue: Resilience engineering precepts. In E. Hollnagel, D.
D. Woods, and N. Leveson (eds), Resilience Engineering: Concepts and Precepts. Aldershot:
Ashgate, 2006, pp. 347–58.
Iflaifel, M. et al. Resilient health care: A systematic review of conceptualisations, study methods
and factors that develop resilience. BMC Health Services Research 20 (2020): 1-–21.
Johnson, A., Clay-Williams, R., and Lane, P. Framework for better care: Reconciling approaches
to patient safety and quality. Australian Health Review 43 (2019): 653–5.
Nyssen, A. and Bérastégui, P. Is system resilience maintained at the expense of individual
resilience? In J. Braithwaite, R. L. Wears, and E. Hollnagel (eds), Reconciling Work-as-
Imagined and Work-as-Done, Boca Raton, FL: Taylor & Francis, 2017, pp. 37–46.
Sujan, M., Spurgeon, P., and Cooke, M. The role of dynamic trade-offs in creating safety: A
qualitative study of handover across care boundaries in emergency care. Reliability
Engineering & System Safety 141 (2015): pp. 54–62.
Wears, R. L., Hollnagel, E., and Braithwaite, J. (eds). Resilient Health Care: The Resilience of
Everyday Clinical Work. Surrey: Ashgate, 2015.
Part 2
Practical application and methodologies of patient safety
Key points
• Measurement is the foundation of improving the safety of the clinical process.
• Measurement is done at national, regional, local, and team levels.
• Data can be collected routinely or for a specific programme.
• Clinical teams will benefit from measures that are relevant to them and to the
patients.
• All measurements should tell a story and should lead to improvement in care.
This chapter presents an overview of measuring patient safety at national, organization, and
system level. The measurement of safety varies according to the level one works at. These
definitions are fluid, depending on one’s specific context, but the key is always to measure for
learning.
ALGRAWANY
• administration of medication by the wrong route
Patient-reported measures
Patient feedback and input are invaluable for the identification of harm; moreover, the
involvement of patients encourages person-centred care (Box 12.2).
Patient feedback can identify good practice, contribute to the sharing of learning, and encourage
improvement.
Patient-reported measures focus on event-predisposing factors, on circumstances of harm, and on
the management of the harm incident.
Everyone can see the services response and the implemented changes.
To understand the level of avoidable harm and to identify areas for improvement requires more
than one single measurement.
Before choosing patient measures, it is important to understand the system in which
improvement will be delivered.
Measurements should be relevant to the user, and the choice of measurement will vary
depending on setting, locality, and country.
When selecting what to measure, involving key stakeholders is vital for ensuring continuous
engagement and for creating a positive safety culture.
Measurement selection can involve patients, healthcare professionals, management teams, and
policy makers.
Co-production of measurement with patients and frontline staff is beneficial.
Each system can learn from other systems, but each system should purposively select the
measures of patient safety that are most relevant and useful to its context.
National-level data
There are several metrics that are commonly used at a national level for monitoring, learning,
and improvement.
There is continuing debate about the use of HSMR and the results should be considered with
caution. But the primary role of HSMR is to identify areas that warrant further investigation.
The results should be investigated locally, with the help of supplemental data, in order to
establish what other factors may cause variation in the data.
The variation may or may not be related to the quality of patient care; issues such as data quality
can also contribute to changing the HSMR.
HSMR can help teams to focus on areas that require improvement or, conversely, on areas to
learn from.
Reviewed over time, HSMR can help systems, organizations, and national bodies to find out
whether their improvement work results in a reduced number of preventable deaths.
HSMR should not be used to rank hospitals or health systems but can be used to learn from one
another and to aid improvement.
Hospital-associated infections
Several hospital-associated infections are measured at the national level and are reported as the
number of cases per 1,000 acute occupied bed days:
Staphylococcus aureus bacteraemia (including MRSA);
Clostridium difficile;
Escherichia coli.
Organization/system level
Organizations and systems could use the metrics described for the national-level data; but they
may also include measures that are relevant to their clinical practice.
Here are some examples of local organization and system measures:
the perspective of patients and their families;
measures of the reliability of critical safety processes;
information on practices that encourage the monitoring of safety;
information on the capacity to anticipate safety problems;
information on the capacity to respond to and learn from safety data;
data on staff attitudes, staff awareness, and feedback from staff;
mortality rate indicators;
data on predefined standards;
incident reports and reporting levels;
reports on excellence.
Each clinical area should define its own measurement strategy as well as that of the organization
and of the national system, according to the type of clinical care delivered. (For examples of
measures, see Box 12.5; see also the case study in Box 12.6.).
Surgical ward
• surgical site infections
• excessive starvation before surgery
• return to the operating room
• pressure ulcers
• urinary tract infections
Ideally, frontline safety data should contribute significantly to systematic, organizational, and
national measures of patient safety. Benchmarking for patient safety is extremely challenging,
except at the high levels outlined in national metrics.
Summary box
Top tips
• Measures must be easy to collect.
• Measures must be relevant to both patients and staff.
• Harm must be recorded in real time.
• Have several measures that reflect the function of the system.
• Focus on what works well as well as on what does not.
• Measures must tell you how the system is working.
• Display measures openly and in a way that can be understood.
• To enable assessment and learning, data can be displayed in different ways.
• Safety crosses are a visual demonstration of the incidence of a designated harm.
• Run charts as time series analysis.
• Use statistical process control charts for statistical analysis.
• Discuss data daily, at safety huddles or meetings.
Further reading
Key points
• Clinical teams can improve outcomes only if they measure their own day-to-day
performance.
• The Vincent framework for measuring and monitoring safety gives clinical teams,
managers, and executives the opportunity to measure performance in a way that can
improve the safety of care.
• The framework is used daily by teams.
• The model assesses the safety of care from the perspective of reliability, human
factors, and resilience theories.
• Harm can be measured in several ways and is represented on tools such as the safety
cross, on run charts, and on statistical control charts.
In healthcare, measurement systems are typically designed to serve the needs of administrators,
regulators, academics, and others, who use data for billing, assurance, or research. Frontline staff
gathers and uploads data that it may never see again, although occasionally these data are used to
judge or admonish staff members.
An alternative view of measurement, proposed by patient safety science, is founded on the
belief that data are critical to understanding problems and to guiding their solutions. This view
also suggests that no one is better positioned to benefit from measurement for improvement than
the people working on the front line of healthcare.
A good frontline safety measurement system requires just enough data to inform users in a
timely way about important processes, cultural indicators, and outcomes. It should also be able to
provide rapid feedback on the “tests of change” that are required to design and improve care.
(Improvement Chapter 14)
Ideal frontline measurement systems are co-produced with those staff members (and, where
applicable, service users) who input and extract data, ensuring that measures are usable and
useful. A good design principle for an effective frontline measurement system is that it should be
easy to use; the ease with which one can gather, input, display, and interpret the data is
important.
Another feature is that the data should reach those who make day-to-day changes as quickly
and clearly as possible. Later on these data can be repackaged to meet regulatory purposes, if
required. To maximize reach and impact, the outputs of such measurement systems should be
shared openly and transparently, including with the patients and their families.
There is no single metric that can fully express the complexity of safety, so a portfolio of
measures is required if we want to give an accurate picture.
Traditionally safety has been measured by the absence of harm. While harm may indicate a
deficit in safety, this is not the only measure of safe care. Considering safety as something that
an organization does rather than has suggests that measuring safe practices and their outcomes is
important.
Safe practices—for example care bundles for the prevention of central line infections or for
team communication—can be measured and used to predict safe outcomes. It is also possible to
examine the shared beliefs and attitudes of practitioners and the culture of safety, all of which
influence the way people behave (Safety Culture Chapter 3).
Organizational knowledge of safe practice and culture obtained from measurement and
feedback also supports learning and guides improvement efforts. This broader view of safety
measurement allows us to ask not only whether we have been safe but also whether we are safe
now and will we be safe in the future.
The Health Foundation’s framework for measuring and monitoring patient safety, also known
as the Vincent framework (see Figure 13.1), suggests a portfolio of five measures:
The goal of the framework is not only to provide assurance (a goal related to past harm) but
also to address potential harm through a proactive management (reliability, sensitivity) of risk
rather than a reactive management of incidents. The key approach is real-time action
(anticipation and preparedness) and learning (integration), prompted and guided by the data
collected in each part of the framework.
Knowledge of past harm is important for the provision of assurance, but it is also a valuable
means for frontline teams to understand harm and generate ideas for improvement. Rather than
looking at individual harm events for preventability, looking across all events for common risks
and themes helps to understand the processes of care involved and what potential solutions there
are. Tools such as root cause analysis (RCA) and the 5 WHYs may be helpful in this endeavour,
but need to be used cautiously (Clinical Incident Chapter 16).
Measuring safety practices such as the reliable use of early warning systems or situation
awareness shared through huddles and team communication serves to enhance operational
sensitivity.
At a system level, safety walkrounds by senior staff can allow clinical teams to report their
views on patient safety, so that there is an alignment of the understanding of real-time safety. It
is important to be able to measure and act on this safety intelligence in a timely way, which
effectively benefits the local department.
Integration and learning: Are we responding to, and improving from, safety
information?
The measurements discussed so far add value and benefits for clinical teams and, ultimately for
patients, if there is reflection on and learning from what the data are saying. In this way reliable
safe care can develop and spread throughout a system.
Learning also needs qualitative measures that take into account the views and experiences of
staff, patients, and families. Qualitative data can provide information on their own; they may
help in triangulation with other, more objective measures or they lend emotional weight to the
reasons why addressing safety is important. Such effects can be achieved through storytelling or
through structured narratives such as after-action reviews (AARs), where collective experience
and sense-making are used to understand events.
Another approach comes from the learning from excellence community (Learning from
success Chapter 15), which has pioneered the reporting of excellence from the front line in order
to elevate episodes of good practice, kindness, and positive action as events to be celebrated and
learned from. Learning from what works well and measuring it is crucial: teams learn how a
certain process generates a certain result, and thus they get to replicate it.
Front line measurement does not need to be complicated. Technology may be useful in the
gathering, analysis, storage, and display of information, but it is by no means essential and
should be considered only for its additional value.
As important as measuring is, the means by which data are analysed and communicated is
more crucial and will determine its impact. Box 13.2 contains some examples of effective
measurement and reporting tools, which can be deployed on paper or used in conjunction with
some rudimentary information technology, to share information that can influence decisions and
shape behaviour.
The safety cross presents data in a cross-shaped matrix that represents a calendar Figure
month of recording a selected metric, such as medication errors or falls. Additional 13.2
information, for example severity, is displayed through colour or shading. This tool
offers real-time incidence data that raise a team’s awareness of the incidents tracked
in this way.
A reliability matrix is a simple tool for recording elements of a care bundle (CB) or Figure
any set of processes where the goal is to deliver all the elements every time. The 13.3
matrix can be used for small samples and simple measures if each element has been
delivered. It allows for simple calculations—such as the performance of each CB
element, which helps to decide where to focus quality improvement (QI) efforts, and
the full bundle delivery (i.e. how many patients received all the CB elements they
should have received) as a measurement of the reliability.
A run chart is a time series analysis that visually demonstrates variation in Figure
processes or outcomes. In small samples (e.g. the daily or weekly number of line 13.4
infections or medication errors), data are plotted over time, to demonstrate the
process performance. There are four common rules for highlighting non-random
variation: a shift (six or more consecutive data points, all above or all below the
mean), a trend (five or more consecutive data points, all going up or all going
down), too many or too few runs, and astronomical points (obviously very different
from the other values). For rare events (i.e. events in which 50% or more of the data
points represent extreme values of the scale), days in between events may be more
useful.
A statistical process control chart (SPC) adds statistical limits to the run chart. Figure
This allows one to differentiate between a normal, common cause of variation in the 13.5
system and a special cause (as shown in Figure 13.5), which is the result of some
atypical event or influence and requires a specific response.
Figure 13.2 Safety cross.
Figure 13.5 Statistical process control (SPC) chart of falls per month.
Summary box
Reference
The Health Foundation. The Measurement and Monitoring of Safety. Spotlight 2013.
https://www.health.org.uk/sites/default/files/TheMeasurementAndMonitoringOfSafety_fullversion.pdf
Further reading
Borzecki, A. M. and Rosen, A. K. Is there a ‘best measure’ of patient safety? BMJ Quality &
Safety 29 (2020): 185–8. https://qualitysafety.bmj.com/content/qhc/29/3/185.full.pdf.
Chapman, S. M. et al. Prevalence and severity of patient harm in a sample of UK-hospitalised
children detected by the Paediatric Trigger Tool. BMJ Open 4.7 (2014): e005066.
https://doi.org/10.1136/bmjopen-2014-005066.
Chatburn, E. et al. Measurement and monitoring of safety: Impact and challenges of putting a
conceptual framework into practice. BMJ Quality & Safety 27 (2018): 81826.
https://doi.org/10.1136/bmjqs-2017-007175.
Hibbert, P. D. et al. The application of the Global Trigger Tool: A systematic review.
International Journal for Quality in Health Care 28.6 (2016): 640–9.
https://doi.org/10.1093/intqhc/mzw115.
Lachman, P. et al. Developing person-centred analysis of harm in a paediatric hospital: A quality
improvement report. BMJ Quality & Safety 24.5 (2015): 337–44.
http://dx.doi.org/10.1136/bmjqs-2014-003795.
Macrae, C. The problem with incident reporting. BMJ Quality & Safety 25 (2016): 71–5.
https://qualitysafety.bmj.com/content/25/2/71.
Peerally, M. F. et al. The problem with root cause analysis. BMJ Quality & Safety 26 (2017):
417–22. https://qualitysafety.bmj.com/content/26/5/417.
Perla, R. J., Provost, L. P., and Murray, S. K. The run chart: a simple analytical tool for learning
from variation in healthcare processes. BMJ Quality & Safety, 20(1) (2011): 46–51.
https://doi.org/10.1136/bmjqs.2009.037895
Vincent, C., Burnett, S., and Carthey, J. Safety measurement and monitoring in healthcare: A
framework to guide clinical teams and healthcare organisations in maintaining safety. BMJ
Quality & Safety 23 (2014): 670–7. http://dx.doi.org/10.1136/bmjqs-2013-002757.
Chapter 14
Practical approaches to safety improvement
Key points
• To improve the safety of clinical processes optimally, an understanding of
improvement methodology is required.
• Combining theories of patient safety (such as human factors, reliability, and
resilience) with the methods of improvement science can create conditions for the
improvement of safety.
• Engaging the clinical team and patients is the first step.
• Studying the process, as well as measuring process and outcomes, will provide
opportunities to improve.
• Through the use of small tests of change, learning and improvement can take place.
Healthcare systems are complex and adaptive. Failures resulting in unsafe care may be the result
of complex interactions between human and environmental factors. Learning from failure and
from success is essential to improving safety. We must always keep in mind that a failure to keep
a patient safe reflects on the entire system, its people and processes, and can create an
opportunity for improvement. Learning from success shows what is possible and how we
replicate it.
All healthcare professionals have a role to play in ensuring that health services are safe and of
a high quality. This requires an understanding of how outcomes are achieved. A learning
organization (or clinical team) will measure its outcomes over time and continually improve in
order to provide ever more reliable care. Meaningful and lasting change requires that all those
involved in healthcare, at every level—clinicians, patients, managers, researchers, and planners
—work together to transform care systems for the benefit of patients and providers. Effectively
improving quality requires the understanding and application of improvement methodology.
These measurements can be taken during a defined period, such as the previous twenty-four
hours. To measure over time, use a run chart, SPC chart, or a safety cross. Evaluate the reliability
of clinical processes, as variation presents an opportunity to improve.
Using a human factors and resilience approach, assess whether you are safe now and whether
the service will be safe in the future. This is best achieved by completing the first two steps and
gathering information in real time so as to develop situation awareness among the team.
Appraise the learning process and how knowledge is managed and transferred. This is an
essential part of improving care, as well as an opportunity to engage the team.
To aid the improvement process, further definition of the problem occurs through the
following steps.
People in the system. How do they behave and interact? For example, do they follow
standing operating procedures reliably or not? Do they measure performance? Time spent
engaging the team will facilitate this step (see the previous step).
Patients receiving care and their specific needs. Often improvement projects “do” things to
patients rather than working with them to improve the process.
The environment within which people work and its impact on safety. These components are
important. Interventions should be tested and adapted to the specific context in which they
will be applied.
The tasks that are completed and how they are undertaken.
The tools and technology required to perform a given task and their effect on how work is
ALGRAWANY
done.
The way the work system is organized. Does it measure performance? Is there a common
purpose, in other words is it the case that everyone knows what the purpose is and how they
must work to achieve desired outcomes? This feature is determined by leadership within the
team.
Useful tools to build understanding include the fishbone diagram. Broad and deep understanding
can in turn be used to develop the aim statement and the theory of change, as represented in a
driver diagram.
Measure variation
Measurement is a key aspect of understanding processes and their outcomes, that is, what
happens to a patient or member of staff. Measurement over time allows dynamic and ongoing
understanding throughout the improvement process. It is important to start by measuring the
baseline, so that you can assess the extent of improvement when you implement a change.
Baseline measurement can begin with a clinical audit, either when you identify the problem (the
first of our eight steps) or when you study the work system (the third step).
Careful study and measurement of a process facilitates the identification of unwarranted
variation. Variation in the process creates unreliable and often unsafe care; a few examples are:
A key part of improving outcomes is to improve the reliability of the process. Process variation
can be studied and analysed using a run chart or SPC chart.
Sometimes a specific patient condition may require variation. This is then warranted variation.
The aim of an improvement initiative is defined by asking: ‘What are we trying to accomplish?’.
The answer to this question directs the desire and will to change; ‘what’ is the thing that needs to
be improved. Aims need to be SMART, that is specific with regard to what is to be improved,
measurable, achievable, relevant (i.e. answer ‘why’ the change is needed) and timebound (i.e.
specify by when date the improvement will be achieved).
The question ‘How will we know that a change is an improvement?’ captures measurement as a
foundation of improvement. Its answer incorporates the baseline and progress in processes and
outcomes over time (see the step on measure variation).
The third question, ‘What changes can we make that will result in improvement?’, captures the
point where your understanding of the work system (the third step) allows the identification of
potential tasks to perform and changes to test.
The cycle plan, do, study, act (PDSA) provides the answer to the ‘how’ question: it tells us
how change is made. PDSA cycles use small, rapid cycle changes designed to test and measure
impact, then test again, in a much faster and more proactive manner than the traditional audit
cycle. While the PDSA cycle may initially appear unfamiliar to the practising clinician, it is
essentially similar to the differential diagnosis and management plan within clinical practice. The
‘plan’ phase is derived from the differential diagnosis and the theory of the possible illness the
patient may have. This leads to a planned treatment. The ‘do’ phase consists of implementing the
treatment plan or the solution to be tested. The ‘study’ phase consists of determining whether the
treatment plan or the solution (or test) has worked. And finally the ‘act’ phase is the point where
we determine whether to continue with our treatment plan and solution or we try something new:
we choose between adopt, adapt, or abandon.
Hardwire the changes into the system and spread the learning
The improvement that is achieved is unlikely to be sustained until it is hardwired into the system
—that is, until it becomes the way work is done by everyone involved. To achieve sustainability,
the new process must be relatively advantageous to the patient and to the clinical staff and must
not be more difficult to do. Sustainability depends on having local champions, as well as an
ongoing measurement of the process and of its outcomes. It is important to pay attention to the
fidelity of the change-in other words to register whether the improvement was due to specific
changes and how they were implemented.
It is important for successful change projects to be spread, so that others with the same
problem can learn from your experience and adapt it to their own context. Successful
improvement in one area and the methodology used can help with the design of future change
and facilitate improvements in other areas.
Problem
In an ICU, a patient experienced an adverse event. Through root cause analysis (RCA) it was
found that the prescription process was unsafe, as prescribers were not reliably following all of
the steps required.
Engagement
A consultant decided to improve the process and engaged the clinical team. A
multiprofessional improvement team was formed that included a patient representative.
Baseline measures
Baseline measures of prescribing errors showed an error rate of 30% over a 1-week period; a
random selection of 5 charts were assessed every day.
People: the prescribers were doctors, ranging from junior to senior trainees. Several nurse
practitioners also had prescribing privileges.
Patients: the patients ranged from the elderly to relatively fit young adults, all with different
pharmacokinetics.
Environment: the environment was busy and noisy, as prescribing took place anywhere on the
unit.
Tasks: the drugs were complex and not all staff members felt comfortable prescribing.
Tools: the tools required were a calculator, a formulary, a list of commonly used drugs, and
standard operating procedures.
Organization: patient safety was identified as being important, but prescribing was not seen as
a priority.
Design idea
Using a human factors concept, it was decided to adopt a ‘sterile cockpit’ in which all
prescribing would take place. It was envisaged that all the tools for prescribing would be
available and that interruptions would not be allowed once a prescriber was in the defined area.
• The aim was to make all prescriptions 100% accurate by December 2021.
Sustainability
Using a structured improvement approach, the aim was achieved: prescribing errors were
eliminated and the number of days between adverse events was increased.
Summary box
Reference
Vincent, C., Burnett, S., and Carthey, J. The measurement and monitoring of safety. Health
Foundation, April 2013. https://www.health.org.uk/publications/the-measurement-and-
monitoring-of-safety.
Further reading
Key points
• We have more good care than harmful care.
• Learning can be achieved by looking from the ‘bright spots’ of success just as much
as by looking from clinical incidents.
• Learning from excellence can build psychological safety and resilience.
• Techniques such as appreciative inquiry can assist in developing a learning
organization.
Figure 15.1 graphically illustrates the consequence of defining safety in terms of failure. In this
hypothetical illustration, the failure rate is 10% (which is consistent with some healthcare safety
research). While significant, failure is a much less frequent outcome than success, so its rate is
lower. Despite this, the prevailing endeavours to improve safety focus on the domain of failure.
Figure 15.1 The consequence of defining safety in terms of failure.
Although success is significantly more prevalent than failure, it can be harder to identify.
Reasons for this paradox include:
the negativity bias, which is a human tendency to display higher sensitivity and stronger
awareness in relation to failure than in relation to success;
habituation, which is a human tendency to become less sensitive to events or phenomena that
occur frequently: since success is a more frequent occurrence than failure, we have a tendency
not to notice it or to take it for granted;
the fact that failures are defined, classified, and measured as part of a regulatory framework (e.g.
fall rate, healthcare associated infection rate, never events), whereas success is not well defined
(usually it is seen as the absence of failure);
the nature of work in healthcare, which is to diagnose and treat illness: this ‘find and fix’
approach is naturally translated to patient safety and quality improvement.
Box 15.1 Methods that can be used in order to learn from success
Appreciative inquiry
This is a strengths-based approach to organizational development and is based on a semi-
structured interview protocol. An example of interview protocol will follow.
Exnovation
This is a process by which staff members demonstrate and discuss day-to-day practices,
uncovering ‘hidden competence’ within a system for the benefit of shared learning.
Positive deviance
This is the identification of unusually successful behaviours within a community. It generates
and tests hypotheses about the cause of success, and this is followed by wider dissemination
across the community.
Summary box
Signpost
Further reading
Kelly, N., Blake, S., and Plunkett, A. Learning from excellence in healthcare: A new approach to
incident reporting. Archives of Disease in Child 101 (2016): 788–91.
Smaggus, A. Safety-I, Safety-II and burnout: How complexity science can help clinician
wellness. BMJ Quality & Safety 28 (2019): 667–71.
Chapter 16
Investigating and learning from adverse events
Introduction
Adverse events
Adverse event management
Reporting
Incident reports
The systems approach to safety and the role of contributory factors
Just culture
The role of patients and families in investigation
Investigation recommendations
What is different about investigations in other industries?
Case study
Key points
• The main purpose of a clinical incident investigation is to learn from the incident and
to implement changes so as to make a difference.
• Clinical incidents are in the main a reflection of how a system works.
• A just culture will hold people accountable, though in a fair way and without blame.
• Patients should be involved in the process, with candour and transparency, as the
foundation for investigations.
• Learning from the investigation will require constant feedback to clinical teams and
across the system.
Introduction
The aim of investigating adverse events is to understand what has happened, why it has
happened, and what can be done to reduce the risk of similar events in the future. Investigations
also serve to provide an explanation of adverse events for patients and families.
There are various structured methods for investigating adverse events, but root cause analysis
(RCA) is the one most widely used in healthcare. This method aims to determine the timeline of
events, identify any root causes and contributory factors, and produce recommendations to
reduce future risk.
RCA has faced criticism, partly because there is rarely a single root cause for an adverse event
and partly because many RCAs focus disproportionately on the actions of individual clinicians
and frontline staff. This risks ignoring the many latent and systems factors that are present in
almost all adverse events and contribute to them. When done well, RCA does attempt to explore
the deep reasons for an adverse event, and some tools (e.g. fishbone diagrams; see Figure 16.1)
may help us to understand its contributory factors.
Figure 16.1 The fishbone diagram
Other safety-critical industries (e.g. aviation, or nuclear power) have moved away from linear
analysis models such as RCA to ones that draw on the knowledge of human factors and on safety
science. They recognize that, while a small percentage of adverse events may be attributed to
egregious or reckless actions of individuals, most are due to failures in the wider system. These
industries have become progressively safer partly because their investigations focus on the wider
systems in which human error occurs rather than just on the actions of frontline staff.
Taxonomy
WHO has commissioned the development of an international taxonomy for patient safety in
order to promote greater standardization of terminology and classification. The source for the
material presented in this section is WHO 2005.
Adverse event
An adverse event is an injury related to medical management, in contrast to complications of
disease (see Reason 1990). Medical management covers all aspects of care, including diagnosis
and treatment, failure to diagnose or treat, and the systems and equipment used to deliver care.
Adverse events may be preventable or non-preventable.
Incident
An incident is any deviation from usual medical care that causes an injury to the patient or
poses a risk of harm. This category includes errors, preventable adverse events, and hazards.
Near-miss
A near miss is a serious error or mishap that has the potential to cause an adverse event but
fails to do so through chance, or because it is intercepted.
Error
Error falls into several categories. An error of execution is the failure of a planned action to be
completed as intended; an error of planning is the use of a wrong plan to achieve an aim (see
Hiatt et al. 1989). Errors may be errors of commission or omission, and usually reflect
deficiencies in the systems of care.
Adverse events
International research shows that 10% to 15% of the patients admitted to general hospitals suffer
an adverse event, of which around half are thought to be preventable. About 10% of these events
cause severe harm or death. Medication errors, problems arising during surgery and procedures,
and deficiencies in monitoring and in the processes of care delivery are the most common types.
Primary and community care have been the subject of less research, but existing data suggest
that adverse events are common in these settings as well.
If an adverse event occurs, a clinician’s first actions should be to take whatever immediate steps
are necessary to ensure that the patient is safe and that every harm has been dealt with or
mitigated.
The clinician should immediately alert colleagues and superiors and seek help from them if
necessary.
Clear documentation of events and any mitigating action will be helpful for subsequent
investigation.
Any equipment involved in the event (e.g. empty syringes or drug vials) should be collected and
retained.
Debriefing as soon as possible after an adverse event has been shown to be beneficial. It enables
risk assessment and management to take place so as to protect other patients from any immediate
outstanding risk.
Clinicians should recognize that they themselves can suffer significant psychological trauma
after involvement in an adverse event (the ‘second victim’ phenomenon). This psychological
effect can harm their health and lead to increased risk to patients. If clinicians are concerned
about this, they should bring it to the attention of supervisors and colleagues.
Clinicians have a professional responsibility, and in some jurisdictions a legal one, to offer an
apology to patients and their families, with an open and transparent explanation of what
happened. This should usually be done by a senior, experienced member of the team.
An apology does not constitute an admission of legal liability and has been shown to reduce
subsequent risk of complaints or litigation.
Action to reduce the risk of adverse events can be taken only if incidents are reported and
investigated. Clinicians involved in adverse events should seek help to report these using
whatever local systems exist.
Reporting
Incident reporting in healthcare has been adapted from an approach used in aviation, where
frontline staff are encouraged to report incidents in order to initiate investigations. Sometimes
these incidents can be reported anonymously or confidentially.
Staff members are also encouraged to report near misses and low-harm events, so that serious
adverse outcomes may be prevented.
Reporting of some of the most serious types of events, such as never events, is mandated.
In aviation, incident reporting is just one component of a much wider safety system, which
ensures that there are mechanisms for investigating and improving systems. In many healthcare
systems reporting has come to be regarded as an end in itself.
Healthcare organizations may have local reporting arrangements, and in many countries there are
also national bodies for the most serious events (e.g. the England’s NHS Learn from patient
safety events service. https://www.england.nhs.uk/patient-safety/learn-from-patient-safety-
events-service/).
National systems are useful for understanding events that might be uncommon in individual
organizations, or where system-wide action might be needed to remedy the problems.
Research has shown that incident reporting systems detect only a minority of adverse events.
Measuring the number of reported events is therefore largely meaningless, even though this is
commonly done in many healthcare systems. Using numbers of reports as a performance
measure is counterproductive.
There are multiple reasons why staff members do not report events. The complexity of the
reporting process, the lack of feedback, the absence of obvious changes as a result of reports, and
fear of unfair or punitive treatment are the reasons most commonly cited.
Incident reports
Incident reports should include enough information to allow investigators to easily identify both
the place of the incident and those involved in it and to retrieve the relevant records.
Investigators do not require a comprehensive account or analysis of the event, since this is
expected to be done during the investigation.
Useful details to include in incident reports are:
While the immediate cause of an adverse event is usually an error or an active failure attributable
to a frontline clinician, a systems approach recognizes that the systems in which people work
have many inherent weaknesses (latent failures) that create the circumstances in which errors are
more likely to occur. Many of these contributory factors arise as a result of decisions made at
higher levels of the organization (e.g. staffing, rotas, the procurement of equipment) or externally
(e.g. the manufacture of devices). Investigations are unlikely to improve safety unless they
capture information on such contributory factors.
There are many approaches to classifying contributory factors the Yorkshire Contributory
Factors Framework is one.
AcciMap
This is an approach to accident analysis that has been used in a variety of industries. It attempts
to illustrate graphically the relationship between the various system factors that contribute to
errors in complex sociotechnical systems.
SEIPS (System Engineering Initiative for Patient Safety Human factors, Chapter 9)
This model examines work systems and structures (tasks, technologies, the wider environment,
etc.), processes, and outcomes in order to understand the complex factors that contribute to
adverse events.
Just culture
Many investigations focus exclusively on the actions of frontline staff and ignore the wider
system issues that underlie most adverse events. As a result, a disproportionate number of
investigations end up in punitive actions towards individuals (disciplinary process, suspension,
re-training, regulatory or even legal action). Not only is this unlikely to reduce similar events in
the future, but it fosters a blame culture where the staff are afraid to report incidents, anticipating
that its members or others would be unfairly punished.
Calls to replace this kind of environment with a ‘no blame’ culture are misplaced:
professionals have to be accountable for their actions because reckless or egregious behaviour by
individuals puts patients at risk, even if this is a factor only in a very small proportion of the
totality of adverse events. Sidney Dekker, an international safety expert, has coined the term ‘just
culture’ to describe the ideal approach (see Dekker 2016).
A just culture admits that individuals will make ‘honest mistakes’ because of multiple systems
issues that are beyond their control. If there is deliberately reckless or egregious behaviour on
their part, then they should be held accountable for it. Honest mistakes should be investigated in
order for us to understand the circumstances in which an individual made a mistake. Human
error is a symptom, not a diagnosis.
A just culture approach has been incorporated into investigations in many safety-critical
industries, but unfortunately is not yet widely practiced in healthcare.
Patients and families frequently report feeling excluded from the investigation of adverse events.
Their reasons include not being fully informed about what has happened, not being asked about
their own recollection of events, not being informed about the progress of the investigation, and
not being shown the final report. Such lack of transparency compounds the psychological trauma
of the event itself, and there is some evidence that it can lead to increased complaints and
litigation.
Clinicians have a professional and sometimes a legal obligation to be open with patients and
families when things go wrong, but the best approach to involving them in investigations is still
unclear. The Healthcare Safety Investigation Branch in the UK is adapting an approach from
other sectors whereby the patient and his or her family are routinely interviewed as part of the
investigation and their account is used as evidence, alongside the accounts of clinicians and
others.
Investigation recommendations
Many investigations in healthcare unfortunately continue to produce weak recommendations. A
recent Australian study found that only 8% of recommendations from RCAs into serious events
had strong recommendations; the recommendations from many RCAs in all healthcare systems
focus on (Institute for Safe Medication Practices, 2013) increased vigilance, raised awareness,
enforcing policies, or training.
Recommendations are most likely to be effective if they can change the system in which
individuals work (see Figure 16.2). The strongest recommendations focus on system change, the
weakest on individual behaviour.
A forcing function is one of the strongest. This is a design feature of a piece of equipment or
software that makes it impossible, or at least more difficult, to do the wrong thing. For example,
some electronic prescribing systems incorporate a forcing function that does not allow drugs that
have serious interactions with each other to be prescribed together. Some equipment is designed
to prevent dangerous processes (e.g. injection by the wrong route), although this does not always
offer complete protection (see the case history in our case study here). Standardization and
automation are also strong system-oriented recommendations. The more ‘human-oriented’
recommendations are, the more likely they are to fail; so, while training has a place among other
measures, on its own it is unlikely to improve systems.
Case study
The following case study demonstrates application of the principles of investegation. (Case
history adapted and modified from a similar incident investigated by the Healthcare Safety
Investigation Branch. www.hsib.org.uk)
The case
A 9-year-old child attended hospital for a renal biopsy. This was to be done on the side room of
the day case ward by the consultant, using IV Midazolam as sedation. The consultant was
usually assisted in these procedures by a senior postgraduate doctor in training (SPGD) and an
experienced nurse practitioner (NP). The NP usually prepared the IV Midazolam in the
procedure room. On this occasion the NP was on leave, so a more junior postgraduate doctor in
training (JPGD) who was covering the wards was asked to help.
The patient was prepared as normal. The SPGD wrote a prescription for IV Midazolam and
sent the JPGD to fetch this from the ward. Being unable to find a nurse to help on that ward,
the JPGD went to another ward. The nurse there read the prescription but inadvertently
prepared Midazolam liquid for oral use rather than IV. (This was stored alongside the IV
preparation.) This was checked by the JPGD against the prescription but neither noticed the
discrepancy. The nurse drew the drug up into a purple syringe, marked ‘for enteral use’ and
the JPGD brought it to the side room. The procedure had already been delayed by about 15
minutes and the patient was becoming agitated.
When the SPGD attempted to connect the purple syringe to the IV cannula it wouldn’t
connect; the syringe has been designed this way to prevent inadvertent IV administration of
medication for oral use. However, believing that the preparation was the IV one that had been
prescribed and being unfamiliar with the purple syringe, the SPGD decanted the drug from the
purple to an IV syringe and administered it. After a few mls had been given he realized that
something was wrong and stopped.
The patient suffered no immediate harm but was very distressed and required an overnight
stay for observation and a general anaesthetic for the biopsy. The patient’s parents were fully
informed of events but were so distressed that they refused to have any further treatment at
that hospital. While this patient did not suffer lasting harm, the inadvertent administration of
an oral medication into a vein can have very serious adverse consequences and can sometimes
be fatal. Purple enteral/oral syringes that are incompatible with IV cannulae were designed to
eliminate this risk. They are coloured purple to highlight the difference.
The findings
The investigation found that:
The analysis
An analysis of this event using the Yorkshire Contributory Factors Framework found the
following contributory factors:
1. Team factors. The safe running of the renal biopsy list was heavily dependent on the NP.
Delegating her tasks to untrained staff without any briefing introduced risk. There was
no routine pre-procedure briefing.
2. Individual staff factors. The JPGD was fatigued and stressed and had a work backlog.
3. Task characteristics. A critical task (preparation of the drug) was delegated to two staff
members who were not familiar with the procedure.
4. Workload and staff factors. The JPGD already had an increased workload—had to cover
an additional ward. It was peak holiday time and many junior doctors had just changed
jobs. There were no standard arrangements to cover the absence of the NP.
5. Training factors. Doctors are not routinely trained on the significance and use of purple
syringes.
6. Equipment design, layout, and physical environment. A human factors expert found that
the purple syringe offered incomplete protection against this error, as its contents could
be decanted to other syringes. Its success was heavily dependent on all clinicians having
been trained and knowing how to use it.
7. Storage of both forms of Midazolam together, and the fact that both were clear liquids,
increased the risk, as did the preparation of the drug in a separate location. Storage of the
purple syringes alongside IV ones increased risk.
1. Arrangements to be made for covering absent colleagues with appropriately trained and
available staff.
2. A pre-procedure briefing should be introduced.
3. Storage and preparation of Midazolam to be undertaken in the same location where it is
administered.
4. Structured communication techniques that allow junior staff to voice concerns or
uncertainty should be implemented.
5. Oral and IV Midazolam and oral and IV syringes should be stored separately and clearly
labelled.
6. Standardized training in the purpose and use of purple enteral syringes to be introduced
for all health professionals.
7. A review of scheduling of routine procedures should be made, so that, where possible,
they are not undertaken when key members of staff are absent or at other high-risk
times.
8. A national review of the design of enteral syringes should include redesign intended to
make decanting more difficult. Any changes need to be evaluated by human factors
experts.
1. Disciplinary processes or other sanctions against the ward nurse or the JPGD and SPGD
doctors.
2. Reminders to increase vigilance or pay more attention.
3. Audit of checking or prescribing processes.
References
Dekker S. Just Culture: Restoring Trust and Accountability in Your Organization, Third Edition.
London: CRC Press, 2016.
Hiatt, H. et al. A study of medical injury and medical malpractice: An overview. New England
Journal of Medicine 321.7 (1989): 480–4.
Reason, J. Human Error. Cambridge: Cambridge University Press, 1990.
WHO. World Alliance for Patient Safety: WHO Draft Guidelines for Adverse Event Reporting
and Learning Systems. 2005. WHO,
https://apps.who.int/iris/bitstream/handle/10665/69797/WHO-EIP-SPO-QPS-05.3-eng.pdf?
sequence=1&isAllowed=y.
Further reading
Conway, J. et al. Respectful Management of Serious Clinical Adverse Events, 2nd edn.
Cambridge, MA: Institute for Healthcare Improvement, 2011.
HSIB. Lessons from never events in England. 2021.
https://www.hsib.org.uk/documents/272/HSIB_Never_Events_-
_analysis_of_HSIBs_national_investigations_Report_V09.pdf.
Institute for Safe Medication Practices. Designing effective recommendations. ISMP, 2013.
www.ismp-canada.org/download/ocil/ISMPCONCIL2013-4_EffectiveRecommendations.pdf
Janet, E. et al. Using Safety-II and resilient healthcare principles to learn from never events.
International Journal for Quality in Health Care, 32.3 (2020): 196–203,
https://doi.org/10.1093/intqhc/mzaa009.
Kok, J., Leistikow, I., and Bal, R. Patient and family engagement in incident investigations:
Exploring hospital manager and incident investigators’ experiences and challenges. Journal
of Health Services Research & Policy 23.4 (2018): 252–61.
https://doi.org/10.1177/1355819618788586.
Leistikow, I. et al. Learning from incidents in healthcare: The journey, not the arrival, matters.
BMJ Quality & Safety 26 (2017): 252–6. https://qualitysafety.bmj.com/content/26/3/252.
McDonald, T. B. et al. Responding to patient safety incidents: The ‘seven pillars’. Quality &
Safety in Health Care 19.6 (2010): e11. https://doi.org/10.1136/qshc.2008.031633.
Parker, J. and Davies, B. No blame no gain? From a no blame culture to a responsibility culture
in medicine. Journal of Applied Philosophy 37 (2020): 646–60.
https://doi.org/10.1111/japp.12433.
Vincent, C. et al. Safety analysis over time: Seven major changes to adverse event investigation.
Implementation Science 12.1 (2017 Dec 28). https://doi.org/10.1186/s13012-017-0695-4.
Weaver, S., Stewart, K., Kay, L. Systems-based investigation of patient safety incidents. Future
Healthc J. 2021;8(3):e593–e597. doi:10.7861/fhj.2021-0147
Wiig, S., Hibbert, P. D., and Braithwaite, J. The patient died: What about involvement in the
investigation process? International Journal for Quality in Health Care, 32.5 (2020): 342–6.
https://doi.org/10.1093/intqhc/mzaa034
Wiig, S. et al. Next of kin involvement in regulatory investigations of adverse events that caused
patient death: A process evaluation. Journal of Patient Safety (2019).
https://doi.org/10.1097/pts.0000000000000630.
Chapter 17
Open disclosure
Key points
• Open Disclosure is the process of the patient and the family coming to understand
what happens.
• The aim is to exercise a duty of candour and to include the patient and the family in
the understanding of what has happened.
• The process is to acknowledge the incident, not to speculate about the cause, and to
show inclusion and information sharing as the investigation proceeds.
• The key is to listen to the patient and his or her family.
• Support for the clinical staff is essential.
Open disclosure is defined as the open discussion, with the patient, the family, and the carers, of
any adverse events that result in harm to a patient while receiving healthcare.
The elements of open disclosure are:
an apology or expression of regret, which should include the words ‘I am sorry’ or ‘we are
sorry’;
a factual explanation of what happened;
an opportunity for the patient, the family, and the carers to relate their discussion of the potential
consequences of the adverse event;
an explanation of the steps taken to manage the adverse event and to prevent its recurrence;
open disclosure is not a one-way provision of information but a discussion between two parties
and an exchange of information that may take place in several meetings over a period of time.
Approximately 1 in 10 patients admitted to hospital will suffer unintended harm, most of which
will not be caused by individual error (the clinician’s). Therefore the compassionate management
of patient disappointment that arises from such harm is a significant component in maintaining
an effective clinician–patient relationship.
Honest and transparent communication from clinicians can facilitate patient and family
acceptance and recovery from the emotional and physical consequences of unintended harm.
Clinicians have ethical and legal responsibilities to respect their patients’ autonomy, and this
requires patients and their families to be informed about important elements of their treatment,
including the impact and consequences of unintended harm arising from their care. In some
jurisdictions this is referred to as a ‘duty of candour’.
To act autonomously, a patient requires sufficient information to make decisions about future
care that aligns with his or her beliefs and values. Failure to provide information about
unintended harm can deny the patient that autonomy.
The requirement ‘first do no harm’ extends to the care administered after unintended harm.
Honesty and transparency can decrease the risk of additional emotional distress and grief caused
by ignorance of the facts or by the loss of trust in those who provide care.
The patient’s insights and feedback as a result of open disclosure conversations can assist in
informing the system’s response so as to prevent recurrences.
Planning and preparing for open disclosure acts as a conduit to ensure that the clinician’s
experience of anxiety or concerns after unintended patient harm can be supported.
The absence of open and honest conversations after unintended harm can lead to:
• loss of trust by patients and their families in clinicians, organizations, and the system;
• additional distress and suffering for the patient;
• increased risk of the patient’s misplaced or ill-directed efforts to seek redress or to hold
to account individual clinicians and organizations on the basis of erroneous
assumptions that an error has been made;
• a culture of secrecy and cover-up, which in turn may lead to unwillingness to report
critical near misses and system faults. Such underreporting can threaten system learning
and increase the risk of recurrence.
Preparation
Prepare (and even rehearse) the wording of information and support that will be provided.
Involve the most senior clinician in the team where possible.
Ensure privacy and patient comfort.
Consider accessing formal advice on any legal and regulatory implications.
Reflect on whether the conversation should be witnessed and by whom (noting the identity of
these witnesses in the medical record).
Clinicians who look after a patient can experience significant emotional and psychological
distress when unintended harm occurs to that patient.
Particularly in cases where clinicians believe they may have made an error, common feelings can
include:
• guilt/shame;
• anxiety/worry;
• self-doubt;
• isolation;
• depression.
Clinicians may also fear facing litigation, possible sanction, loss of reputation and harsh
judgment from their colleagues.
Recognizing these strong emotions and fears in oneself should prompt one to seek collegial and
professional support.
Summary box
Further reading
Australian Commission on Safety and Quality in Health Care, Australian Open Disclosure
Framework. ACSQHC, Sydney. 2013. https://www.safetyandquality.gov.au/our-work/open-
disclosure/the-open-disclosure-framework.
Bismark, M. et al. Accountability sought by patients following adverse events from medical care:
The New Zealand experience. Canadian Medical Association Journal 175.8 (2006): 889–94.
https://doi.org/10.1503/cmaj.060429.
de Vries, E. N. et al. The incidence and nature of in-hospital adverse events: A systematic
ALGRAWANY
review. Quality and Safety in Health Care 17.3 (2008): 216–23.
https://doi.org/10.1136/qshc.2007.023622.
Friele, R. D and Sluijs, E. M. Patient expectations of fair complaint handling in hospitals:
Empirical data. BMC Health Services Research 6.106 (2006). https://doi.org/10.1186/1472-
6963-6-106.
Gallagher, T. H. et al. W. Patients’ and physicians’ attitudes regarding the disclosure of medical
errors. JAMA 289.8 (2003): 1001–7. https://doi.org/10.1001/jama.289.8.1001.
Gallagher, T. H. et al. US and Canadian physicians’ attitudes and experiences regarding
disclosing errors to patients. Archives of Internal Medicine 166.15 (2006)
Helmchen, L. A., Richards, M. R., and McDonald, T. B. How does routine disclosure of medical
error affect patients’ propensity to sue and their assessment of provider quality? Evidence
from survey data. Medical Care 48.11 (2010): 955–61.
https://doi.org/10.1097/mlr.0b013e3181eaf84d.
Institute for Healthcare Improvement. Shining a Light: Safer Health Care through Transparency.
Boston, MA: National Patient Safety Foundation, 2005.
http://www.ihi.org/resources/Pages/Publications/Shining-a-Light-Safer-Health-Care-
Through-Transparency.aspx.
Openness and honesty when things go wrong: The professional duty of candour, 2015. Joint
NMC and GMC guidance. https://www.nmc.org.uk/globalassets/sitedocuments/nmc-
publications/openness-and-honesty-professional-duty-of-candour.pdf.
Sirriyeh, R. et al. Coping with medical error: a systematic review of papers to assess the effects
of involvement in medical errors on healthcare professionals’ psychological well-being.
Quality and Safety in Health Care 19.6 (2010): e43.
https://doi.org/10.1136/qshc.2009.035253.
Smith, K. M. et al. Lessons learned from implementing a principled approach to resolution
following patient harm. Journal of Patient Safety and Risk Management 24.2 (2019):83–9.
https://doi.org/10.1177%2F2516043518813814.
Chapter 18
Caring for the caregivers: The second victim
Background
What is a second victim?
How does a second victim feel?
Long-term impact
What can be done by the clinical team and the organization to support a second victim?
Preventive action
Support for the second victim
How can you support each other?
Summary box
Key points
• A clinical incident has an impact on the patient and family who are the first victims.
• The clinician or clinical team involved the incident can suffer psychological harm
because of the incident and are termed the second victim
• Early intervention to support the clinicians involved in a clinical incident decreases
the impact on their wellbeing and their clinical performance.
• A safety system will address the needs of the first victim through open disclosure, a
transparent investigation process and support for the clinicians involved.
Background
Medical error is a major public health challenge. One in ten of hospitalized patients are involved
in a patient safety incident (PSI) of which nearly 50% are preventable. A PSI is defined by the
WHO as ‘any deviation from usual medical care that either causes an injury to the patient or
poses a risk of harm, including errors, preventable adverse events and hazards” (WHO, 2020,
p14).
Unfortunately, there may be more than one victim after a PSI (Chapter 4). The first victim is
the patient. Alongside the patient, it is his or her family and social network that are the most
important victims. However, the healthcare professionals involved (second victims) and the
healthcare organization and their management (third victims) can also suffer in the aftermath of a
PSI (Figure 18.1). In this chapter, the focus will be on the second victims.
What is a second victim?
The fact that healthcare professionals can also suffer in the aftermath of a PSI has been described
over the last two decades. Scott et al. (2009, p326) defines a second victims as ‘healthcare
providers who are involved in an unanticipated adverse patient event, in a medical error and/or a
patient related injury and become victimized in the sense that the provider is traumatized by the
event. Frequently, these individuals feel personally responsible for the patient outcome. Many
feel as though they have failed the patient, second guessing their clinical skills and knowledge
base.’
Recently there has been some criticism of the term ‘second victim’ and patient communities
have questioned why the concept of second victim has become embedded in patient safety. Some
patient communities have suggested abandoning this term. As an alternative name has yet to be
determined, we will still use ‘second victim’ in this chapter.
Almost 85% of healthcare professionals report being emotionally affected in the aftermath of a
PSI, at least once in their career.
After a PSI, second victims develop symptoms that affect both their personal well-being and
their professional functioning.
Box 18.1 Possible symptoms of a second victim (see also Figure 18.2)
• hypervigilance
• stress
• anxiety
• shame
• flashbacks
• fear
• guilt
• frustration
• anger
• feeling inadequate
• risk avoidance
• insomnia
• unhappy and dejected
• self- doubt about knowledge and skills,
• difficulty concentrating
The symptoms may have a serious impact on individual and team performance, with
consequences for the safe provision of quality of care. Second victims may feel uncomfortable
within the team and may report significantly higher work-home interference. Second victims are
at a greater risk of burnout with higher levels of intention to leave their job.
The prevalence ratio of these symptoms increases the higher the degree of patient harm
reported, namely running from no harm to temporary harm, permanent harm and death. The
reaction of the healthcare professional also depends on the degree of personal responsibility
assumed for the PSI. In Figure 18.2, the duration of the top six symptoms and the level of harm
is visualized.
Figure 18.2 Duration of the top six symptoms that last longer than one month in the aftermath of
a PSI.
Reproduced with permission from Vanhaecht, K. S., D., Schouten, L., Bruyneel, L.,
Coeckelberghs, E., Panella, M., & Zeeman, G. (2019). Duration of second victim symptoms in
the aftermath of a patient safety incident and association with the level of patient harm. BMJ
Open http://dx.doi.org/10.1136/bmjopen-2019-029923
Finally, it is important to know the duration of these symptoms after a PSI, as second victims
are at risk for post-traumatic stress disorder (PTSD). If these symptoms persist for more than one
month, the phenomenon may be indicative of a stressor-related disorder (e.g. PTSD, according to
the criteria in DSM 5).
Understanding the symptoms and their duration can help organizations decide how to support
second victims in a caring, compassionate, and effective way.
Long-term impact
It has been shown that not responding to a PSI in a timely and effective manner can have a
significant impact on the second victims and healthcare organizations. This impact can take the
form of absence of healing, loss of trust, lack of learning, or lack of improvement. It may also
increase the likelihood of legal action and patient complaints.
The impact on doctors or nurses in training can be immense, as it can increase the risk of a
future PSI. Young clinicians who perceive that they have made patient errors in the past
demonstrate less empathy. They are then at risk for subsequent errors. Those with associated
depression are twice as likely to make an additional error in the future.
What can be done by the clinical team and the organization to support a second
victim?
The support given in the aftermath of a PSI is crucial, not only for the second victim but also for
the individual who provided the support. This is required not only in the aftermath of a PSI but
also for healthcare professionals who are involved in a complaint or in a lawsuit, as the
emotional impact is more severe in such cases.
Hospitals have started to accept that they have a role in providing an institutional support
system to meet the needs of second victims. However, there is a gap between the needs of second
victims and the level of support offered by their organization. In addition, individuals within the
organization can play a role in supporting second victims.
Preventive action
In general, organizations should aim for a positive patient safety culture and psychological
safety, as this is associated with lower psychological impact and faster recovery for the
healthcare professionals involved in an adverse event.
The patient safety culture should reflect a non-punitive attitude to errors. This may encourage
supportive actions and openness to discuss error and to mitigate the negative effects of a PSI.
The perception of managerial support and the provision of information about the rights of a
second victim are positively associated with well-being and can reduce defensive practices in
healthcare professionals who are involved in complaint investigations.
A key preventive intervention is to educate and train healthcare professionals about the second
victim phenomenon as part of their professional and post graduate training. Work based learning
includes both immediate support in the aftermath of a PSI and monthly team meetings dedicated
to sharing best practices.
1. Make sure that the second victim is okay and is provided immediate emotional first aid.
This support is sufficient for 60% of the participants.
2. Make sure that support is given to the second victim by peers trained in the second-
victim phenomenon. This will meet the needs of a further 30% of participants.
3. Secure referral to professional counselling. This is required for 10% of participants.
An adapted version of Scott’s three-tiered emotional support system was developed by the
University of Leuven (Figure 18.3), with the addition of emotional and cognitive support to each
tier.
It is important that a culture of psychological safety is present. This implies that team members
feel accepted and respected. They feel safe to share what happened, without fear of negative
consequences.
Summary box
Key points
• Organizations should be prepared and know how to support a second victim.
• Each second victim requires an individual approach, which should be based on their
needs and on symptoms and their duration.
• Teams should be able to support their members.
• Support on how to cope with the symptoms in the aftermath of a PSI, complaint, or
lawsuit is essential, as these can profoundly affect an individual’s personal well-being,
professional performance, and teamwork.
• Early intervention is required to minimize long-term sequelae, as the duration of the
symptoms after a PSI is underappreciated.
References
WHO. Patient safety incident reporting and learning systems: technical report and guidance.
Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
https://www.who.int/publications/i/item/9789240010338
Scott, S. D. et al. The natural history of recovery for the healthcare provider ‘second victim’ after
adverse patient events. Quality & Safety in Health Care 18.5 (2009): 325–30.
https://doi.org/10.1136/qshc.2009.032870.
Van Gerven, E. et al. Psychological impact and recovery after involvement in a patient safety
incident: A repeated measures analysis. BMJ Open 6.8 (2016): e011403.
https://doi.org/10.1136/bmjopen-2016-011403.
Vanhaecht, K. S. et al. Duration of second victim symptoms in the aftermath of a patient safety
incident and association with the level of patient harm. BMJ Open 9.7 (2019).
http://dx.doi.org/10.1136/bmjopen-2019-029923.
Further reading
Conway, J., Federico, F., Stewart, K., & Campbell, M. (2011). Respectful management of
serious clinical adverse events. IHI Innovation Series white paper. Cambridge,
Massachusetts: Institute for Healthcare Improvement, (Available on www.IHI.org).
Mira JJ, Lorenzo S, Carrillo I, et al. Lessons learned for reducing the negative impact of adverse
events on patients, health professionals and healthcare organizations. Int J Qual Health Care.
2017 Aug 1;29(4):450–460. https://doi.org/10.1093/intqhc/mzx056
Panella, M. et al. The determinants of defensive medicine in Italian hospitals: The impact of
being a second victim. Revista de Calidad Asistencial 31 Suppl 2 (2016).
https://doi.org/10.1016/j.cali.2016.04.010.
Seys, D. et al. Supporting involved health care professionals (second victims) following an
adverse health event: A literature review. International Journal of Nursing Studies 50.5
(2013): 678–87. https://doi.org/10.1016/j.ijnurstu.2012.07.006.
Seys, D. et al. Health care professionals as second victims after adverse events: A systematic
review. Evaluation & the Health Professions 36.2 (2013): 135–62.
https://doi.org/10.1177/0163278712458918
Van Gerven, E., et al. Increased risk of burnout for physicians and nurses involved in a patient
safety incident. Medical Care 54.10 (2016): 937–43.
https://doi.org/10.1097/mlr.0000000000000582.
Wu, A. W. Medical error: The second victim. Western Journal of Medicine 172.6 (2000): 358–9.
https://doi.org/10.1136/ewjm.172.6.358.
Zeeman, G. et al. Prolonged mental health sequelae among doctors and nurses involved in
patient safety incidents with formal complaints and lawsuits. European Journal of Public
Health 30.4 (2020): 777–9. https://doi.org/10.1093/eurpub/ckz138.
Part 3
Translating theory into clinical practice
ALGRAWANY
Chapter 19
Patient safety and information technology
Key points
• Safety is dependent on the provision of reliable services.
• Digital solutions can assist in the achievement of safer processes.
• Electronic health records and computerized provider order entry systems both allow
for the standardization of processes by using human factors and reliability theories to
achieve safety.
• The digitalization of processes needs to be implemented within a learning
environment and a culture of safety.
• New opportunities in diagnostics, monitoring, and telehealth can facilitate safer care.
When caring for patients in the healthcare setting, new clinicians will use their best judgement
and reasoning on the basis of their education, experience, pathways, and collaborations with
other team members. Recent advances in technology and information services have added tools
and stressors to clinicians that will both challenge and support them in the work they do to
ensure the best quality, safety, and outcomes for their patients.
Furthermore, the evolution of innovative approaches and technologies designed to address
day-to-day healthcare challenges creates opportunities to achieve better patient safety and quality
outcomes. This chapter will provide an overview of the current state of affairs in this field and
some considerations related to it.
Documentation of clinical activities has been a long-standing and important part of healthcare
activities, whether for payment purposes or for the linear tracking of a patient’s health. In recent
years, technology has created additional mechanisms designed to increase efficiency, to improve
the sharing of data across multiple providers and sites of care, and ideally to enhance quality and
safety within the clinical settings. Similarly, technology can be more efficiently used to order
more tests, medication, follow-up care, and other important patient-related activities that will
enhance overall clinical outcomes.
The Healthcare Information and Management Systems Society (HIMSS) has defined the
electronic health record (EHR) as ‘a longitudinal electronic record of patient health information
generated by one or more encounters in any care delivery setting. Included in this information
are patient demographics, progress notes, problems, medications, vital signs, past medical
history, immunizations, laboratory data and radiology reports. The EHR automates and
streamlines the clinician’s workflow. The EHR has the ability to generate a complete record of a
clinical patient encounter—as well as supporting other care-related activities directly or
indirectly via interface—including evidence-based decision support, quality management and
outcomes reporting’ (Atherton, 2011, 186).
Not all countries or clinical settings are fully integrated into an EHR, and there is often a mix
of paper-based and electronic medical records used in clinics, hospitals, or health systems. This
is not ideal, as mixed environments create opportunities for error owing to cross-referencing
multiple platforms, illegibility challenges, misinterpretation, lack of visibility into a common
view of historical and current activities, and supplementary time needed to ensure that providers
are able to have a complete picture of the care they are offering. Moving to a common platform
is an important priority for those responsible for creating the best clinical environment for
clinical practitioners and their patients.
Computerized provider order entry (CPOE) has been a companion technology to the EHR, with
increasing implementation and presence across care environments. Intending to make care safer
and more efficient, this technology allows for practitioners to enter and send orders for
medications, studies, tests, and so on via computer. Often the CPOE will be used in combination
with e-prescribing systems that can detail the patient’s current and past medications, allergies,
and so on. A prime reason behind the adoption of CPOE is to ensure better patient safety
outcomes by addressing the problem of illegible ordering or by correcting the errors that may
occur in the transcription of orders written by providers. Its usage has also been linked to
increased efficiency and processes that result in reduced length of stay.
Other important aspects of CPOE include:
the provision of feedback to the provider about possible conflicts with orders,
facilitating behind-the-scenes compliance checks with regulatory guidelines,
reporting on effectiveness of the system to the management, to enable improvements to
increase efficiencies and flows,
connecting with mobile devices to ensure seamless and integrated use by providers.
Often the CPOE is integrated in the EHR, which makes the combination a powerful tool for
providers.
Initially the adoption of CPOE was challenging: many physicians embraced this new tool, but
most resisted it in the early phase. A broader adoption occurred once EHRs established a
stronger presence and support in clinical settings. A common goal of health systems or hospitals
is to ensure that up to 90% of orders are entered via CPOE. This is an implicit admission that a
100% adoption rate is difficult in view of the nature of some of the orders: some of them (e.g.
cancer-related medication) are too complex to be entered via this method.
The transition to a digital interface is challenged by a host of unintended problems that are
difficult to solve. Here are some examples:
complex flow of navigating the electronic screens and systems within platforms;
requirement to enter passwords multiple times for privacy protection;
the frequent inability to customize the process of entering information;
alert fatigue;
disconnect between the clinical workflow and the electronic system workflow: this state
may cause further errors, wasted time, or distractions.
Interoperability
A major factor that will impact the success of these systems is interoperability, which continues
to be a challenge across platforms, vendors, health systems and other settings. As defined by
HIMSS interoperability is ‘ the ability of different information systems, devices and applications
(systems) to access, exchange, integrate and cooperatively use data in a coordinated manner,
within and across organizational, regional and national boundaries, to provide timely and
seamless portability of information and optimize the health of individuals and populations
globally.’ (HIMSS, 2021, https://www.himss.org/resources/interoperability-healthcare). As more
systems, devices, and access points for information are developed, the ability to address
interoperability will become increasingly important for ensuring the best patient safety possible.
The advent of digital healthcare in the COVID pandemic has already started this process.
Technology in healthcare settings is evolving at a fast pace, beyond just ‘at the elbow’ tools like
the EHR and CPOE. Newly developed technologies have created unimagined opportunities to
impact patient outcomes, including increased patient safety, improved clinical outcomes, better
adherence, equity of care, and broader access to care. As health systems were unable to
successfully address all the existing challenges in the delivery of care, they have often looked
outside traditional environments for innovative solutions, which have accelerated the application
of these new technologies and the impact they will have on patient care.
However, it is important to recognize that the sources of this innovativeness can be clinicians
at the bedside, venture-funded startups external to the health system, and many other individuals,
companies, and partnerships. The importance of health systems embracing these new innovations
is equalled by the importance that physicians and other clinical providers place on working with
these solutions in order to inform their development, test their impact on patient safety, and
ensure they are truly able to make a difference to the delivery of care.
There is a spectrum of new innovations and technologies that will be helpful to patient care in
the future. For example a focus on ‘citizen health’, artificial intelligence, virtual reality,
blockchain, patient-controlled testing, cognitive computing, wearables, ingestibles, absorbables,
sensor activations, and patient-created devices.
There are thousands of examples globally that illustrate both the importance of trying new
solutions and the significant effect they can have on patient safety and quality in healthcare
settings.
These brief examples, picked out of thousands, demonstrate the power of the possibilities that
innovation and new technologies can create when addressing conditions within healthcare.
A final note: these technologies, once created and used, will add to the demands of the
healthcare provider and other clinicians, as will the need to address genetic, microbiomic, and
other -omic data in the care of patients in the future. More data will create a more informed view
of patients, but will also lead to other challenges, such as those related to interpreting and
interfacing with all these data in meaningful ways for clinicians to be successful in application,
diagnosis, and treatment.
External factors can sometimes force healthcare providers to adopt new technologies in an effort
to become more agile. During 2020, the global pandemic ushered in an increased use of
telehealth to connect patients and physicians for care.
While around for decades, telehealth had not been widely adopted or used consistently as a
tool until COVID-19 forced new ways of interacting with patients on the basis of ‘stay-at-home’
orders, lockdowns, and social distancing. By mid-2020, US providers had rapidly scaled their
telehealth offerings and via this technology increased the number of patients seen per unit time
than seen previously with in person consultation. Similar adoption rates have been experienced
globally.
In the future, telehealth will probably be used much more than it was in the past; however,
there will be greater variability in the frequency of its use. Society has realized the benefits of
this technology and consumers may now prefer this option for care.
Additionally, telehealth has proven to be of great benefit in addressing challenges systems
have faced for years (healthcare equity, access, etc.). As healthcare providers identify the best
ways to engage with patients in delivering care, telehealth will probably be an ongoing option;
with appropriate patients and settings and for specific conditions, it can add immense value.
Telehealth will have to be thoughtfully balanced with both traditional and future means of
providing care to patients. Additionally, more focus on new technology and digitization has led
some organizations to create Chief Digital Officer positions which have been instrumental in
shaping this space.
Within the clinical setting and within healthcare environments, there are several key individuals
who will partner with providers in order to enhance their ability to be effective with the
technologies described in this chapter. The chief information officer (CIO) will work closely
with caregivers, providers, and employees across the healthcare setting to ensure that both the
hardware (computers) and the systems (e.g. the EHR and CPOE) function optimally and support
clinical activities.
Many organizations are now hiring chief medical informatics officers (CMIOs), whose
primary responsibility is to bridge the information services and provider worlds. The critical
nature of these physician roles cannot be understated: CMIOs have often been both key
champions for physicians, as they adopted new technology in effective ways, and representatives
of the administration and of the CIO in implementing new systems (such as the EHR and
CPOE). The CMIO will often have a direct link to and partnership with the chief quality officer,
as they both ensure that quality outcomes are achieved.
Finally, chief innovation officers (CIxO) have become more prevalent in health systems, as
they begin to recognize the critical need to drive change through approaches that have not been
tried in the past. Their partnership with the providers, who often serve as champions for
innovative technology trials and for proof of concept, implementation, and scaling, is another
means by which patient safety can be secured, namely through the introduction of new
technologies such as the ones exemplified in this chapter. It is important to establish strong,
collaborative relationships that will help to leverage technology in the right way and to deliver
exceptional patient care.
Summary box
The use of the new ways of documenting and communicating medical information, both in real
time and retrospectively, has increased healthcare practitioners’ ability to improve the quality of
outcomes and to ensure the best patient safety in our health systems globally.
Supporting hospitals, health systems, and practitioners in their work of implementing and
using new technology, many countries and organizations have established guidelines and support
mechanisms.
The SAFER Guides, established by the US government (www.HealthIT.gov), constitute such
an example. This is a corpus of nine guides that aim to guarantee base practices for the safe use
of health information technology, specifically the electronic health record. They offer self-
assessment tools designed to identify possible risks and the ways to mitigate them. Another
example is the work carried out by the World Health Organization (WHO) in providing
structure, recommendations, and guidelines for digital interventions, eHealth, and innovations—
all towards rendering these new technologies and their governance helpful in the delivery of safe
healthcare for all.
There is no doubt that the use of technology in healthcare will help to create a safer experience
for patients and communities, while improving quality and reducing the rate of medical error.
Even with all these additional efforts to support providers and practitioners in their day-to-
day work, one will always have to be vigilant and make efforts both to minimize the
unintended consequences of this technology and to realize its true benefit for all patients.
The movement from paper to electronic documentation and ordering has led to the following
positive outcomes (among others):
• decreased medication errors;
• improved adherence to applicable care pathways and guidelines;
• aligned and coordinated care across care providers;
• renewed focus on improving patient safety;
• improved satisfaction for physicians, nurses, and other clinical professionals.
Signpost
The following websites have good information on information technology.
Digital Health Australia https://www.digitalhealth.gov.au/
Digital Health Canada https://digitalhealthcanada.com/
E-Health Ireland https://www.ehealthireland.ie/
NHS Digital https://digital.nhs.uk/
US Government https://www.healthit.gov
World Health Organisation https://www.who.int/ehealth/en
References
Artherton J. Development of the Electronic Health Record Virtual Mentor. 13(3) (2011): 186–
189. doi:10.1001/virtualmentor.2011.13.3.mhst1-1103.
Healthcare Information and Management Systems Society (HIMSS). What is Interoperability?
https://www.himss.org/resources/interoperability-healthcare
Stanford Medicine. White paper: The future of electronic health records. 2018.
www.med.stanford.edu/content/dam/sm/ehr/documents/SM-EHR-White-Papers_v12.pdf.
Further reading
Key points
• A safe medication management system comprises of four key processes: prescribing,
dispensing, administration, and reconciliation.
• Each process requires reliablity and standardization to ensure safety and to mitigate
the risk of harm
• Polypharmacy is a challenge with the increasing complexity of the healthcare
• Methods to improve health literacy can decrease medication harm.
Medications are the most common intervention in healthcare. No matter the setting of care, it is
likely that a patient will be prescribed, or will receive, a medication. As a result, medications are
associated with a high rate of medication errors and medication-related harm. It is estimated that
annually as many as 1.5 million Americans experience harm as a result of medication errors. The
WHO reports that globally the costs associated with medication errors have been estimated at
$42 billion USD per annum.
Why is it a challenge?
Common terms
Medication The appropriate use of medication that does not cause harm to the patient.
safety
Medication Any preventable event that may cause or lead to inappropriate medication use
errors or patient harm while the medication is in the control of the healthcare
professional, patient, or consumer. (NCC MERPP). Not all medication errors
lead to harm.
Medication- An experience of the patient that may or may not be the result of an error.
related
adverse
event or
harm
Adverse Unexpected or documented side effects of a medication.
drug
reactions
(ADR)
Potential Those events that under other circumstances might cause harm to the patient
adverse drug but on a given occasion did not.
events
ALGRAWANY
Medication errors are classified using the NCC MERP Index, as indicated in Figure 20.1. This
enables clinical teams to assess all degrees of error and therefore allows for learning and
remedial action.
Medication safety requires a system approach for each step of the medication process:
prescribing, preparation and dispensing, administration and monitoring.
Use standardization and simplification, for example protocols, algorithms, and order sets.
For addition to the formulary, select medications that are safe and effective for the population
you serve.
Develop criteria for prescriptions that include the patient’s name, an identifier if appropriate, and
information concerning age, weight, known allergies, indications, the generic name of the drug,
dosage (using standard doses if possible), frequency, and route.
Incorporate clinical decision support systems in the electronic health record (EHR) and in the
computerized physician order entry (CPOE)
Limit the use of verbal orders to emergency situations.
Do not use orders that are sent via SMS (text orders).
Include a pharmacist’s review of the prescriptions for appropriateness, drug interactions and
therapeutic duplication.
Use ‘read back’ as a way to confirm verbal orders in the event of an emergency (for pharmacists
and nurses).
Dispensing
Use bar codes to identify medications so as to minimize dispensing and administration errors.
Administration
Provide protected space and time for nurses who administer medications to minimize distractions
and interruptions: a ‘sterile cockpit’ in which interruption is not allowed.
Ensure proper monitoring of patients after medication administration in order to determine if a
patient is experiencing adverse effects.
Develop nurse-managed protocols for medications such as narcotics and benzodiazepines, so as
to be ready to administer reversal agents or rescue medications as quickly as possible in the event
of an adverse event.
Understand the needs and risks associated with the care of different populations such as children,
elderly people, obese people, and people with organ dysfunctions.
Collect the best possible list of the medications that a patient is taking on admission to a hospital
or during a visit to a clinic or in a doctor’s office.
Use the list to determine whether therapy is to be continued, modified, or discontinued on the
basis of the treatment plan for the patient.
Ensure that changes to patients’ medications are communicated with other providers in care and
with patients and their families.
Use digital solutions where available, so as to reconcile medications.
Look for signs of low health literacy levels through interactions with the patient.
Provide instructions at the level of literacy that is appropriate for the patient.
Use ‘teach back’ to confirm that the patient has understood the instructions.
Use ‘show back’ to confirm that the patient has the ability to execute the use of inhalers and to
self-administer medications.
Be prepared to manage a larger number of older patients who have more comorbidities and
greater need for medications.
Understand the use of pharmacogenomics and its implications for medication treatment plans
and the provision of equitable care.
Monitor the literature for newly identified drug interactions and adverse events related to
medication use.
IT solutions such as CPOE can be introduced. More recently, blockchain-based systems have
been used for the management of electronic health records, including medications; in these
systems a decentralized, continuously growing online ledger of the medication record is
validated peer to peer by the clinicians, nurses, and pharmacists who work in the system.
Summary box
• Medication errors resulting in adverse events constitute the largest part of patient safety
harm.
• Attention to the entire medication process, from prescribing to dispensing and
administration, is essential for lowering the possibility of errors that result in an adverse
event.
• The study of near misses is important for improving the process.
• Regular medication safety huddles can make a difference to decreasing harm.
Further reading
AHRQ. AHRQ Health Literacy Universal Precautions Toolkit. February 2015, last updated
September 2020. https://www.ahrq.gov/professionals/quality-patient-safety/quality-
resources/tools/literacy-toolkit/index.html.
American Society of Health-System Pharmacists. ASHP guidelines on the pharmacy and
therapeutics committee and the formulary system. American Journal of Health-System
Pharmacy 65 (2008): 1272–83.
Assiri, G. A. et al. What is the epidemiology of medication errors, error-related adverse events
and risk factors for errors in adults managed in community care contexts? A systematic
review of the international literature. BMJ Open 8 (2018): e019101.
https://doi:10.1136/bmjopen-2017-019101pmid and
http://www.ncbi.nlm.nih.gov/pubmed/29730617.
Farre, A. et al. How do stakeholders experience the adoption of electronic prescribing systems in
hospitals? A systematic review and thematic synthesis of qualitative studies. BMJ Quality &
Safety 28 (2019): 1021–31. http://dx.doi.org/10.1136/bmjqs-2018-009082.
Farrell, B. et al. Reducing polypharmacy in the elderly. Canadian Pharmacists’ Journal 146.5
(2013): 243–4.
Frankel, A. et al. Framework for Safe, Reliable, and Effective Care (White Paper). Cambridge,
MA: Institute for Healthcare Improvement and Safe & Reliable Healthcare, 2017.
How-to Guide: Prevent Adverse Drug Events by Implementing Medication Reconciliation.
Cambridge, MA: Institute for Healthcare Improvement, 2011.
How-to Guide: Prevent Harm from High-Alert Medications. Cambridge, MA: Institute for
Healthcare Improvement; 2012.
Isaacs, A. N. et al. Hospital medication errors: A cross-sectional study. International Journal for
Quality in Health Care 33.1 (2020). https://doi.org/10.1093/intqhc/mzaa136.
Koyama, A. K. et al. Effectiveness of double checking to reduce medication administration
errors: A systematic review. BMJ Quality & Safety 29 (2020): 595–603.
http://dx.doi.org/10.1136/bmjqs-2019-009552.
Lambert, B. L. et al. Automated detection of wrong-drug prescribing errors. BMJ Quality &
Safety 28 (2019): 908–15. http://dx.doi.org/10.1136/bmjqs-2019-009420.
Langer, T. et al. Patient and families as teachers: A mixed methods assessment of a collaborative
learning model for medical error disclosure and prevention. BMJ Quality & Safety 25.8
(2016): 615–25. http://dx.doi.org/10.1136/bmjqs-2015-004292.
Luetsch, K., Rowett, D., and Twigg, M. J. A realist synthesis of pharmacist-conducted
medication reviews in primary care after leaving hospital: What works for whom and why?
BMJ Quality & Safety 30.5 (2021): 418–30. http://dx.doi.org/10.1136/bmjqs-2020-011418.
Machen, S. et al. The role of organizational and professional cultures in medication safety: A
scoping review of the literature. International Journal of Quality in Health Care 31.10
(2019): G146–G157. doi: 10.1093/intqhc/mzz111. (Erratum: 804.)
Padula, W. V. and Steinberg, I. What current and missing data can teach us about medication
errors. BMJ Quality & Safety 30.2 (2020): 89–91. doi: 10.1136/bmjqs-2019-010555.
Rozich, J. D., Haraden, C. R., and Resar, R. K. Adverse drug event trigger tool: A practical
methodology for measuring medication related harm. Quality and Safety in Health Care 12
(2003): 194–200.
Schnipper, J. L. et al. Effects of a multifaceted medication reconciliation quality improvement
intervention on patient safety: Final results of the MARQUIS study. BMJ Quality & Safety
27 (2018): 954–64. https://doi:10.1136/bmjqs-2018-008.
Westbrook, J. I. et al. Associations between double-checking and medication administration
errors: A direct observational study of paediatric inpatients. BMJ Quality & Safety 30.4
(2020). doi: http://dx.doi.org/10.1136/bmjqs-2020-011473.
WHO. Medication without Harm. WHO, 15 May 2017.
https://www.who.int/initiatives/medication-without-harm.
Wolf, Michael S. The role of health literacy in patient safety. PSNet. 2009.
https://psnet.ahrq.gov/perspective/role-health-literacy-patient-safety.
Chapter 21
Safe prescribing in paediatrics
Key points
Medication safety in children has specific challenges.
• Dose is related to age and is calculated by weight.
• Doses therefore change and need to be calculated as appropriate.
• Therapeutic index is narrow and margin of error is small.
• Doses are extrapolated as there are few clinical trials in children.
• Every stage of the medication process carries a risk to medication safety.
Paediatric patients are more susceptible to medication errors and are at higher risk of
experiencing adverse events related to those errors. The increased risk of medication errors is due
to pharmacokinetic differences at different stages of development, dependency on parents and
other caregivers to provide medications, and unique epidemiology of medical conditions.
The rate of potential adverse events has been estimated by Kaushal et al. (2001, 2007) to be
potentially three times higher in pediatric patients than it is in adult patients
• Most errors originates in the prescribing phase.
• The rate of errors and potential adverse drug events is significantly higher in the
neonatal intensive care unit.
The severity of adverse events in paediatric patients has been shown to be serious or life
threatening in up to 35% of events identified (Tham et al. 2011).
Harm events reported by age show that
• children aged 0–4 years had the highest proportion of serious event types;
• children aged 5–14 years had the highest rate of total events and medication errors,
specifically (Field et al. 2019).
Therefore medication errors and resultant adverse events are an important safety issue in the
paediatric population.
Achieving medication safety in the paediatric population has significant challenges. These
challenges permeate the medication process, from procurement to administration. The
medication process is depicted in Figure 21.1.
Figure 21.1 The medication process.
Procurement
Acquiring specific paediatric formulations is especially difficult, since most manufactured
products do not come in a paediatric dosage format. In addition, in the era of drug shortages, the
drug of choice in paediatric patients may no longer be available, and this can lead to errors.
Surveys on harm events associated with drug shortages have found that up to 20% of the events
reported involve paediatric patients. The lack of published evidence on the use of medications in
paediatrics exacerbates the risks associated with drug use in children when the few options that
have evidence to support their use are in short supply. Counterfeit drugs pose an even greater
risk to paediatric medication safety, as an estimated 10% of medical products in low- and
middle-income countries are substandard or falsified, thereby exposing children to even greater
risks.
Prescribing
Many medication errors originate in the prescribing phase of the medication use process (see
Box 21.1). The dosing of most medications in paediatrics is initially based on adult data. An
important factor that contributes to errors is the need for individualized dosing in paediatric
patients, as opposed to the ‘one dose fits all’ approach that may be seen in adults. Children
require multistep calculations to individualize doses according to their age and weight, and this
can lead to calculation errors. In addition, children have pharmacokinetic variation that is based
on age and organ system development and that changes rapidly as they grow and develop. Obese
children are at higher risk of adverse events if their actual weight rather than their ‘ideal weight’
is used in medication dosage calculations.
Another factor that may potentiate the risk of error during the ordering phase is risk associated
with transitions of care. Increased risk of errors has been shown in paediatric patients during
admission, during discharge, and in the outpatient setting. This result is consistent with the fact
that adult studies show transitions of care to be a high-risk area. Another factor complicating
transitions of care occurs if volumetric rather than weight-based dosing of a drug is used.
The non-standardized approaches to compounding paediatric formulations may further
confuse things if a patient is being transitioned to an inpatient setting or moving from one facility
to another.
Digital solutions can improve prescribing, if the process is fully understood and a safe
prescribing culture is in place (see Box 21.2). However, most of the technology for medication
use has been developed for the adult population and requires customization for children.
Many medications must be compounded into a liquid dosage form from the manufacturer’s
tablets. The way compounded liquids are provided for patients can vary from one institution to
another, causing confusion for the clinicians and the patients. The dose that the clinician or the
parent is used to drawing up may have changed significantly, depending on how the formulation
is compounded.
The specificity of paediatric doses also complicates intravenous medication preparation. In
adult institutions, it is common to batch many doses of the same drug and doses, because many
different patients will be receiving it. Paediatric patients have specific dosing requirements,
which necessitate much more individualized intravenous (IV) compounds. There is often a need
to make different concentrations for very small patients or for patients who cannot handle a very
diluted drug. Care must also be taken with rounding doses up or down so that the dose being
delivered is in measurable form.
Administration
Dose measurement can become a challenge in adult facilities, for example emergency rooms that
may not be equipped with oral syringes of the proper size, which are necessary for measuring
smaller doses (1 or 5 mL syringes). In addition, the measurement of doses from outpatient to
inpatient or between facilities may be inconsistent, changing from teaspoons to droppers to oral
syringes. Interruptions to nurses’ work during the medication process increase the risk of error,
either in the preparation or in the administration of a dose. These challenges are summarized in
Box 21.4.
As in issues with CPOE, many drug delivery systems were not designed with children in
mind. The small doses that are given to children may not fit into a bag for accurate
administration and may require a longer infusion than what is possible when pushing by hand.
Owing to narrow therapeutic index medications and to pharmacokinetic variation in children,
closer monitoring is required after administration. Administration to a child (or young person) as
ALGRAWANY
an outpatient is a safety concern because, as a healthcare provider, you are relying on that child
(or young person) or on their caregiver to give medications appropriately at home or at school;
and some studies have indicated that the risk may be higher in those settings.
Procurement
A formulary should be in place for all facilities that care for paediatric patients, and oversight of
this formulary should be given to an interdisciplinary team such as a pharmacy and therapeutics
committee (see Box 21.5). This group should:
A drug shortage management plan should be in place to mitigate the risks associated with drug
shortages. This management plan should include:
Prescribing
These elements should be included in the ordering phase (see Box 21.6):
Electronic health records should include CPOE and be customized with the clinical decision
support specific to the paediatric population:
Box 21.7 Key recommendations for the safe preparation and dispensing of medications
• Standardize concentrations and limit dosage strengths.
• Use commercially available products.
• Use national-standard compounded solutions.
• Require pharmacist verification of sterile components prior to mixing.
• Employ barcode verification in preparation of IV and oral liquids.
• Consider the increasing use of dispensing robots that may decrease the frequency of
medication errors (e.g. IV sterile preparation robots).
Administration
Some medication errors occurring in the administration phase can be mitigated with the
following measures (see Box 21.8):
Use syringe pumps when applicable.
Use smart infusion pumps with an activated library for the administration of high-alert
medications.
High-alert medications should require independent double-checking before administration.
Nurses should mathematically double-check calculated doses.
Require a bedside barcode scanning system for medications.
The administration of medications at home or in the school setting is less under the control of
healthcare providers. However, with proper patient and guardian education, errors at home can
be decreased. Improved communication between healthcare providers and parents and improved
communication between pharmacists and parents is the best prevention strategy. Clinicians
should use methods such as ‘teach back’ and require parents, before they leave the hospital,
clinic, or pharmacy, to show how they will dose a medication. This will demonstrate that the
clinician or patient knows exactly how the medication should be given. Caregivers should also
be counselled to give doses only with the measuring device that comes with the medicine and not
to use household spoons for measuring doses.
Summary box
• Children are at higher risk of medication errors and adverse events than adults.
• Hospitals and health systems treating paediatric patients should work to increase the
detection of medication errors in this population and to identify system improvements that
can limit these errors.
Many of the safety issues concerning paediatric patients stem from the fact that
•
medications and medication devices were created with the adult patient in mind.
• Major improvements can be made throughout the medication process by focusing on
developing a culture of medication safety, understanding each part of the process,
applying reliability and human factors theory, standardizing medication processes and
procedures, and then applying technological solutions.
References
Field C, et al. Exploring Vulnerability to Patient Safety Events along the Age Continuum. Pa
Patient Saf Advis 2019 Mar;16(1).
Kaushal, R. et al. Adverse drug events in pediatric outpatients. Ambulatory Pediatrics 7.5
(2007): 383–9.
Kaushal, R. et al. Medication errors and adverse drug events in pediatric patients. JAMA 285
(2001): 2114–20.
Tham, E. et al. Sustaining and spreading the reduction of adverse drug events in a multicenter
collaborative. Pediatrics 128 (2011): e438–e445.
Further reading
Key points
• Healthcare-acquired infections (HCAIs) are a major safety risk to people who are
receiving care.
• The impact of HCAIs on individuals is significant: increased length of stay in
hospitals, increased morbidity, and increased mortality.
• The financial cost is significant—for individuals, for the healthcare system, and for
society.
• Many HCAIs can be prevented and many are due to lapses in care.
• The application of reliability methodology such as care bundles, human factors
methods in design, and cognitive approaches can decrease or eliminate specific
HCAIs.
• A culture of safety is essential to implementing the changes required.
Why is it a challenge?
Not all HCAIs are preventable; preventable cases generally range between 30% and 70%,
depending on the type of infection.
Reducing the incidence of HCAIs requires a multimodal approach (see Figure 22.1).
Figure 22.1 Prevention and control of HCAI and AMR
CLABSI = central line associated bloodstream infection; RIMD = reusable invasive medical
device
Hand hygiene
The importance of hand hygiene was first demonstrated in 1847 by Semmelweis who decreased
puerperal sepsis mortality from 16% to 3% in the maternity ward he worked in. His finding was
not accepted for many years, but the importance of hand hygiene has been repeatedly
demonstrated over the past 50 years.
Studies demonstrating a sustained improvement in hand hygiene compliance use a multimodal
strategy focused on system and behaviour changes.
Box 22.1 Components of WHO’s multimodal hand hygiene improvement strategy (see
WHO 2009)
• system change: provide access to safe, continuous water supply, soap, and towels;
provide readily accessible alcohol-based hand rub at point of care;
• training/education: provide regular training to all healthcare workers;
• evaluation and feedback: monitor hand hygiene practices, infrastructure, perceptions, and
knowledge; provide results of feedback to healthcare workers;
• reminders in the workplace: prompt and remind healthcare workers;
• institutional safety climate: create an environment and perceptions that facilitate
awareness-raising about patient safety.
Behavioural approaches to improving hand hygiene compliance are likely to be successful by:
• targeting a combination of determinants;
• focussing on social influence, attitude, self-efficacy, and intention rather than only
knowledge, awareness, action control, and behaviour facilitation (see Table 22.1).
Table 22.1 Behaviour change determinants and techniques most likely to improve hand
hygiene compliance
Device-related infections
These can be caused though invasive medical device exposure in hospitalized patients.
Here are examples of the reported prevalence of invasive device use among hospitalized adults in
the USA (AHRQ 2014):
• peripheral venous catheter (PVC): 90%;
• CVC: 35%–50% in ICU, 10%–20% in non-ICU;
• urinary catheter (UC): 50%–80% in ICU, 12%–24% in non-ICU;
• ventilator support: 25%–45% in ICU.
The risk of infection begins at the time when the device is inserted and persists for a while after
removal (the duration varies by device).
The reduction of device-related infection rates generally uses bundled approaches focused on
optimizing device insertion, maintenance, and removal (Figure 22.2).
Box 22.2 Typical components of Central Venous Catheter (CVC) care bundles
Insertion bundle
• hand hygiene (with alcohol-based hand gel) before insertion;
• aseptic technique throughout insertion, with maximal sterile barrier precautions;
• mask, cap, gown, sterile gloves, sterile full-body drape;
• insertion site chosen so as to minimize infectious and non-infectious complications on the
basis of the individual patient’s characteristics;
• femoral site to be avoided in obese adult patients;
• choice of CVC with minimum number of ports/lumens required for the individual patient;
• insertion site prepared with 2% chlorhexidine in 70% alcohol;
• sterile gauze, transparent, or semipermeable dressing applied to the insertion site.
Maintenance bundle
• daily review and recording of ongoing requirement for CVC;
• daily checking that the CVC dressing is intact and was changed within the previous 7
days;
• alcohol CVC hub decontamination (‘scrub the hub’) to be performed before each hub
access;
• hand hygiene before and after all CVC maintenance/access procedures;
• use of chlorhexidine 2% in 70% alcohol for cleaning the insertion site during dressing
changes;
• daily bathing with chlorhexidine of ICU patients over the age of 2 months.
Box 22.3 Suggested methods for making the delivery of all CVC bundle elements more
reliable
• Keep standardized/preferred equipment for CVC insertion stocked in a cart or kit.
• Use an insertion checklist that includes all bundle elements for CVC insertions.
• Empower all the staff involved in CVC insertion to stop the process if element(s) of the
bundle are not being executed.
• Use team-based behavioural change methods to support this (e.g. crew resource
management (CRM), TeamSTEPPS, safety pauses).
• Include an assessment for the removal of CVC in daily goal sheets.
• State the line day (e.g. ‘line day 6’) during rounds, as a reminder of how long the CVC
has been in place.
• Ensure hand hygiene materials (e.g. alcohol hand gel dispensers) are readily available at
the bedside and ergonomically sited.
• Measure bundle compliance using an ‘all or nothing’ measurement and share compliance
data with the staff.
• Make feedback as close to real time as possible.
ALGRAWANY
United States (annually, 2002 data):
• 13,000 attributable deaths;
• 2–4 days increased hospital stay;
• $1200–2400 additional cost per case.
Risk factors for CAUTI:
• prolonged duration of UC use;
• female sex;
• older age;
• diabetes mellitus;
• UC insertion outside the operating room;
• breaches in the closed system of UC drainage.
Box 22.6 Typical components of Clostridioides difficile infection (CDI) prevention care
bundles
• antimicrobial stewardship:
• facility-wide reduction in antimicrobial consumption;
• interventions targeting the use of ‘the five Cs’: cephalosporins, co-amoxiclav,
clindamycin, carbapenems, fluoroquinolones (‘ciprofloxacin’);
• antibiotics to be stopped where possible, if CDI is suspected;
• hand hygiene and contact precautions:
• alcohol gel before, soap and water after contact with the patient, as alcohol gel is
ineffective on spores;
• gloves and apron/gown for direct patient contact;
• dedicated patient equipment;
• staff education;
• patient education;
• environmental cleaning;
• use of chlorine-based disinfectant prior to re-use of room;
• patient isolation;
• proton pump inhibitor stewardship;
• use to be limited to ICU or specific indications;
• systems and workflow changes.
Outcome measures
Device-related infection rates (number of Need clear and easily applied laboratory and
episodes per 1,000 device days) clinical criteria for defining episodes.
Robust surveillance case definitions
produced by CDC (US), ECDC (Europe),
WHO.
Daily device ward census (number of patients Also raises awareness of who has a device in
with device at given time each day) provides place each day.
acceptable denominator
Process measures
Hand hygiene compliance Observational audits (WHO methodology):
people prone to the Hawthorne effect
Alcohol gel consumption (e.g. litres per 100 Surrogate marker of hand hygiene
bed days)
Monitors of adherence to the process
1. % compliance with insertion bundle
2. compliance with maintenance bundle
3. audit of indication for device insertion
4. percentage of devices with at least one
documented and agreed indication
5. median duration of device placement
(days)
6. device prevalence (percentage of
patients with device in place each day,
averaged over week or month)
Summary box
References
Huis et al. A systematic review of hand hygiene improvement strategies: a behavioural approach.
Implementation Science 7 (2012), article 92.
http://www.implementationscience.com/content/7/1/92
Institute for Healthcare Improvement. Measures to prevent healthcare-associated infections. IHI,
n.d. http://www.ihi.org/resources/Pages/Measures/MeasurestoPreventHAIs.aspx.
Society for Healthcare Epidemiology of America et al. Compendium of Strategies to Prevent
Healthcare-Associated Infections in Acute Care Hospitals: 2014 Update. SHEA, 1 May
2014. https://www.shea-online.org/index.php/practice-resources/41-current-guidelines/417-
compendium-of-strategies-to-prevent-healthcare-associated-infections-in-acute-care-
hospitals-2014-update.
Chapter 23
Sepsis and antimicrobial stewardship
Key points
• Sepsis is associated with high levels of morbidity and mortality
• Sepsis-related mortality can be reduced through early recognition and prompt
protocolized therapy
• Antimicrobials are life-saving drugs, but are associated with adverse drug events,
secondary infections, and selection of antimicrobial resistance
• Antimicrobial stewardship is a balance between early effective therapy and avoiding
unnecessary antimicrobial use
• Care bundles methodology can improve the reliability of processes relating to sepsis
management and antimicrobial stewardship
Sepsis
Sepsis is defined as a life-threatening organ disfunction caused by a dysregulated immune
response to infection.
It has a rate of 15% to 24% attributable mortality among hospitalized adults.
It has a long-term impact on survivors, causing cognitive and functional impairment, sustained
inflammation and immune dysfunction, reduced health-related quality of life, and increased
mortality.
Early recognition and treatment of sepsis can decrease mortality.
Antimicrobial stewardship
20%–40% of antimicrobial therapy is considered inappropriate.
20% of patients receiving antimicrobials have an adverse drug event.
Infections caused by antimicrobial resistant organisms could become the commonest cause of
death.
• About 10 million deaths per year are projected worldwide by 2050.
Both mortality and financial costs are doubled for infections caused by resistant versus sensitive
bacteria.
Antimicrobial stewardship programs reduce mortality, morbidity, and financial costs, while
reducing the selective pressure for antimicrobial resistance.
Why is it a challenge?
Sepsis
Sepsis has been described as ‘the perfect storm of immense public health burden combined with
unexplained practice and outcomes variation’ (Walkey and Lindenauer 2017: 1019)
Sepsis is a heterogeneous syndrome, comprising multiple subtypes.
• Variation in prognosis and response to therapy between sepsis subtypes may explain
the failure to demonstrate improved survival in randomized control trials (RCTs).
Clinicians may fail to recognize sepsis in the absence of supportive tools, and its diagnosis is
variable and can be subjective.
Overtreatment of sepsis leads to unnecessary antimicrobial exposure, investigations, and
healthcare resource use.
Both the rational management of sepsis and the rational use of antimicrobials are influenced by
behavioural biases.
Projects focusing on improved sepsis recognition tend to look at patients with lower illness
severity.
• Lower mortality may be due to sepsis intervention, changes in the casemix, or a
combination of both.
• Reporting outcomes only for patients with a final diagnosis of sepsis may miss
unintended consequences for patients with alternative final diagnoses.
Antimicrobial stewardship
Antimicrobial prescribing is a complex task, comprising multiple subtasks.
Prescribers often lack knowledge of key aspects of antimicrobial use, such as:
• spectrum of activity of the antimicrobial;
• pharmacokinetics/pharmacodynamics of the antimicrobial;
• antimicrobial susceptibility data at individual patient and unit/institution level;
• propensity for selection for antimicrobial resistance;
• frequency and type of associated adverse drug events.
Antimicrobial prescribing is often reflexive and based on local habits and culture.
Lack of access to or availability of rapid diagnostics to identify pathogens to guide initial
antimicrobial prescribing decisions can result in incorrect choice of antibiotic
Management of infection, including sepsis, is often seen as an immediate or individual patient
care issue.
• Antimicrobial resistance and other adverse effects of antimicrobials are often seen as
longer-term societal issues.
The duration of antibiotic courses is rarely evidence-based.
• This duration is often based on ‘magic numbers’ (multiples of 5 or 7).
• Antibiotics are continued after the infection is cured or ruled out.
◦ This practice reflects inertia, habit, or the lack of a planned stop date.
An effective recognition and management of sepsis and rational antimicrobial use share some
common features:
• understanding behavioural biases, the local culture, and the context;
• understanding the role of human factors and ergonomics;
• getting access to laboratory diagnostics;
• getting access to the relevant experts in the field;
• using measurement and feedback of data for improvement;
• using care bundles, checklists, and other cognitive support tools.
Sepsis
Sepsis care bundles are mostly aimed at the early recognition and immediate management of the
condition.
They are closely linked to early warning systems for the recognition of illness severity or
deterioration.
Box 23.1 Components of the 2018 Surviving Sepsis campaign ‘Hour-1 Bundle’ for the
immediate resuscitation and management of sepsis (see
http://www.survivingsepsis.org/Pages/default.aspx)
• Measure the lactate level; re-measure if >2 mmol/L.
• Obtain blood cultures before giving antibiotics.
• Administer antibiotics.
• Give 30 mg/kg crystalloid for hypotension or lactate ≥4 mmol/L.
• Give vasopressors if patient remains hypotensive despite fluid resuscitation.
Antimicrobial stewardship
Antimicrobial stewardship in acute hospitals
Persuasive approaches are most likely to deliver sustained improvement and culture changes in
relation to antimicrobial use.
Examples of persuasive approaches:
• audit and feedback of prescribing data to prescribers;
• academic detailing:
◦ peer-to-peer educational outreach;
◦ meetings with prescribers targeting specific aspects of antimicrobial use;
• ‘handshake’ stewardship:
◦ rounding-based review of prescribed antimicrobials;
◦ face-to-face feedback to prescribers by a pharmacist–physician team.
Restrictive approaches are most likely to deliver quick wins, but may not be sustainable.
• They work only for antimicrobials that are targeted for restriction.
• They may lead to ‘squeezing the balloon’: prescribers may overprescribe non-restricted
agents.
Examples of restrictive approaches:
• formulary restrictions:
◦ only selected antimicrobials are available on the hospital formulary;
• requirement for authorization by infection specialists before prescribing specified
agents:
◦ resource intensive;
◦ can be an opportunity for the infection specialist to deliver academic detailing or
ALGRAWANY
handshake stewardship.
Antimicrobial care bundle ‘Start Smart, then Focus’ (see Figure 23.1):
• ‘Start Smart’ reflects the initial diagnostic uncertainty and the need for empiric
prescribing.
• ‘Then Focus’ reflects the ability to make an informed antimicrobial decision in light of
the diagnostic information and clinical course.
Behavioural ‘nudges’ can drive desired changes in prescribing practice.
Examples of successful antimicrobial stewardship nudges:
• suppressing susceptibility results for selected antimicrobials on microbiology reports;
• provision of relevant clinical/prescribing advice on microbiology reports;
• replacing suggested therapy duration in prescribing guidelines with specific guidance as
to when to stop antimicrobial;
• provision of laminated cards with common antibiotic indications to attach to ID badges;
• reminder stickers in charts/prescription records (Figure 23.2), or pop-up dialogue boxes
on electronic healthcare records.
Figure 23.1 ‘Start Smart, Then Focus’: The antibiotic prescribing bundle.
Source: RCPI Hospital Antimicrobial Stewardship Working Group. Adapted, with permission,
from the UK Department of Health’s ‘Start Smart, Then Focus’ hospital antimicrobial
stewardship programme
Figure 23.2 Example of sticker inserted into clinical notes to support the ‘Then Focus’ antibiotic
decision
Reproduced with permission of Chris Little Capital and Coast District Health Board New
Zealand
Sepsis
Process measures:
• % compliance with sepsis care bundle elements:
◦ start with one or two key elements (e.g. time to guideline-compliant antibiotic
administration);
• time to completion of care bundle elements:
◦ important to define ‘time 0’ clearly.
Outcome measures:
• number or rate of sepsis cases detected;
• hospital mortality, 30-day readmission, length of stay among patients with discharge
ICD code for sepsis. Note potential bias due to detection of less severe cases.
Antimicrobial stewardship
Process measures:
• % compliance with elements of the Start Smart, then Focus (SSTF) bundle.
• Combined compliance with local prescribing guideline plus documentation of
indication for therapy is a useful initial measurement for improvement.
Measurement of antimicrobial consumption:
• days of therapy (DoT) per 100 bed days:
◦ accurate measure of antimicrobial use;
◦ difficult to obtain without electronic health records (EHRs) or an e-prescribing
system;
• defined daily dose (DDD) per 100 bed days:
◦ underestimation of antimicrobial use if low doses used (e.g. paediatrics, kidney
failure)
◦ overestimation if high doses used (e.g. guidelines recommend increased
individual dose for a given condition: number of doses stays the same, but DDD
increases);
• point prevalence surveys (PPSs) of antimicrobial use:
◦ provision of baseline data for improvement. Frequent rapid surveys may be the
most feasible measurement in long-term care settings.
Outcome measures:
• Clostridioides difficile infection (CDI) rates are useful for antimicrobial stewardship, as
they target a broad spectrum of antibiotic use (particularly fluoroquinolones and other
agents associated with high CDI rates).
• Antimicrobial resistance:
◦ It is difficult to define a standardized measure of antimicrobial resistance.
◦ Usually you should target a specific local antimicrobial resistance issue (e.g. rate
of infections caused by extended spectrum beta lactamase (ESBL)-producing
Gram-negative bacilli).
• Antimicrobial-related adverse drug events:
◦ Accurate measurement may require post-discharge follow-up.
◦ Usually you should target a specific local adverse drug event (ADE) issue (e.g.
acute kidney injury related to nephrotoxic antimicrobials).
Summary box
References
Further reading
Davey P, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients.
Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD003543.
doi:10.1002/14651858.CD003543.pub4.
Fitzpatrick et al. Sepsis and antimicrobial stewardship: Two sides of the same coin. BMJ Quality
& Safety 28 (2019): 758–61. https://qualitysafety.bmj.com/content/early/2019/04/24/bmjqs-
2019-009445.info.
Ivers, N. et al. Audit and feedback: Effects on professional practice and healthcare outcomes.
Cochrane Library, 13 June 2012.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000259.pub3/full.
O’Neill J. et al. Tackling drug-resistant infections globally: final report and recommendations: he
Review on Antimicrobial Resistance. 2016, London. Wellcome Trust.
https://wellcomecollection.org/works/thvwsuba/items
Rhee, C. et al. Diagnosing sepsis is subjective and highly variable: A survey of intensivists using
case vignettes. Critical Care 20.89 (2016). https://doi.org/10.1186/s13054-016-1266-9.
Chapter 24
Preventing and limiting deterioration on the medical wards
Deterioration
Why is it a challenge to prevent deterioration?
Assessment
Staffing/environment
Human factors
How can one be safe and what is the theoretical basis?
Early warning systems
How do you measure safety on a medical ward?
Falls
Pressure ulcers
Hospital-acquired infections
Specific tools for measuring safety on a medical ward
Summary box
Key points
• Patients can deteriorate unexpectedly and needlessly die.
• Situation awareness of all the factors and anticipation of deterioration can improve
outcomes.
• Risk of deterioration must be managed proactively.
• This includes the use of early warning systems, the assessment of family concerns,
and having a high level of awareness.
• Other risks to patients, such the risk of falls, pressure injuries, and hospital acquired
or healthcare associated infections (HAIs), must be anticipated.
Deterioration
The definition of clinical deterioration has evolved over time, as methods of describing adverse
events have moved from end events (mortality) to describing discrete complications (ICU
admission, cardiac arrest) in the currently prevailing framework, which uses parameters of
physiological instability to predict risk of deterioration. The United Kingdom’s National Early
Warning Score 2 (NEWS2) calculates an aggregated score and, when a predetermined threshold
is reached, a predefined response is triggered (i.e. a review by a clinician). Delayed recognition
of deterioration is a commonly identified safety event.
The recognition of and response to the acutely unwell patient provides multiple barriers and can
be challenging. Patient safety is integral to escalation and to the response to the deteriorating
patient. It is recognized that a delay in time-critical care and treatment can lead to suboptimal
results. The challenges in preventing deterioration can be categorized into three key areas:
Assessment
• Not knowing the patient well: the need for appropriate handover: the use of structured
handover tools such as ISBAR (introduction, situation, background, assessment,
recommendations) has been shown to improve communication and confidence about
recognizing deteriorating patients, with subsequent improvements in patient safety.
• The importance of using family members, friends, and relatives of the patients: this
practice supports clinicians to recognize soft signs of deterioration and subtle changes in
behaviour.
• Failure to recognize and escalate: the NEWS or the paediatric early warning score
(PEWS) is normal but the patient looks unwell.
• Delays in escalation: these are delays in the escalation of care secondary to a hierarchical
process of escalating through ‘the knowledge of skills ladder’, often from healthcare
assistant (HCA) to junior nurse, ward sister, junior doctor, specialist registrar and
appropriate consultants as needed.
Staffing/environment
Human factors
• Non-technical skills relate to communication, raising concerns, and having ‘gut feelings’.
Common themes from incidents regarding missed deterioration or failure to rescue a
patient are communication barriers and situational awareness.
• Poor leadership should be eliminated. It has been reported that detecting and limiting
deterioration and improving patient safety depends on good role models within the
organization.
• Senior clinicians, including ward managers and supervisors, need to ensure an
environment where staff members feel able to raise a concern and create a ‘no blame’
culture. While a ‘no blame’ culture is important, individuals involved in caring for
deteriorating patients need to be supported and educated appropriately.
This third key area of challenge is discussed in Chapter 9. Application of the SEIPS model
is helpful to understand the challenges to detect deterioration.
To optimize the ward nurse’s response to a deteriorating patient, it is essential to flatten the
hierarchical structure of clinical practice. A multidisciplinary response to the deteriorating
patient has been shown to improve patient outcomes dramatically, in conjunction with
developing the non-technical skills associated with escalation and leadership.
The measurement and documentation of vital signs is often delegated to junior staff members,
who often see it as an observation round and as a task-oriented process rather than as a clinical
assessment of the trend in the patient’s physiology. The observation rounds are an opportunity to
include a full physical assessment, encompassing visual prompts and enlisting the aid of touch.
The staff may become reliant on technology and scoring systems to trigger concerns about a
patient; however, a holistic assessment is equally important.
The National Patient Safety Agency (2004) published Seven Steps to Patient Safety, which sets
out seven steps that healthcare organizations should take to improve patient safety and to help
them to meet their clinical governance and risk management targets.
Table 24.1 highlights practical approaches in which individuals and their microsystems,
mesosystems, and macrosystems can follow these steps in order to improve patients’ safety on
the medical ward.
In 2017 the Royal College of Physicians (RCP) published NEWS2, where it aimed to improve
safety for patients with hypercapnic respiratory failure by suggesting a separate oxygen
saturation (SpO2) parameter scoring system for such patients. The plan was to have this system
adopted by all acute hospitals by March 2019. Similar early warning systems are available in
other countries.
The system allows for a common language between the community setting, the ambulance
service, and intra-hospital people in order to avoid any potential delays in responding to an
unwell patient.
A clinical response is required for NEWS of 5 and above, as this is an indication of a
potentially acutely unwell patient. Evidence is growing to support the view that NEWS2 is more
sensitive to the identification of sepsis and allows improved management and recognition of
patients with hypercapnic respiratory failure.
Falls
Falls in the in-patient setting are the most commonly reported patient safety incident type across
England and Wales, accounting for 240,000 incidents, as per the consensus statement from
Public Heath England, 2017. All in-patients over the age of 65, and those between 50 and 64
years who are considered high falls risk, should be considered for a multifactorial assessment
during their in-patient stay. (See Frailty Chapter 34)
Pressure ulcers
The prevalence of pressure ulcers on a general medical ward is estimated to be 4.7% (Thompson,
Healey, and Scobie 2007). Estimates for the daily cost of a pressure ulcer are between £43 and
£374. Hospital-acquired pressure ulcers extend the length of an in-patient stay by an average of
5–8 days per pressure ulcer (Bennett, Dealey, and Posnett 2004). All adult in-patients should
have on admission, a risk assessment designed to determine the likelihood of their developing a
pressure ulcer, and those identified as high risk should be treated with preventable measures.
(See Frailty Chapter 34)
Hospital-acquired infections
Hospital-acquired infections, also termed healthcare-associated infections, develop either as a
result of a medical or surgical intervention or through contact with a healthcare environment.
Every year, approximately 300,000 individuals develop a hospital-acquired infection—a
prevalence of 6.4% of in-patients across all specialities, as per the Health Protection Agency’s
annual survey in 2012/13. The most common types of hospital-acquired infection on a general
medical ward are respiratory infection, urinary tract infection, including catheter-associated
infection, gastrointestinal infection, and blood stream infection. (See HAI Chapters 22 and 23)
Specific tools for measuring safety on a medical ward
Mortality and morbidity meetings are an essential method for measuring and analysing safety.
The RCP has developed a National Mortality Case Record Review (NMCRR) toolkit to support
trusts to implement a standardized way of reviewing case records in adults who have died in
acute hospitals across England and Scotland. The national programme aims to improve
understanding and to promote best practice across the NHS. Here are some of the tools:
audit of medical emergency calls and cardiac arrests;
survival to discharge following cardiac arrest;
monitoring escalation to higher levels of care;
staff turnover and staffing levels;
patient experience;
friends and family complaints and feedback to assess satisfaction (in the UK this is part of
required reporting);
serious incidents and monitoring incidents of hospital-acquired infections such as MRSA and
Clostridium difficile;
compliance with hand hygiene and monthly audits of practice;
compliance with sepsis screening and NEWS compliance;
the NHS safety thermometer is a point-of-care survey instrument designed to provide a
‘temperature check’ of harm locally. Safety thermometer tools are available for different clinical
areas such as mental health, paediatrics, and medication safety. The original tool, which is used
on medical wards, involves measuring harm from pressure ulcers, falls, catheter-associated
urinary tract infections, venous thromboembolism, and harm-free care;
mandatory and statuary training: intermediate, advanced, and basic life support (ILS, ALS,
BLS);
completion of the mandatory General Medical Council Survey and learning from its results.
Summary box
References
Bennett, G., Dealey, C. and, Posnett, J. The cost of pressure ulcers in the UK. Age Ageing. 33.3
(2004): 230–5.
National Institute of Clinical Excellence. Improving the detection and response to patient
deterioration: Shared learning database. NICE, February 2011.
https://www.nice.org.uk/sharedlearning/improving-the-detection-and-response-to-patient-
deterioration.
National Patient Safety Agency. Seven Steps to Patient Safety: An Overview Guide for NHS
Staff. NPSA 2004.
https://www.publichealth.hscni.net/sites/default/files/directorates/files/Seven%20steps%20to%20safety.pdf
Purling, A. and King, L. A literature review: Graduate nurses’ preparedness for recognisisng and
responding to the deteriorating patient. Journal of Clinical Nursing 21.23–24 (2012): 3451–
65.
Thompson, R., Healey, F., and Scobie, S. Safer Care for the Acutely Ill Patient: Learning from
Serious Incidents. Patient Safety Observatory Report. National Patient Safety Agency, 2007.
https://www.baccn.org/static/uploads/resources/NPSA_Report.pdf.
Further reading
Ball, C., Kirkby, M., and Williams, M. Effect of the critical outreach team on patient survival to
discharge from hospital and readmission to critical care: Non-randomised population based
study. BMJ 327.7422 (2003), article 1014. doi: 10.1136/bmj.327.7422.1014.
Joint Position Statement on Rapid Response Systems in Australia and New Zealand and the
Roles of Intensive Care. ANZICS 2016.
https://www.cicm.org.au/CICM_Media/CICMSite/CICM-
Website/Resources/Professional%20Documents/IC-25-Joint-ANZICS-and-CICM-Rapid-
Response-Systems-Position-Statement.pdf.
Leonard, M., Graham, S., and Bonacum, D. The human factor: The critical importance of
effective teamwork and communication in providing safe care. BMJ Quality and Safety 13.1
(2004): i85–i90.
Massey, D., Chaboyer, W., and Anderson, V. What factors influence ward nurses’ recognition of
and response to patient deterioration? An integrative review of the literature. Nursing Open
4.1 (2017): 6–23.
Royal College of Physicians. National Early Warning Score (NEWS) 2. 19 December 2017.
https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2.
Thompson, J. et al. Using the ISBAR handover tool in junior medical officer handover: A study
in an Australian tertiary hospital. Postgraduate Medical Journal 87.1027 (2011): 340–4.
Winters, B. D. et al. Rapid response systems: A systematic review. Critical Care Medicine 35.5
(2007):1238–43.
Chapter 25
Preventing and limiting diagnostic error
Key points
• The process of diagnosis commences at the point of deciding whether to investigate
or not.
• The process needs to be co-produced with the patient and family.
• Safety challenges occur at every step: ordering, then performing the investigation,
interpreting the results, and giving feedback to the patient
• Human factors, reliability, and resilience theories assist in designing a safe process.
The use of investigation is a key part of the diagnostic process. There are many possible steps in
the process that can lead to error or delay in diagnosis, from taking the specimen or ordering the
intervention to performing the test, interpreting the results, and acting on the results. In addition,
delays to the process may result in harm.
In this chapter we focus on the system that delivers diagnosis rather than on the individual
who makes a wrong judgement or overlooks a finding. By identifying the key components of the
patient’s journey and designing that journey with the patient’s safety in mind, the team will
mitigate the risks of error.
The adoption of a proactive approach will ensure that every member of staff has a
commitment to high-quality safe care at every stage of the process, not only during that part for
which he or she has direct responsibility (see Table 25.1).
We have focused on imaging, but apart from the specific safety issues around ionizing
radiation, the sequence of the patient’s journey and the approaches to reducing the risk of
diagnostic error are very similar in any diagnostic service.
Why is it a challenge?
All diagnostic services (including imaging, endoscopy, laboratory, interventional radiology) are
complex systems. The risk of error is considerable in these departments and in their interactions
with referring clinicians, patients and their families, and the organization at large.
Measuring error is undertaken on a case-by-case basis, as well as through the regular review of
processes for reliability. Equipment is rigorously maintained to agreed standards, and ionizing
radiation in particular is highly regulated in its use.
All diagnostic units and departments are now expected to create the infrastructure and internal
programmes that help them to understand where errors can occur and to take action to reduce or
remove these risks. Within the NHS the quality standard for imaging (QSI, formerly known as
ISAS) is designed for the purposes of quality improvement. Similarly, for endoscopy, the joint
accreditation standards for endoscopy (JAG) define the service standards that cover all aspects of
an endoscopy service to ensure safe high-quality diagnosis. The NHS National Safety Standards
for Invasive Procedures (NatSSIPs) provide examples and guidance on how to minimize the risk
of harm in surgery and other situations where an invasive procedure is undertaken—renal biopsy
or chest drain insertion, for example. The combined approach of agreed standards, a formal
accreditation system, and regulatory oversight share and develop best practice and inspire
confidence that the latter is being adhered to.
1. Referrer’s knowledge, including the evidence base and decision support systems:
a) Test requesting is designated according to the experience of the referrer (example:
only a consultant or a senior staff member can request or authorize tests).
b) Knowledge and accreditation of the referrer is required (example: Ionizing Radiation
(Medical Exposure) Regulations (IR(ME)R) for requesting ionizing radiation).
c) Easy and required access to decision support/evidence base supporting appropriate
tests (examples: I Refer; Image Wisely). If requesting is computerized, such decision
support can be a mandatory part of the ordering sequence.
2. Patient information:
a) Three or more unique identifiers for the patient need to be produced at and on every
request.
b) Relevant history of the patient is required, not just symptoms and signs.
c) Co-morbidities are described and defined where they add to the risk of the
examination (example: renal function when impaired and IV contrast may be used).
3. Referrer–diagnostician communication and relationships:
a) There needs to be openness of communication and mutual access between referrer and
diagnostician.
b) There needs to be shared responsibility for the patient’s outcome and agreement
among all that the test is required and as to how and when it should be performed.
4. The feedback and learning system:
a) regular review of cases together, to learn and share new knowledge or understand the
role of the test in the patient’s journey (example: multidisciplinary weekly meetings);
b) regular review and open discussions on errors of omission or commission identified by
the department or referring clinicians (example: READ newsletter from the Royal
College of Radiologists);
c) whole departmental review of errors or near misses related to referral or the
scheduling of diagnostic examinations.
An open learning culture requires all parties to share their interpretations of images and, where
there are differences in opinion or judgement, to find a constructive means to resolve them with
the patient’s best interests at heart (example: develop a regular whole team review meeting
where errors of commission and omission and interesting cases are considered).
The patient’s feedback and involvement are used to co-design a safer and more effective care
(examples: designing children’s services to reduce anxiety included parents’ or children’s
involvement in or advice about decorating the endoscopy or scanner area; approaches to
venepuncture to reduce anxiety and improve procedural quality).
Summary box
Safety theories and improvement methods that can be used to enhance diagnostic safety
Human factors analysis (example: work environment, task design)
Process reliability (example: patient ID check and scanning protocols)
Team building and team performance (example: open culture and regular review of near
misses and errors of commission and omission)
Standardized communication tools (example: request and report templates)
System resilience (example: well defined and tested process for reporting unexpected and or
significant findings)
Technical resilience (example: comprehensive equipment maintenance and repair
programme)
Co-production (example: using the patient’s experience to reduce the risk of harm or the use
of excess radiation or sedation
Further reading
What are the key safety issues in primary care and general practice?
Why is it a challenge to be safe?
How can one be safe?
What is safer care?
Focus areas to prevent harm
The essence of time
What do you need to do to be safe?
Leadership for a culture of safety
Mitigation
Risk control
How do you measure your safety?
Measures of culture
Measures of process
Summary box
Key points
• Adverse events in primary care and general practice are common.
• The care provided in primary care is complex, heterogeneous, and longitudinal. This
leads to unique safety challenges.
• Higher-risk aspects of general practice are identified and more specific safety
concerns explored.
• Rates of remote consultation have increased significantly owing to COVID 19.
Advice for safer remote consulting is included.
• Practical approaches to improving safety in primary care and general practice are
presented, including leadership, mitigation and risk control.
• Useful strategies for measuring and learning from safety culture, processes, and
events are detailed.
What are the key safety issues in primary care and general practice?
Approximately 90% of all patient encounters in the United Kingdom occur in general practice
(over 300 million each year). There is a lack of robust epidemiological data to quantify the
current level of safety in primary care accurately. It is estimated that 1%–2% of all consultations
involve an adverse event, and it is thought that 11% of all prescriptions contain an error (Health
Foundation 2017). It is believed that most errors do not affect patients adversely or cause harm;
however, given the enormity of the overall number of patient interactions, it is possible that the
total burden of harm is greater in primary than in secondary care.
While much of the science of patient safety originated in secondary care, there is an ever
increasing emphasis and recognition of its importance in primary care. In the unique
environment of primary care the challenges, measures, and tools associated with providing safe
care must be adapted and made suitable to the particular nature of the care provided.
General practitioners interact with large numbers of patients in relatively short consultations.
Patients are living longer with multiple comorbidities, which involve increasingly complex care.
Patient care often involves multiple care providers, spread across both primary and secondary
care, with relatively poor levels of integration across care interfaces. In addition to this, general
practitioners are expected to provide unparalleled levels of personalized care, responsive to
patient values and preferences in a community context.
The number of general practitioners practising single-handedly continues to fall, as care shifts
to larger group practices, with resultant impacts on the continuity of care for individual patients.
There is also an increasing emphasis on the provision of allied health and multidisciplinary care
closer to home for patients. In this context, improving patient safety in primary care is
challenging.
Diagnosis
General practitioners (GPs) are expert at managing uncertainty in diagnosis. When managing
large volumes of minor problems, it is neither feasible nor good practice to investigate every
patient to the level where absolute diagnostic certainty can be achieved. Over investigation is a
recognized cause of patient harm.
However, it is also incumbent upon GPs to diagnose and appropriately manage more rare
serious conditions within this milieu. The rate of diagnostic error in general practice is estimated
to be approximately 4%. Diagnostic error can be attributed to one incident in time, for example
to the misinterpretation of a laboratory result, or can unfold over weeks or months, with an
accumulation of errors. The most common cause for litigation in primary care is failure or delay
in diagnosis, particularly for cancer and myocardial infarction in adults and meningitis in
children. Common features contributing to diagnostic difficulty include:
co-morbid illnesses;
non-specific presentations;
atypical presentations of the disease;
very low prevalence of the condition.
Communication
Modern models of healthcare require patients and their data to cross care boundaries regularly,
both between providers in primary care and between providers in primary and secondary care.
Communication of essential patient data is often suboptimal. Errors can arise in communicating
referral and discharge information, investigation requests and results, and medicines
reconciliation. Poor and ineffective communication between primary care and the many other
elements of the healthcare and social care system are a major source of error and patient safety
incidents (see Box 26.2).
Variation
There is widespread variation in how different conditions are managed across all healthcare
sectors, but especially in primary care, given its heterogeneity. Safer care requires the consistent
application of best evidence-based practice where appropriate in the care of each individual
patient. This can be achieved through the application of reliability theory. The use of care
bundles for chronic illnesses such as chronic obstructive pulmonary disease, diabetes, and
hypertension, as well as the use of standardized community antimicrobial prescribing guidelines,
can assist in reducing unwanted variation.
Out-of-hours work
Care provided in out-of-hours settings is different in many ways from routine general practice.
Many out-of-hours care structures provide nurse-led phone triage services and scheduled
appointments at centralized care settings. In most cases, the care provider is not the patient’s
usual GP, and the consultation is more likely to focus on a single presenting complaint.
However, as the treating doctor may not have access to comprehensive health and medication
records, previous clinical knowledge of the patient, or the opportunity to provide further follow-
up care, the level of error is recognized as being considerably higher, with an estimated error rate
of 2% to 6% for all out-of-hours consultations.
Remote consultation
With increasing demand on services and changing patient expectations, general practices are
increasingly caring for patients via remote consultation (see Box 26.3). This type of consultation
can be synchronous (telephone or video call) or asynchronous (email, text message, or instant
messenger).
While currently there is a lack of robust data on specific safety concerns related to consultation
through these media, tailoring the appropriate medium of consultation to the clinical concern to
ensure diagnostic accuracy and timely, effective management is essential. For example, emailing
a photograph of a chronic intermittent rash may be safe and could aid diagnosis, but email would
not be a suitable or safe means of assessing a patient with central crushing chest pain.
When using electronic media, it is advisable, where possible, to ensure good quality and a fast
and reliable connection, in order to optimize communication and enhance the clinician’s
sensitivity to illness cues (verbal and non-verbal). It is also important to plan how these types of
consultations can be safely accommodated and organized during a busy working day.
Disease Is based on average disease evolution time. Error arises when disease or treatment
Tempo effects do not follow the expected time pattern for a given condition, be they too
slow or too fast.
Office Relates to the organization of working time (e.g. consultation times, interruptions,
Tempo non-work commitments). Risk arises when the availability or capability of the GP
to provide focused care is compromised, often as a result of competing demands.
Patient Considers the perspectives and behaviours of individual patients. Risk can increase
Tempo if patients minimize their symptoms, do not have the same health priorities as their
GP, or fail to arrange follow-up as planned.
System Comprises the time spent navigating through the healthcare system outside the GP
Tempo surgery. Patient safety can be compromised if referral pathways are ineffective, if
there are unexpected delays in the system, or if communication across care
interfaces is suboptimal.
Doctor Refers to how time affects the clinical performance of the doctor. Safety can be
Tempo compromised if the doctor cannot cognitively synthesize all the available
information effectively, if knowledge or expertise is not used in the correct way, or
if expected steps in examination are neglected.
Mitigation
Mitigated patient safety events result in less frequent and less severe harm to patients. The
mitigator can be the clinician, the patient, or a family member. It is estimated that mitigation
ameliorates almost a quarter of all harm events and is an often overlooked tool for patient safety
improvement.
Risk control
Proactive management of risk will decrease harm. Risk control strategies can occur at the level
of the individual GP or of the system.
To take prescribing as an example, an individual GP may control risk by insisting that a
particular medication be dispensed in fixed amounts on a weekly basis. At a system level,
medication risk control may include restrictions around prescribing and dispensing high-tech
medications, some medications requiring a prescription or administration in specialist secondary
care settings.
Other examples of risk control strategies are individual GPs capping the number of patients that
they will see in a day or the number of patients under their care at any one time.
Many of the measures that follow also represent excellent focal points to drive improvement.
Measures of culture
General practice safety climate survey tools (e.g. GP-SafeQuest):
• The climate tool measures safety perceptions among all members of the primary care
team and can be used to facilitate reflective discussions on safety concerns within the
practice, as well as useful comparisons with other practices.
Safety culture frameworks, for example the Manchester Patient Safety Framework (MaPSaF):
• The MaPSaF makes the concept of patient safety more accessible and enables teams to
reflect upon and explore the safety culture within their organization.
Measures of process
Safety checklist for general practice (e.g. the monitoring risk and improving system safety
(MoRISS) checklist):
• The safety checklist is a comprehensive systems-based approach aiming to combine
existing checking processes into a single checking system within the general practice
environment. Ideally it is undertaken every four months.
Prescribing safety indicators (e.g. the indicators developed by the British Journal of General
Practice and the PINCER Audit Tool):
• These indicators identify scenarios where there is potentially unsafe prescribing. They
can be adapted for use in individual practices or expanded with online software to allow
benchmarking both locally and nationally.
Medicines reconciliation tool (e.g. the National Institute for Health Research School for Primary
Care Research (NIHR-SPCR) Medicines Reconciliation Tool):
• The medicines reconciliation tool is an audit tool for assessing the quality of medicines
reconciliation following discharge of a patient from secondary to primary care.
Patient safety questionnaire (e.g. the Patient Reported Experiences and Outcomes of Safety in
Primary Care (PREOS-PC):
• The patient survey tool assesses patient experiences of safety in the general practice.
Always events are an indicative list of practices or behaviours that encourage optimal patient and
family experience when implemented consistently. They should be measurable, deliverable, and
feasible as part of routine healthcare delivery.
The trigger tool is a simple and quick checklist for screening a small sample of electronic patient
files to identify and learn from previously unrecognized risks and potential harm events.
The SEA is a team-based systematic approach to identifying and learning from significant
occurrences, both positive and negative, in order to improve quality and safety in general
practice. Enhanced SEA incorporates and applies human factors principles to this learning (see
Box 26.5).
Box 26.5 Significant event analysis
Never events
Never events are a list of serious but preventable patient safety incidents used to focus on, and
drive, safety improvements in general practice. Examples include prescribing a drug to a patient
with an allergy to that drug, failing to send a referral for a patient with a suspected diagnosis of
cancer, or prescribing a teratogenic drug to a pregnant patient (see Box 26.6).
Summary box
Top tips
• Appreciate the unique challenges in providing safe care in primary care, given its
complexity and heterogeneity.
• Maintain awareness of, draw attention to, and measure known high-risk aspects of
primary care and general practice.
• Recognize the role and relationship that time can have with risks to safety in primary care
and general practice.
• Apply the theories and tools presented in this chapter towards creating a culture of safety
in primary care and general practice.
Reference
The Health Foundation. Evidence scan: Levels of harm in primary care. The Health Foundation,
2011, November. https://www.health.org.uk/publications/levels-of-harm-in-primary-care.
Further reading
Amalberti, R. and Brami, J. ‘Tempos’ management in primary care: A key factor for classifying
adverse events, and improving quality and safety. BMJ Quality & Safety 21.9 (2012): 729–
36. doi: 10.1136/bmjqs-2011-048710.
Bowie, P., De Wet, C., and Pringle, M. Significant Event Analysis: Guidance for Primary Care
Teams. NHS Education for Scotland, 2011. http://www.cpdconnect.nhs.scot/media/1362/sea-
guidance-for-primary-care-teams.pdf.
de Wet, C., O’Donnell, C., and Bowie, P. Developing a preliminary ‘never event’ list for general
practice using consensus-building methods. British Journal of General Practice 64.620
(2014): e159–e167. doi: 10.3399/bjgp14X677536.
Garfield, S. et al. Quality of medication use in primary care: Mapping the problem, working to a
solution: A systematic review of the literature. BMC Medicine 7.50 (2009). doi:
10.1186/1741-7015-7-50.
Greenhalgh, T., et al. Planning and Evaluating Remote Consultation Services: A New
Conceptual Framework Incorporating Complexity and Practical Ethics. Frontiers in digital
health 3 726095.(2021), doi:10.3389/fdgth.2021.726095
Healthcare Improvement Scotland. Scottish Patient Safety Programme: Primary Care.
https://ihub.scot/improvement-programmes/scottish-patient-safety-programme-spsp/spsp-
programmes-of-work/spsp-primary-care/
Royal College of General Practitioners. Patient safety toolkit for general practice. RCGP, 2021.
https://www.rcgp.org.uk/clinical-and-research/resources/toolkits/patient-safety.aspx.
Singh, H. et al. Identifying diagnostic errors in primary care using an electronic screening
algorithm. Archives of Internal Medicine 167.3 (2007): 302–8. doi:
10.1001/archinte.167.3.302.
Vincent, C. and Amalberti, R. Safer Healthcare: Strategies for the Real World. Springer Open,
2016. https://link.springer.com/book/10.1007%2F978-3-319-25559-0.
Wallace, E. et al. The epidemiology of malpractice claims in primary care: A systematic review.
BMJ Open 3 (2013): e002929. doi: 10.1136/bmjopen-2013-002929.
Chapter 27
Safety in the emergency department
Key points
The emergency room offers several safety challenges:
• The environment may not be ideal due to overcrowding.
• Patients have varying degrees of acuity that require rapid assessment.
• The tasks required are varied and the clinical staff needs to have a range of skills to
complete these tasks.
• Organization culture is important if one is to have situation awareness.
• People’s cognitive biases can lead to diagnostic error.
• Solutions require teamwork and effective communication.
What is the safety issue?
Clinical practice in the emergency department contains the same patient safety risks and
challenges as all other areas of medicine. However, there are environmental and organizational
factors that are specific to emergency medicine and cause unique problems that require bespoke
solutions.
A definition of emergency medicine has been suggested by the International Federation of
Emergency Medicine: ‘A field of practice based on the knowledge and skills required for the
prevention, diagnosis and management of acute and urgent aspects of illness and injury affecting
patients of all age groups with a full spectrum of undifferentiated physical and behavioural
disorders’ (https://www.ifem.cc/about-us).
This definition is relevant because it emphasizes that a core component of emergency
medicine is the management of undifferentiated patients. An emergency medicine environment
requires staff to understand how to diagnose and treat a range of conditions across a range of
ages. The risk of cognitive biases, that is, of unknowingly making incorrect decisions through
reliance on heuristics, is high. It is not possible to provide complete management in a short
period of time in some cohorts of patients, as to do so would structure processes and resources
that would be impossible to deliver in any healthcare system.
Clinicians must work with limited information to make appropriate diagnoses in a timely
fashion, and then determine which patients need further investigation and treatment and which
ones can be discharged to other environments, including their own residence.
In order to do this with large numbers of patients, there need to be systems of triage (ordering
of patients by degree of urgency and acuity), rapid assessment, treatment, resuscitation, and risk
stratification. Specific to emergency medicine are four factors that impact on the effectiveness
and safety of the department regardless of its location in the world (see Figure 27.1).
Figure 27.1 Pressures on the emergency department work system.
Crowding
In order to process patients effectively, it is important for the outflow from the department to be
high—that is, when a decision to admit or discharge is made, this should happen swiftly. Many
hospitals reach their bed capacity very quickly, and therefore there is nowhere to ‘bed’ patients
from the emergency department (inflow being greater than outflow). Patients who remain in the
emergency area take up a physical resource (a bed) and a practical resource (clinical staff must
continue to care for them while looking after newly arriving patients as well).
Crowding is consistently related to increased mortality rates, which are multifactorial.
Crowding is also related to decision-making within the emergency department, which may cause
crowding (repeated unnecessary investigations) or be impacted by it (cognitive fatigue).
Ultimately crowding demonstrates that flow through the department is not optimized; and flow is
essential to ensure processes are safe.
High acuity
Patients with higher than average acuity may demand increased observation and investigation if
they are acutely unwell—with appropriately reversible pathology and therefore greater resource
per patient. It is difficult to predict periods of high acuity, but seasonal changes (e.g. a flu
epidemic) or mass casualty incidents are common triggers.
High inflow
Attendance per unit time can overwhelm triage and assessment processes, regardless of whether
outflow is good. A long time to initial triage can be detrimental, since high-risk patients may not
always be visibly unwell but can be at high risk of sudden, unexpected deterioration (e.g. a
neonate with a fever).
Staffing
The management of undifferentiated, undiagnosed patients from first principles is very different
from the actual experience of in-hospital medicine. Operating at the limit of competence—a
situation many staff members assigned to the emergency department will initially find
themselves in—places an increased burden on them and requires the presence of a senior
decision maker to facilitate the correct patient management. While staffing levels impact all
clinical environments in the emergency department, there are also particular dependencies on
skilled staff in certain areas. Triage is a particular practice that needs to be performed by a
specifically trained staffing group, often according to set protocols and towards the end of the
patient’s journey in an emergency department. The absence of competent decision makers affects
patient flow, and therefore increases crowding.
Why is it a challenge?
Crowding, high acuity, high inflow, and staffing have a variety of impacts on patient care.
Individual impact
In emergency department practice, the rapid flow of patients promotes reliance on heuristics.
These are cognitive shortcuts that the clinical staff use in order to avoid spending significant
amounts of time processing all the available information all the time; heuristics prevent delays in
the delivery of patient care and expedite the flow. They are extremely useful and generally
reliable, but introduce the possibility of cognitive biases in the decisions that staff members
make.
Cognitive biases
Assumption bias is the tendency to use a small amount of information to confirm a diagnosis
when there should be uncertainty (e.g. the belief that the abdominal pain of an intravenous drug
user is an addicted person’s route to being prescribed an opiate, when in fact that person has
appendicitis).
Attribution bias occurs when a specific sign or system is used to confirm, and therefore
close, an investigative pathway because it fits neatly with the presenting pattern of the disease
that the clinician has in mind. For example, if a person presents with chest pain and the diagnosis
is solely considered to be cardiac in origin, without other possibilities considered such as
pulmonary embolism. The presence of flow charts and algorithms (thought to improve safety)
may have the opposite effect here, encouraging an incorrect patient to be put on the ‘correct’
pathway.
Diagnostic momentum is also prevalent in patient pathways in the emergency department,
especially when the staff are under pressure to see as many patients as possible in a short period
of time. The patient with breathing difficulty, chest pain, and a mild elevated temperature is
easily placed on a sepsis pathway rather than being worked up properly for the pulmonary
embolus he or she actually has.
These cognitive biases increase when internal and external pressures are placed on an
emergency department and staff members do not have sufficient time or sufficient access to
senior staff to ‘sense-check’ decisions.
The diversity and complexity of patients and the gruelling shift in patterns to cope with
workloads give emergency medicine a higher than average incidence of burnout. Burnout
impacts patients’ safety through individual disenfranchisement, compassion fatigue, and system
resource issues, as members of staff are absent in increasing numbers and rotas struggle to
complement.
Finally, unprofessional behaviours are recognized to impact on the quality of care and on
patient outcomes, doing moral injury to members of staff. The mixing of specialty groups in
emergency departments often causes disputes over the best approach to management with
differing attitudes to risk and responsibility. While these issues may be present at any time,
during peak demand or when crowding, acuity, and inflow are high, both the emergency
department and other hospital staff may display maladaptive behaviours to each other, further
decreasing the chance of effective communication.
System factors
Emergency departments have a suite of processes they use to balance the large number of
patients who need to be seen by a relatively finite group of staff members. During periods of
high acuity or overcrowding, these systems can begin to fail. While escalation policies with
defined and measurable end points should be in place for exceptional circumstances, the high-
pressure state is increasingly the norm, creating a constant platform for errors to occur. Housing
patients in corridors, with significantly long waits until the initial assessment, and managing
patients through staff not familiar with their underlying illness both contribute to an increase in
mortality when demand exceeds the capacity of the hospital. This creates a patient safety issue at
all the levels of potential harm for the individuals involved—patients and providers.
One could mitigate the risk by sharing it throughout the hospital. For example, if the
emergency department is housing patients for considerable periods of times (more than 12
hours), all wards in the hospital could take extra patients, even if it meant that their nurse-to-
patient ratio is exceeded; in this way the risk would be shared.
Case studies
Trauma systems
There is considerable evidence supporting the treatment of patients with significant injuries in
departments that are used to dealing with these patients. To ensure that the most appropriately
trained staff is available, some emergency departments do not receive such patients, while others
become major trauma centres where patients are preferentially taken, even if this means a longer
journey. The benefits of this approach are well documented; and there is a similar initiative in
stroke and myocardial infarction. In England, the Trauma and Audit Research Network (TARN)
is a national organization that collects data on all significant injuries in patients presenting to
emergency departments; and TARN has highlighted the importance of specialist and experienced
staff being available to improve outcomes.
Summary box
Five key interventions can make a difference in safety in the emergency department
Further reading
Amaniyan, S. et al. Learning from patient safety incidents in the emergency department: A
systematic review. Journal of Emergency Medicine 58.2 (2020): 234–44.
https://doi:10.1016/j.jemermed.2019.11.015.
Ramlakhan, S. et al. The safety of emergency medicine. Emergency Medicine Journal 33 (2016):
293–99. http://dx.doi.org/10.1136/emermed-2014-204564.
Chapter 28
Safety in ambulatory care
Key points
• Ambulatory care has been introduced to provide person-centred care in a safe
environment and thereby avoid unnecessary admissions to hospital.
• Safety risks include deterioration, lack of adequate facilities and equipment, and lack
of robust procedures to ensure safe care.
• The proactive mitigation of risk includes using human factors and reliability theories
to design a safe work system and a standardized process of care.
• Good communication is an essential factor in safety in ambulatory care.
The meaning of the term ‘ambulatory care’ varies in different settings. In this chapter we define
ambulatory care units as clinical settings where people who would have historically been
admitted to an in-patient bed can be managed as their clinical condition allows. This way of
managing such people requires rapid reviews, timely assessments and investigations ideally
performed on the same day.
The avoidance of unnecessary admissions will always carry an element of risk, requiring
careful management of processes and pathways. These processes must certify that patients are
appropriately selected for ambulatory care, as well as managed safely while on the unit.
There are significant gaps in ambulatory safety research, as few studies focus on patient
engagement and on accurate diagnosis. Ambulatory care differs substantially from in-patient
care, and studies have identified the following points as key safety issues pertinent to ambulatory
care (Box 28.1).
Clinical:
• medication safety and adverse drug events;
• missed or delayed diagnosis;
• treatment delays or lack of preventive services.
Investigations:
• missing laboratory reports, imaging procedures, and consultations;
• separate IT programmes for the unit, the emergency department, and other departments,
whose results other teams in the hospital may not be able to access.
The challenge faced when designing for safety is that, despite increasing numbers of patients
being managed in ambulatory care settings worldwide, there has been less research and scrutiny
into quality and safety in such settings than in high-risk in-patient settings. There may be risks
and unintended consequences that are not well recognized. The management of some patients
and the assessment of the suitability of patients for ambulatory care may vary among clinicians.
Lines of responsibility between multiple clinicians may become blurred. To address this
problem, a human factors approach is beneficial when designing the work system, as described
in Chapter 11. Careful consideration of the works system and of the agreement of processes is
required (see Box 28.2).
Box 28.2 Actions to take in design of the work system in ambulatory care
Organization
• communication to all about the unit and its purpose;
• scope and function of the unit specified;
• limitations: inclusion and exclusion criteria clearly defined;
• safety culture enhanced.
Process
• standard operating procedures agreed and followed;
• referral pathways agreed with all stakeholders;
• management of out-of-hours referrals;
• clear processes for the transfer or redirection of patients who attend, but are not safe to
stay in the environment;
• safety net provisions in the event of a deterioration in patients.
People
• engagement and co-design with patients, to manage expectations;
• appropriate skills in staffing.
Tasks
• All staff should be skilled enough to undertake the procedures and the monitoring.
Measurable outcomes
• The unit measures process and outcomes as well as staff and patient satisfaction and
experience.
Maintaining safety in a constantly developing and evolving service is often difficult and needs to
have clear systems and operational policies in place to communicate and document procedures
and ensure that the staff can follow these to maintain patient safety. The key areas of safety are
patient selection and standardized processes (see Box 28.3).
Each pathway should outline clear exclusion and inclusion criteria for patients. There should also
be an agreed integrated pathway that details the diagnostic, follow-up arrangements, and the lines
of responsibility in each case. For example, the use of OPAT (out-patient parenteral
antimicrobial therapy) is well described, with clear specifications for any class, dosing, and
duration of antibiotics, microbiologist and pharmacist oversight, and community nursing and
primary care support. These pathways should be clear and communicated to all relevant parties.
Summary box
• Ambulatory emergency care comes with its own distinct and specific challenges for
managing safety.
• Managing patients on the same day and avoiding unnecessary admissions is always a risk,
which should be carefully managed through sensible patient selection and clearly defined
pathways and processes. These should highlight roles and responsibilities.
• A clear governance structure and a process of communication and engagement of key
stakeholders are also imperative if we want to ensure a smooth running service with
minimal risk to staff or patients.
• Given the busy environment of ambulatory care and the heightened potential for
communication errors, a ‘brief—huddle—debrief’ model can reduce harm by increasing
situation awareness.
References
Ala, L. et al. Selecting ambulatory emergency care (AEC) patients from the medical emergency
in-take: The derivation and validation of the Amb score. Clinical Medicine 12.5 (2012): 420–
6.
Cameron, A. et al. A simple tool to predict admission at the time of triage. Emergency Medical
Journal 32 (2015): 174–9.
Further reading
Webster, J. S. et al. Understanding quality and safety problems in the ambulatory environment:
seeking improvement with promising teamwork tools and strategies. In K. Henriksen et al.
(eds), Advances in Patient Safety: New Direction and Alternative Approaches, vol. 3:
Performance Tools. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
http://www.ncbi.nlm.nih.gov.
Chapter 29
Safety in the operating theatre
Key points
• The operating room (theatre) is a complex adaptive system that presents risk for staff
and patients.
• The application of reliability, human factors, and resilience theories can assist
proactively in decreasing the risk to patients.
• Psychological safety is an essential component of a safe surgical team.
• Non-technical skills (human factors) and social cognitive and personal resource
management are important to developing safe care.
• Teamwork, communication, and situation awareness are essential to delivering high-
quality patient care.
• Care bundles and checklists can improve safety.
• Designing the environment facilitates safe care.
The operating room is a highly complex system with multiple interdependent processes. While
some of these processes can be standardized, others are too complex to be made completely
reliable.
Unfortunately not all adverse events can be predicted, as all medical procedures have risks.
While it may not be possible to eliminate human error, the goal should be to minimize risk
proactively and to learn when errors and harm occur, in order to reduce the chance of the same
errors reoccurring.
Non-technical skills are important in the delivery of safe surgical care. The non-technical
skills that have been identified as contributing to safety and efficiency in the operating room are:
These skills can be assessed within the SEIPS model described in Chapter 9 on human factors,
which provides a framework for examining the system factors in the operating room work that
can affect safety adversely (see Figure 29.1).
ALGRAWANY
Figure 29.1 SEIPS 2.0
(Reproduced with permission from Holden et al. (2013).
Leadership
A culture of safety and the way the team works will be determined by the type of leadership that
is present in the operating room. Each team member has a role and is required to lead in that role;
however, the surgeon may set the tone for how safety is achieved.
Leadership commences before the list starts, with the planning of the list and of the surgery in
pre-operative meetings. The active development of psychological safety needs more than the
transactional leadership based on the tasks required for decision-making.
A transformational leadership style encourages the flattening of hierarchy, so that all the staff
present participates in the achievement of safe care. This takes place during and after the
operation. The safety checklist provides a framework for the development of a learning
environment.
Routine checks
To ensure that the equipment is available and in working order, the operating room will undergo
routine checks of the environment and equipment.
All surgical and anaesthetic equipment is checked.
All drug stocks are checked and confirmed.
All staff members are confirmed to be present.
Each patient is signed in in the anaesthetic room, where it is confirmed that they are fasting, their
allergy status is confirmed, the availability of blood products is confirmed, their consent form is
checked, and the surgical site is confirmed.
Before commencement of surgery, the patient’s details are again confirmed and consent is
checked by the nurses, the surgeons, and the anaesthetists (the ‘time out’).
Safety checklists
The aim of the WHO checklist is to integrate all the other checks and to facilitate situation
awareness. The introduction of the safety checklist has had a major impact on the reduction of
safety events. A study published in the NEJM in 2009 demonstrated a significant reduction in
mortality with a three-stage checklist coupled with team training and briefings. This checklist is a
tool that requires attendance and the active participation of every member of the team in the
operating room, no matter the seniority. The checklist will identify actions that may need to be
taken to improve safety. To be effective, it requires training and a culture of safety.
While there are different versions, the basic steps are the five ones indicated in Table 29.2.
People-related factors
Human beings are the most important defence against error. However, their mistakes
significantly contribute to a high proportion of errors. This being so, their individual
performance and how the wider team affects them are key to safety. Here are some of the factors
that affect performance.
Tiredness due to the lack of sleep has an effect on human performance. It may result from
extended work hours or to home circumstances.
External stress, for example relationship and financial problems, can impact work performance.
The safety climate and safety culture of the operating team present in the room will affect how
staff members think and behave. Psychological safety is essential: it guarantees that the fallibility
of senior staff is acknowledged; it encourages questioning; and staff members are asked to look
out for potential safety risks.
• Performance is higher in supportive environments.
• The behavior of senior members of the team sets the climate.
Learning from mistakes is important. However, learning from situations in which things go well
(i.e. learning from excellence) creates a more positive conversation.
Team-related factors
The way the team functions is important to effectiveness and safety in the operating theatre.
Teams may develop organically; however, safe clinical teams often require planning and
training.
In high reliability organizations the development of safe teams is not taken for granted and
training is considered mandatory. Such training will include ensuring that senior staff members
are able to mentor and coach within the concept of psychological safety, that simulation is
routine, and that teams learn together. Skills and assessments are standardized. Methods to
improve team performance include:
assessment of team performance using non-technical skills assessments;
human factors team training using programmes such as crew resource management (CRM);
team training such as TeamSTEPPS, which may improve team performance.
Responsible Action
Surgeon Identification: person at risk when booking surgery
Ward staff No shaving: in preparation for surgery, to decrease micro spread of
bacteria
OR staff Hypoglycaemia: prevention, therefore delay fasting and attend to
delays in operating lists
OR staff Hypothermia: prevention
Anaethetist and Antibiotic administration: in the 30 minutes before knife to skin
surgeon
Surgeon and Aseptic technique and use of chlorhexidine at opening and closure of
surgical team incision
https://pathways.nice.org.uk/pathways/prevention-and-control-of-healthcare-associated-
infections#path=view%3A/pathways/prevention-and-control-of-healthcare-associated-
infections/preventing-and-treating-surgical-site-infections.xml&content=view-index
The use of statistical control charts has demonstrated that the reliable application of the bundle
can decrease infection rates.
The measurement of safety requires a multifaceted approach to the patient’s journey, from the
moment of the decision for surgery until at least thirty days after surgery (see Table 29.4).
Process
measure 1. Waiting list for 1. This is an indication of the performance of the
surgery system
2. Cancelled surgeries 2. Number of cancelled surgeries for non-clinical
3. Operating room reasons
utilization time 3. Ratio of time spent by patients in OR to total
4. Waiting time for OR time available
surgeons 4. Length of time spent by surgeons waiting prior
5. Start time of to the start of scheduled surgeries
operations 5. Percentage of lists that start within 15 minutes
6. Surgical checklist of scheduled time
7. Time antibiotic 6. An all or nothing measure, completed in full
given with all staff present.
7. Percentage of antibiotics given in full within 30
minutes of start of surgery
Patient
centric 1. Measures of pain 1. Patient reported pain scores
2. Post-operative 2. Patient reported delirium rates
delirium 3. Waiting time of patient prior to the start of their
3. Starvation time scheduled or urgent surgeries.
Summary box
Reference
Holden, R. J. et al. SEIPS 2.0: A human factors framework for studying and improving the work
of healthcare professionals and patients. Ergonomics 56.11 (2013): 1669–86.
https://doi.org/10.1080/00140139.2013.838643.
Vickers, R. Five steps to safer surgery. Annals of the Royal College of Surgeons of England 93.7
(2011): 501–3. http://doi:10.1308/147870811X599334.
Further reading
Guidance
NICE. Perioperative care in adults. NG180, August 2020.
https://www.nice.org.uk/guidance/ng180/chapter/Recommendations
Incidents
Bosma, E., Veen, E. J., and Roukema, J. A. Incidence, nature and impact of error in surgery.
British Journal of Surgery 98.11 (2011): 1654–9. http://doi:10.1002/bjs.7594
DiCuccio, M. H. The relationship between patient safety culture and patient outcomes: A
systematic review. Journal of Patient Safety 11.3 (2015): 135–42.
http://doi:10.1097/PTS.0000000000000058.
Hyman, N. Nature, causes and consequences of unintended events in surgical units. British
Journal of Surgery 97.11 (2010): 1730–40. http://doi:10.1002/bjs.7204.
Human factors
Holden, R. J. et al. SEIPS 2.0: A human factors framework for studying and improving the work
of healthcare professionals and patients. Ergonomics 56.11 (2013): 1669–86.
http://doi:10.1080/00140139.2013.838643.
Leadership
Hu, Y. Y. et al. Surgeons’ leadership styles and team behavior in the operating room. Journal of
the American College of Surgeons 222.1 (2016): 41–51.
http://doi:10.1016/j.jamcollsurg.2015.09.013
Stone, J. L. et al. Effective leadership of surgical teams: A mixed methods study of surgeon
behaviors and functions. Annals of Thoracic Surgery 104.2 (2017): 530–7.
http://doi:10.1016/j.athoracsur.2017.01.021.
Checklist
Bethune, R. et al. Use of briefings and debriefings as a tool in improving team work, efficiency,
and communication in the operating theatre. Postgraduate Medical Journal 87.1027 (2011):
331–4. http://doi:10.1136/pgmj.2009.095802.
Haynes, A. B. et al. A surgical safety checklist to reduce morbidity and mortality in a global
population. New England Journal of Medicine 360.5 (2009): 491–9.
http://doi:10.1056/NEJMsa0810119.
Treadwell, J. R., Lucas, S., and Tsou, A. Y. Surgical checklists: A systematic review of impacts
and implementation. BMJ Quality & Safety 23 (2014):299–318.
http://dx.doi.org/10.1136/bmjqs-2012-001797.
Teams
AHRQ. TeamSTEPPS. n.d. https://www.ahrq.gov/teamstepps/index.html.
Gross, B. et al. Crew resource management training in healthcare: A systematic review of
intervention design, training conditions and evaluation. BMJ Open 9 (2019): e025247. doi:
10.1136/bmjopen-2018-025247.
Hull, L. and Sevdalis, N. Advances in teaching and assessing nontechnical skills. Surgical
Clinics of North America 95.4 (2015): 869–84. http://doi:10.1016/j.suc.2015.04.003
Li, N. et al. Systematic review of methods for quantifying teamwork in the operating theatre. BJS
Open 2.2 (2018): 42–51. http://doi:10.1002/bjs5.40.
Pronovost. P. J. and Freischlag, J. A. Improving teamwork to reduce surgical mortality. JAMA
304.15 (2010): 1721–2. http://doi:10.1001/jama.2010.1542.
Sevdalis, N., Hull, L., and Birnbach, D. J. Improving patient safety in the operating theatre and
perioperative care: Obstacles, interventions, and priorities for accelerating progress. British
Journal of Anaesthetics 109 Suppl. 1 (2012): i3–i16. http://doi:10.1093/bja/aes391.
Surgical site infection
Phelan, L. et al. Evaluation of a bundle of care to reduce incisional surgical site infection after
gastrointestinal surgery. Journal of Infection Prevention 21.2 (2020): 52–9.
http://doi:10.1177/1757177419892072.
Williams, V. and Leis, J. A. Applying rigour to the interpretation of surgical site infection rate.
BMJ Quality & Safety 29 (2020): 446–8. http://dx.doi.org/10.1136/bmjqs-2019-009964.
Measurement
Ilieş, I. et al. Large-scale empirical optimisation of statistical control charts to detect clinically
relevant increases in surgical site infection rates. BMJ Quality & Safety 29 (2020): 472–81.
http://dx.doi.org/10.1136/bmjqs-2018-008976.
Russ, S. et al. Measuring safety and efficiency in the operating room: Development and
validation of a metric for evaluating task execution in the operating room. Journal of the
American College of Surgeons 216.3 (2013): 472–81.
http://doi:10.1016/j.jamcollsurg.2012.12.013
Chapter 30
Safety in paediatrics and child health
Key points
• Safety in paediatrics requires a focus on providing highly reliable, effective care and
reducing avoidable harm in both lower-income countries, where the emphasis is on
neonatal care, and higher-income countries, where hospital care is increasingly
complex as a result of preventable harm.
• Safety is a challenge in paediatrics because children present four main differences
from adults—namely in development, in dependence, in differential epidemiology,
and in demographics.
• Most of the preventable harm is related to medication, deterioration, sepsis, and
hospital-acquired infections. Early warning systems, care bundles, and other
frontline tools and initiatives outlined here can help to reduce harm and improve
situation awareness.
• A multidisciplinary approach to safety—one based on human factors principles and
supported by a culture of patient–parent engagement—is crucial.
• The paediatric trigger tool is a useful way to measure harm and identify areas for
improvement.
• Multisite collaborative improvement networks are a good starting point for
improving paediatric patient safety.
What are the key safety issues in paediatrics?
When one considers paediatric patient safety, one needs to look at it in the context of where the
child lives. Globally, according to the World Health Organization, the under-five mortality rate
has dropped from 93 deaths per 1,000 live births in 1990 to 38 per 1,000 in 2019.
(https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/child-mortality-and-causes-
of-death). This is largely due to public health measures that focus on conditions that can be
prevented or treated with access to immunization, oral rehydration, and safe water. Now, nearly
half of the deaths of children under the age of five worldwide occur during the neonatal period,
which makes safe childbirth and effective neonatal care an important safety aim.
In high-income countries, the key safety goals concentrate around reducing preventable deaths
and harm in paediatric hospital departments, where care is provided in an increasingly complex
environment. The 2007 UK CEMACH report ‘Why Children Die’ found preventable factors in
26% of reviewed cases. These factors were predominantly related to poor communication and
delayed recognition of the condition of the deteriorating child—mainly sepsis. Children are at an
increased risk of adverse events from medication.
Safer care means that children receive appropriate, evidence-based care the first time and
every time, in the right environment. This includes attention to psychological safety. The focus
should be on providing highly reliable care to all children, in the higher- and lower-income
countries alike, and on preventing avoidable harm.
Harm can be defined as anything that one would not like to happen to oneself, one’s own
child, or a member of one’s family. (Chapman, 2014:2) This allows us to take a broad view of
harm. For example, in the hospital environment, harm ranges from ventilator-acquired
pneumonia to multiple failed attempts at cannulation or inadequate psychological support; in the
community, it may extend over the poor control of diabetes, failures to identify child protection
concerns, or inappropriate equipment for children with neurodisability. Examples of preventable
harm are shown in Box 30.1.
Children have changing physiology as they develop and cannot be treated as ‘little’ adults. The
following differences are key factors that influence safety in paediatrics.
The harm listed here is mostly related to hospital paediatrics, and it is important to recognize
that there is relatively little research into the burden of harm that occurs in the home or in
community settings. Incidents in primary care are under-reported, and there is a need for
improved communication and listening skills when providing healthcare to children. The
National Patient Safety Agency has already signalled both a lack of recognition and appropriate
management of mental health issues in young people and the lack of an integrated approach to
children’s risk management—an approach that should incorporate health, education and social
care.
Safe care in paediatrics relies on integrated care with clinical leadership and a culture of patient–
parent engagement, governance, teamwork, and education. Crucial also to creating a culture of
safety is knowledge of, and capability for, safety and quality improvement.
A systems approach to safety for children is essential; where possible, the design of the work
system should take human factors principles and standardizing processes into account.
1. Family concerns should always be taken seriously, even if vital signs are normal.
2. High-risk therapies raise the risk and make the child a potential candidate for
deterioration.
3. Presence of an elevated early warning score is a marker, though it is not always present.
4. Special attention needs to be paid if any member of staff senses that the child is ‘not
right’. The patient is termed to be a “Watcher’—a patient who needs added attention as
there is an undefined risk of deterioration.
5. Concerns about communication with the patient, the parent, or the family are discussed
(e.g. they speak a different language from yours and your team’s).
The Paediatric Trigger Tool is a structured case note review tool; the review in undertaken by
medical and nursing teams on a regular basis, in order to identify unintended harm within the
local department. Although trigger tools are designed to identify common causes of harm, they
also pick up other causes when broad definitions of harm are used. By understanding the types of
harm that occur, the organization may focus its improvement work on areas of greatest impact
and monitor improvements over time (see Chapter 12).
The tool measures adverse events with high sensitivity and specificity, through a rapid
(maximum 20-minute) structured review of randomly selected case notes. Triggers listed in the
tool are identified (e.g. INR > 5), then a closer examination of the notes determines whether an
adverse event has occurred (e.g. bleeding). If an adverse event has occurred and harm has
resulted, then the category of harm is assigned. The purpose of the review is to identify harm, not
to discuss whether it could be prevented.
The use of trigger tools has revealed how frequently harm occurs in the paediatric in-patient
hospital setting. Studies have suggested that as many as one in four children experience at least
one episode of harm during their hospital stay. The most common cause of harm in hospitalized
children has been identified in one study as tissue injury related to intravenous cannulas.
System-wide data are also important: they provide a greater understanding of harm, allowing
consensus on the most prevalent adverse events and generating opportunities to learn about
infrequent but definite harms (e.g. hyponatraemia caused by 0.18% saline fluid) and to share
quality improvement interventions from different sites.
Summary box
The application of the safety theories presented in this book will enable you to provide safe care
for children. A good place to start is to explore paediatric collaborative improvement networks
that use multisite data to drive safety initiatives—for example the Pediatric International Patient
Safety and Quality Community (PIPSQC at www.pipsqc.org), Making It Safer Together
(www.mist-collaborative.net), and Solutions for Patient Safety
(www.solutionsforpatientsafety.org).
Box 30.5 Key actions one can take to improve paediatric patient safety
All frontline staff in paediatrics, be it in the community or in hospital, can execute the
following four actions to improve safety:
References
Further reading
Chapman SM, et al. Prevalence and severity of patient harm in a sample of UK-hospitalised
children detected by the Paediatric Trigger Tool. BMJ Open. 2014 Jul 3;4(7):e005066. doi:
10.1136/bmjopen-2014-005066.
Cheung, R., Roland, D., and Lachman, P. Reclaiming the systems approach to paediatric safety.
Archives of Disease in Childhood 104.12 (2019): 1130–3. https://doi:10.1136/archdischild-
2018-316401.
Kirkendall, E. S. et al. Measuring adverse events and levels of harm in pediatric inpatients with
the Global Trigger Tool. Pediatrics 130.5 (2012): e1206–e1214.
Mueller, B. U. et al. Principles of pediatric patient safety: Reducing harm due to medical care.
Pediatrics 143.2 (2019): e20183649.
Stockwell, D. C. et al. A trigger tool to detect harm in pediatric inpatient settings. Pediatrics 135
(2015): 1036–42.
Important resources
Key points
1. Pregnancy and childbirth are safe and are associated with successful outcomes.
However, serious preventable harm still occurs, and systems issues can be
contributory.
2. Challenges in the provision of maternity services include the complexity of patients
who attend maternity services and the recruitment and retention of highly skilled
staff for safe service provision.
3. Frameworks such as the PIER (prevention, identification, escalation and response)
framework and standards can be used at the system level to address key issues in
maternity care.
4. Independent statutory authorities can promote safety and quality in the provision of
maternity services.
5. The development and use of care bundles make it easier for healthcare providers to
work closely with women so as to prevent adverse events.
6. Every maternity team should have performance measures in place that can be used
for quality improvement.
7. Improvement-led groups known as ‘improvement collaboratives’ can help
maternity and neonatal care providers to improve safety and outcomes by reducing
unwarranted variation.
Optimal maternal health, together with safe, high-quality maternity care in pregnancy and
throughout the puerperium, can have a marked effect on the future health of both mother and
baby.
For most women and their partners, pregnancy and childbirth are safe and are associated with
successful outcomes. However, despite high levels of safety and patient satisfaction with
maternity services, serious preventable harm still occurs.
Serious preventable incidents can result in preterm birth, stillbirth, early neonatal death,
serious brain injury in term babies, and direct and indirect maternal death. Behind these
devastating endpoints are very important systems issues.
Clinical complexity
The need for maternity services is likely to remain high. Factors such as increasing maternal age,
increased rates of medical co-morbidity, and increasing rates of obesity contribute to the
complexity of patients who attend maternity services.
Liberati et al. 2020 have developed a framework named For Us (For Unity Safety), which
identifies seven key features of safety in maternity units (see Box 31.1). Each feature of the
framework is synergistic in nature and each one is necessary, but none is sufficient on its own.
This framework can be used at the system level, to address the key issues in maternity care.
Standards of care
The Health Information and Quality Authority (HIQA) in Ireland has developed national
standards to address the challenges faced in maternity care by using eight central themes. These
eight themes are grouped into two central concepts—‘safety and quality within a service’ and
‘services capacity and capability’ (Table 31.1)—and form a template for designing a safe service
that incorporates the themes in Box 31.1.
Table 31.1. The delivery of safety and quality within a services capacity and capability
Box 31.2 Immediate and essential actions to improve care and safety in maternity
services: Seven themes
• enhanced safety and the culture of safety;
• listening to women and families;
• staff training and working together;
• improving the management of complex pregnancies;
• better proactive risk assessment throughout pregnancy;
• improved monitoring of foetal well-being;
• informed consent at all stages of the process.
Adapted from Ockenden Report 2020
These actions correlate with the action plan for the safer maternity care programme, which
focuses on five key drivers of the delivery of safer maternity care (Box 31.3).
The achievement of these-high level aims requires improvement at the front line through the
core values of person- and family-centred integrated care of a safe and accessible nature. In this
system both the mother and the neonate are looked after by skilled multiprofessional teams.
The Royal College of Obstetricians and Gynaecologists (RCOG) has recommended key
standards for maternity care (Table 31.2).
Table 31.2 Summary of RCOG standards for maternity care
Key Standards
Pre- Key public health messages should be promoted (e.g. regarding diet, exercise,
pregnancy smoking)
services Pre-pregnancy counselling should be provided for women with complex
medical needs
Antenatal Should be accessible to women at the right time and from the appropriate
Care provider
Vulnerable Local and regional perinatal mental health strategies should be in place
Women Multidisciplinary care for alcohol and substance misuse should be in place
Multiagency partnerships for women who are at risk of, or experience,
domestic abuse should be in place
Medical Access to specialized care with a multidisciplinary team should be secured
Complexity Each case to be reviewed by a senior obstetrician before discharge, with a clear
plan for the postnatal period
Inpatient Coordinated care should be underpinned by clear, accurate information
Care exchange between healthcare professionals
Elective Options for birth should be discussed, including pros and cons of different
Birth modes of delivery, with available written information
Intrapartum Choice of birth setting and transfer of care, if required
Management Clinical leadership, accountability and governance
Learning and improving by audit and review
Staffing, training, and communication across the MDT
Postnatal Smooth transition between birthing unit and ongoing care in the community
Care Monitoring and reporting of postnatal readmission rates
Breastfeeding support
Foetal All women whose foetus has a suspected or confirmed disorder should have
Medicine timely access to patient-focused high-quality evidence-based care
Perinatal Implement strategies to prevent perinatal loss
Loss Offer care and support when perinatal loss occurs
Learn lessons from perinatal loss
Communicate when perinatal loss occurs
Adapted from Royal College of Obstetricians and Gynaecologists 2016.
To implement the standards, one needs to apply improvement and patient safety methodology.
System-wide drivers: Independent statutory authorities
An independent statutory authority can be used to promote safety and quality in the provision of
maternity services for the benefit of the health and welfare of women and their babies. The
HIQA in Ireland and the Care Quality Commission (CQC) are examples. These authorities can
be responsible for setting standards, monitoring services, and using health technology assessment
and health information (Table 31.3).
Setting Developing person-centred standards and guidance on the basis of evidence and
standards international best practice
for
maternity
care
Monitoring Monitoring standards and compliance against most of the national standards
services assessed during this monitoring programme
Health Evaluating the clinical and financial effectiveness of health programmes,
technology policies, medicines, medical equipment, diagnostic, and surgical techniques,
assessment health promotion and protection activities, and providing advice to enable the
best use of resources and the best outcomes for people who use our health
service
Health Advising on the efficient and secure collection and sharing of health
information information, setting standards, evaluating information resources, and publishing
information on the delivery and performance of maternity services
Adapted from Health Information and Quality Authority 2020
Outcome measures
Obstetric events:
• eclampsia
• uterine rupture
• peripartum hysterectomy
• pulmonary embolism
Perinatal events:
• stillbirth
• perinatal mortality
• hypoxic ischaemic encephalopathy
• admission to NICU
• low birth weight
Process measures
• Delivery metrics
• Induction
• Instrumental delivery
• Caesarean section
• Number of clinical incidents
Adapted from Health Information and Quality Authority 2020
Improvement collaboratives
Improvement-led collaboratives can help maternity and neonatal care providers to improve safety
and outcomes by reducing unwarranted variation.
An example is the Maternity and Neonatal Safety Improvement Programme (MatNeoSIP; see
Box 31.6). Driver diagrams and change packages have been developed that can be used as part of
a systematic approach designed to improve maternity and neonatal services. The programme
identified five drivers underpinned by a strong focus on safety culture, systems and processes,
engaging with staff members, women, and families, and learning from error and excellence.
In Scotland, the Maternity and Children Quality Improvement Collaborative (MCQIC) brings
together maternity, neonatal, and paediatric care communities, promoting the use of
improvement methodologies among frontline staff in order to improve the quality of care and
build global capacity and capability through support visits, online educational sessions, and
networking events.
Summary box
• Important identifiable systems issues are responsible for many serious but preventable
incidents. These incidents can result in preterm birth, stillbirth, early neonatal death,
serious brain injury in term babies, and direct and indirect maternal death.
• Although there are significant challenges to the provision of safe, high-quality maternity
care, for example challenges related to clinical complexity and the maintenance of safe
clinical teams, there are several standards and frameworks in place to guide healthcare
providers.
• Additionally, safety bundles and improvement collaboratives are useful tools that can be
used at an institutional level to improve safety and outcomes by reducing unwarranted
variation.
References
Further reading
Department of Health. Safer Maternity Care: The National Maternity Safety Strategy: Progress
and Next Steps. Department of Health, 2017.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/662969/Sa
_progress_and_next_steps.pdf
Healthcare Inspectorate Wales. National Review Maternity Services, Phase One. 2020.
https://hiw.org.uk/sites/default/files/2020-
11/20201118HIWNationalReviewofMaternityServicesEN_0.pdf.
Kirkup, B. The Report of the Morecambe Bay Investigation. 2015.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/408480/47
National Maternity Review. Better Births. 2016. https://www.england.nhs.uk/wp-
content/uploads/2016/02/national-maternity-review-report.pdf?PDFPATHWAY=PDF.
National Quality Board. Safe, Sustainable and Productive Staffing: An Improvement Resource
for Maternity Services. 2018.
https://improvement.nhs.uk/documents/1353/Safe_Staffing_Maternity_final_2.pdf.
NHS England. Saving Babies’ Lives Version Two: A care bundle for reducing perinatal
mortality. 2019. https://www.england.nhs.uk/wp-content/uploads/2019/07/saving-babies-
lives-care-bundle-version-two-v5.pdf.
Royal College of Obstetricians and Gynaecologists. Each Baby Counts. 2015.
https://www.rcog.org.uk/globalassets/documents/guidelines/research--audit/each-baby-
counts-2015-full-report.pdf.
Scottish Government. The best start: A five-year forward plan for maternity and neonatal care in
Scotland. 27 January 2017. https://www.gov.scot/publications/best-start-five-year-forward-
plan-maternity-neonatal-care-scotland/pages/3.
Scottish Patient Safety Programme. Maternity and children quality improvement collaborative.
n.d. https://ihub.scot/improvement-programmes/scottish-patient-safety-programme-
spsp/maternity-and-children-quality-improvement-collaborative-mcqic.
Welsh Government. Maternity care in Wales: A five-year vision for the future, 2019–2024.
https://gov.wales/sites/default/files/publications/2019-06/maternity-care-in-wales-a-five-
year-vision-for-the-future-2019-2024.pdf.
Chapter 32
Safety issues in mental health
Key points
People with mental health conditions are at a specific risk of harm when in healthcare.
The main areas of concern are:
• self-harm, including suicide;
• delayed diagnosis and misdiagnosis;
• medication harm.
These risks are amplified in health facilities that do not have the skills to meet the
needs of individuals with mental health problems.
Like definitions of harm, metrics tend to be based on physical characteristics. These can be
calculated at different levels, depending on their purpose or on the need: for example, hospital
level, ward level, bed numbers, number of admissions, and bed occupancy.
Internationally, there is a push towards zero suicides on wards and in the community. Zero
Suicide outlines organizations that collect data for the numbers of patients who are screened for
suicide risk. For those who are deemed high risk, Zero Suicide recommends that metrics should
be collected and recorded on the following themes: whether a risk assessment was carried out;
whether there was a developed safety plan; whether lethal means counselling was offered and
undertaken. Additionally, the organizations in question should check whether there were missed
appointments for those with a suicide care plan and whether there was contact within 24 hours
after acute care transition for those who had been hospitalized or who had attended emergency
services.
For measures to consider in mental health, see Box 32.2.
For mental health professionals delivering psychological interventions, a checklist has been
developed to capture side effects and adverse treatment reactions: the UE-ATR checklist. This
list covers the following domains: symptomology, the well-being of the patient, the therapeutic
relationship, the patient’s social and family networks, and changes in the patient’s circumstances
and situations.
Developing safe care in mental health means targeting factors across the following levels:
patient, provider, organization, and physical environment (Brickell et al. 2009). Table 32.2
outlines some of the different areas that should be considered at each level:
Factor Consideration
Patient factors Impact of diagnosis: it can affect communication
Self-stigma can affect whether patients seek help and communicate in case
harm has been caused
Co-morbidity combined with substance misuse can lead to aggression
Provider factors Limited time and high workloads lead to low or poor interaction with
patients and harm is missed
There can be poor communication between staff, other providers of care,
and patients’ families
Organizational Low retention of staff can cause new procedures not to be embedded
factors
The embedding and revisiting of safety training programmes can be
affected
Physical There can be inadequate resources to minimize aggression, boredom, or
environment impulsive behaviour
Mixed-sex wards can make patients feel vulnerable
Fittings can increase the risk of injury or death
Adapted from Brickell et al. 2009.
Clinicians, services, and organizations can employ the following methods to deliver safer care in
mental health (see Emanuel et al. 2013):
Mental health practitioners as well as clinicians in a general hospital can undertake improvement
projects to benefit the safety of their patients. The two case studies in Box 32.2 and Box 32.3
show an application of the theories presented in the book, with a focus on the patient’s specific
needs.
Clinical care
A protocol was developed for assessing patient risk and for steps to be undertaken at each level
of risk.
• Access – improved patient access via drop-in group medication appointments, same-day
access appointments, and e-mail ‘visits’.
Communication
• Information flow – information systems were updated to allow confidential information
to flow better, and a secure website was developed for patients and family members.
Research comparing mortality data suggested a statistically significant decrease of 75%.
Box 32.3 Case 2: Reducing prone (face down) restraint on wards (adapted from 2gether
NHS Foundation Trust 2017)
There is increasing debate around the use of prone restraint, which can prove harmful to both
patients and staff. As a result, the 2gether NHS Foundation Trust attempted to reduce the
amount of prone restraint within its wards.
Safety in mental health can be challenging. However, if one applies the principles of patient
safety and the specific requirements of mental health, one can achieve safety. In general
hospitals this can be difficult, and the approach described here can make a difference to the
safety of this vulnerable group of patients.
Deliver high quality personalized care. This should draw on the principles of:
• recovery-oriented care;
• trauma-informed care;
• culturally responsive care.
Understand what safety metrics should be captured and how these are recorded.
Training and education on safety indicators should be refreshed periodically.
On inpatient wards or wards where patients may be staying, create environments in day
rooms that are stimulating and engaging. Minimize fittings and fixtures, which could be used
for self-harm and injury.
References
Alshehri, G. H., Keers, R. N., and Ashcroft, D. M. Frequency and nature of medication errors
and adverse drug events in mental health hospitals: a systematic review. Drug Safety 40.10
(2017): 871–86.
Brickell, T. A. et al. Patient Safety in Mental Health. Edmonton: Canadian Patient Safety
Institute and Ontario Hospital Association, 2009.
Care Quality Commission. The state of care in mental health services 2014 to 2017. Newcastle,
2017. https://www.cqc.org.uk/sites/default/files/20170720_stateofmh_report.pdf.
Coffey, C. E. Pursuing perfect depression care. Psychiatric Services 57.10 (2006): 1524–6.
Dimidjian, S. and Hollon, S. D. How would we know if psychotherapy were harmful? American
Psychologist 65.1 (2010): 21–33.
Emanuel, L. L. et al. (eds). The Patient Safety Education Program, Canada: Module 13: Mental
Health Care. Ontario: PSEP-Canada, 2013.
Gara, M. A., et al. A naturalistic study of racial disparities in diagnoses at an outpatient
behavioral health clinic. Psychiatric Services 70.2 (2019): 130–4.
Mascherek, A. C. and Schwappach, D. L. Patient safety priorities in mental healthcare in
Switzerland: A modified Delphi study. BMJ Open 6.8 (2016): e011494.
Mitchell, A. J., Vaze, A., and Rao, S. Clinical diagnosis of depression in primary care: A meta-
analysis. Lancet 374.9690 (2009): 609–19.
2gether NHS Foundation Trust. Improving patient safety by reducing prone restraint, through
better use of data, targeted training and other improvement initiatives. NHS Improvement
Report, June 2017.
Chapter 33
Patient safety in critical care
Key points
• Patients in intensive care are at risk of several specific safety risks, owing to the
complexity of the care processes.
• Safety must be planned and risk proactively managed.
• The application of human factors and reliability theory can mitigate the risk and
decrease harm.
• A culture of safety with teamwork, good communication, and situation awareness
will facilitate safe care.
These are just a few examples of safety-related issues in critical care and by no means form an
exhaustive list. Later in this chapter we will discuss in greater detail some of the issues
mentioned here.
Modern critical care arose from the poliomyelitis epidemic in the 1950s; patient safety within
critical care has been considered a challenge around the globe since its inception. If one analyses
the work system using the Systems Engineering Initiative for Patient Safety (SEIPS) model (see
Chapter 9), one can see that critical care patients are at an increased risk of harm, as in shown in
Table 33.1.
Table 33.1. Examples of risk factors in the critical care work system
Some of these factors are in the very nature that defines critical care, hence there is very little
that we can do about it. However, if we focus on the principles of a safe system then we can
Prevent, Detect and Mitigate these risks by improving the working environment and making
critical care a safer place for both patients and staff.
Ventilator-associated pneumonia
Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in the critical
care unit and accounts for a large proportion of the antibiotics delivered. It is defined as a type of
pneumonia that develops in hospital 48 hours or more after the patient was on mechanical
ventilation. It is associated with increased lengths of stay, costs, morbidity, and mortality.
Several strategies have been found to reduce the incidence of VAP. When combined to create
a care bundle of evidence-based interventions, the output and benefits of the bundle are greater
than the sum of individual parts. Using a bundle approach to improve ventilator care processes
and reduce ventilator-associated pneumonia has subsequently led to significant improvement in
reducing the incidence of VAP.
VAP bundle
CLABSI bundle
• hand washing;
• full-barrier precautions during the insertion of the central line;
• cleaning the skin with chlorhexidine;
• avoiding the femoral site if possible;
• removing unnecessary catheters.
This central line care bundle was used in 103 intensive care units (ICUs) in Michigan and
demonstrated decreased infection rates by up to 66% following implementation.
Pressure ulcers
Pressure ulcers can cause significant morbidity for patients and their families. They are a real
problem for the NHS, costing between £1.4 billion and £2.1 billion annually, or 4% of the NHS
budget. Critical care patients are at increased risk of pressure ulcers, mainly because of their
increased vulnerability (hypotension/sedation) and immobility. Pressure ulcers are defined as
localised injuries to the skin or to the underlying tissues, usually over bony prominences; they
are due to pressure, or to pressure in combination with shear.
Hospital-acquired pressure ulcers are mostly preventable occurrences. Many interventions
have been taken to minimize the risk; these include improving staff education and knowledge of
pressure ulcer prevention, guidelines and policies with evidence-based practices, and risk
assessment of all patients within six hours of admission. Critical care patients are at risk of both
device-related (e.g. endotracheal tube ties) and non-device-related pressure sores. The SKIN
bundle is an evidence-based checklist designed to assist the staff in implementing pressure ulcer
prevention strategies.
Medication errors
Critical care patients are at higher risk of medication errors and harm: the risk is around 2–3
times greater than for non-critically ill patients and has a probability of mortality that is
approximately 2.5 times higher when the error happens. This is due to the complexity of the
patients’ drug regimens and to the stressful environment. They are often on heavier medication
than non-critically ill patients, and this can result in drug interactions and altered
pharmacokinetics owing to organ failure. Critical care patients are also more likely to develop
drug-induced events such as acute kidney injury and coagulopathies. Unsuccessful medication
reconciliation and interruptions during medication preparation and administration can also
increase the chance of errors.
Over the years there have been many interventions intended to make it easy to do the right
thing and more difficult to do the wrong thing, all in an attempt to improve medication safety.
These interventions are listed in Box 33.1:
In recent years, patient safety has been at the forefront of patient care. There has been a huge
drive to improve the quality of care as well as the patient’s safety, with national campaigns such
as the Scottish Patient Safety Programme and the Patient Safety First Campaign in NHS
England. There are four common interventions associated with these campaigns:
The first two interventions involve critical care directly, and the last two interventions have
direct impact on both critical care and its patients.
As healthcare professionals of the modern era, we are familiar with care bundles, processes,
and checklists that exist to improve patient safety. For example, the World Health Organisation
(WHO)’s safer surgical checklist prevents never events from happening and improve surgical
outcomes.
The situation is no different in critical care. Critical care driver diagrams and improvement
plans are composed of numerous standardized care bundles related to daily practice and frequent
tasks in the ICU that, when carried out together, can improve a patient’s outcome. Some
examples are:
In addition to the care bundles, we also use various checklists in critical care, in order to
prevent the error of omission, which is usually noticed because of slips and lapses. Here are
some examples of the checklists used:
1. multidisciplinary ward rounds with daily goal checklists: these are meant to ensure, as a
matter of daily routine, the consideration of interventions such as stress ulcer prophylaxis,
VTE prophylaxis, medicine reconciliation, sedation interruption, and spontaneous breathing
trials, as well as the consideration of therapeutic targets such as blood gas parameters and
weaning plans;
2. rapid sequence induction intubation checklists;
3. routine interventions for patients admitted with out-of-hospital cardiac arrest or major
trauma;
4. transfer checklist for both intra- and inter-hospital transfer;
5. death checklist, to ensure that all the relevant paperwork has been done and the relevant
parties have been informed.
All-or-none compliance with the individual elements of the checklist and care bundles is as
important as the bundle itself, as this has been proven to improve the effectiveness of the
checklist. As a result, it is the implementation of the bundle that affects patient outcome.
In general, there are five knowledge systems that have been identified to support
improvement:
In addition to continued improvement projects, the adverse events reporting system has been
used in all areas of healthcare, including critical care. This has prompted the identification of
problems and has stimulated a process of conducting root cause analysis, which will lead to
learning from error and system change. Moreover, we can use technology to our advantage: for
instance we can use electronic health records to prompt interventions, and electronic prescribing
to minimize medication errors.
Communication
Finally, poor communication among the critical care team members has been shown to be a
contributing factor to errors and adverse events. This can be communication during handover,
during ward activities, or during an emergency. Some of the interventions to improve
communication that have also been shown to improve patient safety are listed in Box 33.2.
1. Standardized written handovers are used as prompts, to ensure that all the relevant
information is communicated to the receiving team.
2. Safety briefs every morning ensure that all the important safety issues are known to the
wider multidisciplinary team.
3. Daily goals written clearly, either on paper or electronically, during the ward round
ensure that medical staff plans are communicated and accessible to the nursing staff.
4. Structured SBAR referrals and handovers take place among doctors when reviewing
patients without critical care settings.
5. ‘Check back’ is a simple technique designed to ensure that the information conveyed by
the sender is understood by the recipient as intended. Example: Doctor: ‘Give 2 mg
morphine IV bolus.’ Nurse: ‘2mg morphine IV bolus.’ Doctor: ‘That is correct.’
6. ‘Call out’ is a strategy for communicating important information to all team members
simultaneously during emergent situations. Example: ‘Airway status? Airway clear.
Breath sounds? Breath sounds reduced on left side. Trachea? Trachea deviated to the
right. BP? BP is 70/30.’ ‘Call out’ helps the team to anticipate the next steps and directs
responsibility to a specific individual for carrying out the task.
7. It is important to develop tools for team-training and assess communication and
teamwork in critical care (e.g. high-fidelity simulation).
Measurement is central to a team’s ability to monitor and improve care. It is an integral part of
both clinical audit and quality improvement; and there is no standard scale for measuring safety.
Patient safety can be defined as evidence of reduced harm or of absence of harm to the patients;
hence, to measure any improvement in safety, we would need to measure the reduction in the
numbers of patients harmed before and after the implementation of an intervention. There are
various quality indicators in the critical care unit that are used to measure safety. Therefore we
need to be able to have a data collection process that can enable quality data collection; and we
also need frequent analysis of the data to determine whether any change is an improvement.
As such, it is important that we monitor key measures of:
Structure: Participation in a national comparative audit such as the Intensive Care National Audit
& Research Centre (ICNARC) or the Scottish Intensive Care Society Audit Group is an example.
Process measures: Are the different steps in the process (e.g. bundle or checklist compliance)
performing as planned?
Outcome measures: How is the system performing? What is the result? (Examples: the VAP rate
or the standardized mortality ratio.)
Balancing measures: Look at the system from a different perspective. Are there any
unanticipated consequences? (Examples: MRSA, VRE, Clostridium difficile.)
Running frequent PDSA (plan, do, study, act) cycles and producing statistical process control
charts and run charts can help to measure the improvement in patient safety after interventions.
Some examples of quality indicators of patient safety in critical care are:
1. Adhere to a strict infection control policy such as the five moments of handwashing,
wearing appropriate attire, and using personal protective equipment when in contact with
patients.
2. Report any critical incidence, significant events and near misses using the incidence
reporting system.
3. Keep up to date with developments in education and evidence-based medicine that will
help with the implementation of bundles and guidelines.
4. Participate in exercises designed to improve communications as a team.
5. Ensure compliance and adherence to existing guidelines and care bundles for patient safety.
6. Remember that the patient is at the centre of our care and we can start to improve patient
safety with one doctor, one nurse, one patient at a time.
Summary box
In summary, in this chapter we have discussed some of the key issues of patient safety in
critical care, the harms we can prevent, and what we can do about them as healthcare
professionals. Ensuring patient safety in a high-risk environment such as the critical care unit
can sometimes feel like an uphill battle, and one that we may get burnout from. However, when
critical care is practised responsibly, with little or no patient safety incidents, it can also
contribute to joy at work.
Words like ‘safety’, or even ‘harm’, can lose their impact because we use them so often.
However, thanks to growing awareness of patient safety issues and different approaches
designed to improve critical care (e.g. care bundles and quality improvement projects), over
the years we have seen progress: critical care units across the country have achieved a sizeable
reduction in the rates of ICU-acquired and device-related infections such as CLABSI and
VAP.
At the end of the day, as healthcare professionals, we all share the same dedication to
making care better for our patients and their families, and this will serve as a motivation to
continue searching for new and better ways to improve patient safety.
Further reading
Chrusch, C. A., Martin, C. M., and The Quality Improvement in Critical Care Project. Quality
improvement in critical care: Selection and development of quality indicators. Canadian
Respiratory Journal 2016 (2016). https://doi.org/10.1155/2016/2516765.
Daniel, M. et al. Details behind the dots: How different intensive care units used common and
contrasting methods to prevent ventilator associated pneumonia. BMJ Quality Improvement
Reports 4.1 (2015). doi: 10.1136/bmjquality.u207660.w3069.
Peden, C. J., and Rooney, K. D. The science of improvement as it relates to quality and safety in
the ICU. Journal of the Intensive Care Society 10.4 (2009): 260–5.
Pronovost, P. et al. An intervention to decrease catheter-related bloodstream infections in the
ICU. New England Journal of Medicine 355 (2006): 2725–32.
Resar, R. et al. Using a bundle approach to improve ventilator care processes and reduce
ventilator-associated pneumonia. Joint Commission Journal on Quality and Patient Safety
31.5 (2012): 243–8.
Rooney, K. Humanizing Health Care: The Language of Patient Safety. Institute for Healthcare
Improvement, 2016.
Scottish Intensive Care Society Audit Group. VAP Prevention Bundle Guidance for
Implementation. NHS National Services Scotland, 2012.
Sundaram, R., and Rooney, K. D. Reliable critical care: Making it easy to do the right thing.
British Journal of Anaesthesia 115.2 (2015), 161–3.
Tayyib, N. and Coyer, F. Effectiveness of pressure ulcer prevention strategies for adult patients
in intensive care units: A systematic review. Worldviews on Evidence-Based Nursing, 13.6
(2016), 432–44.
Welters, I. D. et al. Major sources of critical incidents in intensive care. Critical Care, 15 (2011).
https://doi.org/10.1186/cc10474.
Chapter 34
Safety in patients with frailty and complex long-term
conditions
As society has grown older, the demographic of these attending healthcare facilities has changed
across care settings. An ageing population presents unique safety challenges. Any of the
potential harms can have a devastating effect on the individual and carry a high cost for the
individual and the family, for healthcare facilities, and for the wider society.
This chapter reviews how we can optimize the safety of persons who are at risk for:
delirium;
polypharmacy;
falls;
pressure injuries;
infection.
These are five key factors commonly associated with frail older adults. In each of the cases
presented here the application of reliability theory will be introduced to ensure that the right care
is provided.
Each of these risks may have increased with the impact of the COVID-19 pandemic. Older
adults are more likely to present with atypical forms of COVID-19, including delirium and falls.
Why is it a challenge?
Delirium can be challenging to detect and diagnose unless regular screening takes place. It is also
difficult to treat, no effective pharmacological therapies being available to date. There is no
evidence that anti-psychotic medications shorten the duration of delirium or lengthen the hospital
stay.
As a result, delirium prevention measures and early recognition are of the utmost importance.
However, delirium is often under-recognized.
Predisposing factors
• older age;
• male sex;
• sensory impairment (hearing, vision);
• cognitive impairment;
• depression;
• alcohol excess.
Precipitating factors
• medications (hypnotics, anticholinergics)
• surgery and or anaesthesia;
• acute illness (infection, stroke, myocardial infarction);
• pain;
• laboratory abnormalities (glucose, electrolytes, thyroid, anaemia);
• withdrawal states (alcohol, drugs).
There are several validated tools available for screening for delirium at the bedside. These
include the Confusion Assessment Method (CAM), the Nursing Delirium Screening Scale, and
ALGRAWANY
the 4AT.
The American Geriatrics Society, the National Institute for Clinical Excellence, and the
Scottish Intercollegiate Guidelines Network have all published guidelines on the prevention and
management of delirium.
The prevention of delirium requires reliable delivery of seven key interventions, as indicated
in Box 34.2.
The management of delirium requires early diagnosis and active interventions, as indicated in
Box 34.3.
The key intervention is awareness, assessment, and prevention and, if delirium does occur,
proactive management.
Why is it a challenge?
Frail older adults are more likely to have multiple chronic conditions and require appropriate
therapy. However, they are also more likely to experience polypharmacy. Adverse drug events
are also more common, owing to changes in pharmacokinetics and pharmacodynamics that occur
as part of the ageing process. These changes include altered distribution of fat soluble and
protein-bound medications, decreased renal glomerular filtration rate, and decreased hepatic
clearance.
Care must be taken to prescribe new medications safely, particularly high-risk ones such as
anticoagulation and insulin. Initiation of a medication in a frail older adult must be justified
according to need (see the seven steps) and with additional information, as indicated in Box 34.6.
Why is it a challenge?
Falls do not usually have a single aetiology but are more often multifactorial in origin and
require a risk factor assessment to prevent further events.
Older adults are also more likely to have complex neurological conditions, which are
associated with increased falls risk. Parkinson’s disease and stroke are associated with
impairment of gait, which may be difficult to treat.
Gait should be assessed by observing the patient walking, but also by performing a validated
balance assessment such as the Timed Get Up and Go test (normal range less than 12 seconds), a
30-second chair stand test, or a 4-stage balance test.
There are several scales available to assess a patient’s risk for falls while in hospital. The
Morse Fall Scale is a widely used and validated tool.
After assessment, a safe mobility plan should be implemented while the patient is in hospital.
Falls prevention strategies need to be individualized to reflect the patient’s specific risk factors
and care needs (Box 34.8).
Box 34.8 Safe mobility care bundle
Why is it a challenge?
Pressure injuries are a challenge because they can be difficult to treat and there is no robust
evidence base regarding treatment options.
Prevention is imperative and requires input from all members of the interdisciplinary team.
All frail older adults should be assessed for the risk for pressure injuries (Box 34.10). A
validated risk stratification tool such as the Waterlow score or the Braden or Norton scale can be
used.
Patient-specific preventive measures should be implemented on the basis of patients’ risk factors
(Box 34.11).
Why is it a challenge?
Accurate diagnosis and recognition of infection is a challenge.
Frail older adults may have a blunted or absent rise in temperature in response to infection.
Rise in white blood cell count may not be present.
The clinical presentation of infection in this population may be atypical; symptoms such as
delirium or change in behaviour are more likely to occur.
The diagnosis of infection can be challenging in this patient group. A positive blood culture
result does not always confirm active infection. This is particularly so in the case of tract
infections (UTIs) where bacteriuria may be present in the absence of symptoms and active
infection.
Another challenge is the appropriate use of antibiotics. Frequent use of antibiotics in this
population increases the development of drug-resistant pathogens and pseudomembranous
colitis.
Summary box
Frail and older adults are at higher risk of safety events. These can all be prevented by
following safety principles:
• identification of the risk by pre-assessment;
• preventive measures to decrease the risk;
• constant monitoring to assess changes in risk;
• co-production of preventive measures with individuals and their carers;
• implementation of early interventions when a risk is identified.
Further reading
Delirium
Bauernfreund, Y. et al. TIME to think about delirium: Improving detection and management on
the acute medical unit. BMJ Open Quality 7 (2018): e000200. https://doi:10.1136/bmjoq-
2017-000200.
Inouye, S. K. et al. Clarifying confusion: The confusion assessment method: A new method for
detection of delirium. Annals of Internal Medicine 113.12 (1990): 941–8.
https://doi:10.7326/0003-4819-113-12-941.
NICE. Delirium: Prevention, diagnosis and management: Clinical guideline (CG 103). 2010.
https://www.nice.org.uk/guidance/cg103.
Delirium tests
Gaudreau, J. D. et al. Fast, systematic, and continuous delirium assessment in hospitalized
patients: the nursing delirium screening scale. Journal of Pain Symptom Management 29.4
(2005): 368–75. https://doi:10.1016/j.jpainsymman.2004.07.009.
Husser, E. K. et al. Implementing a rapid, two-step delirium screening protocol in acute care:
Barriers and facilitators. Journal of the American Geriatrics Society 69.5 (2021): 1349–56.
https://doi:10.1111/jgs.17026
Polypharmacy
American Geriatrics Society. Updated AGS Beers Criteria® for potentially inappropriate
medication use in older Adults. Journal of the American Geriatrics Society 67.4 (2019): 674–
94. https://doi:10.1111/jgs.15767.
Mair, A., Wilson, M., and Dreischulte, T. The polypharmacy programme in Scotland: Realistic
prescribing. Prescriber 30.8 (2019): 10–16. https://doi.org/10.1002/psb.1779
NHS Scotland. Polypharmacy Guidance. Scottish Government, 2018.
https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-
2018.pdf.
O’Mahony, D. STOPP/START criteria for potentially inappropriate medications/potential
prescribing omissions in older people: Origin and progress. Expert Review of Clinical
Pharmacology 13.1 (2020): 15–22. https://doi:10.1080/17512433.2020.1697676.
World Health Organization. Medication Safety in Polypharmacy: Technical Report. Geneva,
2019 (WHO/UHC/SDS/2019.11). Licence: CC BY-NC-SA 3.0 IGO.
https://apps.who.int/iris/handle/10665/325454.
Falls
Ganz, D. A. and Latham, N. K. Prevention of falls in community-dwelling older adults. New
England Journal of Medicine 382.8 (2020): 734–43. https://doi.org/10.1056/nejmcp1903252.
Morse, J. M., Morse, R. M., and Tylko, S. J. Development of a scale to identify the fall-prone
patient. Canadian Journal on Aging 8.4 (1989): 366–77.
https://doi.org/10.1017/S0714980800008576.
NICE. Falls in older people: Assessing risk and prevention: Clinical guideline (CG161). 12 June
2013. https://www.nice.org.uk/guidance/cg161.
Royal College of Physicians. FallSafe resources: Original. 13 August 2015.
https://www.rcplondon.ac.uk/guidelines-policy/fallsafe-resources-original
Pressure ulcers
NICE. Pressure ulcers: Prevention and management: Clinical guideline (CG179). 23 April 2014.
https://pathways.nice.org.uk/pathways/pressure-ulcers.
Websites:
HSE Ireland:
https://www.hse.ie/eng/about/who/qid/nationalsafetyprogrammes/pressureulcerszero.
NHS Scotland:
http://www.healthcareimprovementscotland.org/our_work/standards_and_guidelines/stnds/pressure_ulcer_st
Infections
AGS. Choosing wisely. 2017. https://www.choosingwisely.org/wp-
content/uploads/2018/02/Antibiotics-For-Urinary-Tract-Infections-In-Older-People-
AGS.pdf.
British Geriatrics Society. COVID-19: Managing COVID-19 pandemic in care homes for older
people. 2020. https://www.bgs.org.uk/resources/covid-19-managing-the-covid-19-pandemic-
in-care-homes.
Lithander, F. E. et al. COVID-19 in older people: A rapid clinical review. Age and Ageing 49.4
(2020): 501–15. https://doi:10.1093/ageing/afaa093.
Chapter 35
Safety in a multidisciplinary team
Key points
• Chronic care requires the integration of different specialties.
• Clinical teams need to come together to coordinate care.
• A multidisciplinary team can increase shared understanding, develop shared goals
and decrease the potential for safety events.
• The team will require a change in culture and mutual respect for all members.
In Chapter 6 the development of safe clinical teams was discussed. In clinical care, the complex
ways in which services are designed and the increasing number of comorbidities in people with
chronic conditions require working across clinical teams.
Healthcare is delivered in many different scenarios, from community and primary care to
secondary or tertiary care. This involves many stakeholders from different layers of the treatment
pyramid. Within a hospital, clinical teams often work in silos and the patient is seen as a disease
entity rather than as a person with multiple problems that require integration. The lack of
integrated care can result in safety and quality challenges.
From the perspective of the person receiving care, the main issues are:
From a safety perspective, given the development of chronic illnesses of increasing complexity,
the traditional mode of care delivery by a single clinician can be a safety issue. Multidisciplinary
teams (MDTs) aim to integrate care, putting the patient and the family at the centre of all
decision-making.
The MDT aims to develop shared understanding in order to achieve desired outcomes.
Benefits of MDT include improved experience and improved outcomes. Despite this, care
remains uncoordinated and the implementation of integrated care remains a challenge. Box 35.1
shows some of the evidence-based benefits of MDT care that have been found in the care of
people with chronic conditions and cancer.
Why is it a challenge?
Core MDTs usually consist of team leaders and members who are direct care providers, such as
nurses, dentists, pharmacists, doctors, allied professionals, and case managers.
A team established to take care of a person with cancer would make a good example. There
are numerous specialities involved there, from the primary care team, the hospital physician, and
the surgeon to the radiotherapist and the oncologists. They may work in different departments
and hospitals. Once they are engaged in the care of the patient, they form the core team.
However, without a formal MDT process they may act in silos.
Team members with vastly differing education, experience, backgrounds (both personal and
professional) and skills may complement one another well. Yet, whether they deliver chronic
care in the community or run a cardiac arrest in the intensive care unit, it is crucial that
healthcare providers cooperate, function as effective MDTs, and avoid harmful behaviours such
as the silo or halo effect, where individuals may be blamed for failures of the team.
Just as building a safe clinical team requires respect for all members and psychological safety,
when one brings the MDT together, this is extended across a whole patient journey. The
approach to the complexity of care is to have a view of the entire care pathway and of all that is
required in order to provide safe care. The Systems Engineering Initiative for Patient Safety
SEIPS 3.0 (Figure 35.1) offers a human factors approach to the SEIPS 2.0 model discussed in
Chapter 9.
The model enlarges the clinical team, encompassing all the care providers needed for reaching
desired outcomes across the entire patient journey. It includes management-level decisions,
which define the conditions under which patients are treated. It also includes non-medical areas
such as the purchase, supply, and design of services and personnel administration.
To ensure safe care in an effective MDT, a few steps are required.
Figure 35.1 SEIPS 2.0
(Reproduced with permission from Holden et al. (2013).
1. They include all those who are involved in the care of patients.
2. They treat the patient and the family as equal participants.
3. They define a collaborative plan of care.
4. They identify major safety issues and daily patient goals.
5. They address major safety issues and daily patient goals.
6. They develop a quality indicator/care bundle sheet.
7. They implement a quality indicator/care bundle sheet.
8. They address care bundle compliance.
9. They comply with evidence-based protocols (DVT prophylaxis, and vaccination).
10. Identify and address gaps in patient care
11. Identify the plan for transition to other levels of care
12. Develop team understanding
13. Implement rounding form
The challenge is to have key personnel join the rounding against competing priorities.
Changing the safety culture in a wide range of specialities can be difficult. Strategies to facilitate
the implementation of multidisciplinary rounds include:
identifying change champions (particularly physician leaders);
defining roles and expectations clearly;
holding frequent learning sessions; and
communicating with staff members.
It is best to start small, conduct small tests of change, identify opportunities to streamline
processes, and celebrate success.
Combined clinics provide a potential solution. This solution also limits hospital visits. MDT
collaboration with different backgrounds and viewpoints facilitates knowledge transfer between
specialities and can contribute to the evolution of the service. Different specialities working side
by side and delivering the same advice to vulnerable patients can be very effective.
Summary box
Reference
Carayon, P. et al. SEIPS 3.0: Human-centered design of the patient journey for patient safety.
Applied Ergonomics 84 (2020). doi:10.1016/j.apergo.2019.103033.
Further reading
Clinical Excellence Commission, New South Wales. Multidisciplinary team rounds. NSW 2019.
https://www.cec.health.nsw.gov.au/improve-quality/Safety-Fundamentals-for-
Teams/multidisciplinary-team-rounds.
Emmel, B. and Golden, J. Multidisciplinary Rounds: Not MORE work, but THE work. Institute
for Healthcare Improvement 2019.
http://www.ihi.org/resources/Pages/ImprovementStories/MultidisciplinaryRoundsNotMOREWorkbutTHEW
Epstein, N. E. Multidisciplinary in-hospital teams improve patient outcomes: A review. Surgical
Neurology International 5, Suppl. 7 (2014): S295–303.
Weller, J., Boyd, M., and Cumin, D. Teams, tribes and patient safety: Overcoming barriers to
effective teamwork in healthcare. Postgraduate Medical Journal 90.1061 (2014): 149–54.
doi: 10.1136/postgradmedj-2012-131168.
Chapter 36
Safety in the laboratory
Key points
• Up to 95% of the clinical pathways rely on patients having access to pathology
services.
• 500 million biochemistry and 130 million haematology tests are carried out per year
by the NHS.
• 300,000 tests are performed every working day.
• 50 million reports are sent from labs to GPs every year.
• 2 million units of donated blood are transfused every year.
• 40% of the tests ordered are unnecessary.
There are a variety of subspecialties in laboratory medicine that offer a vast array of tests.
Knowledge of the type of test offered, of how to choose the correct test and how to interpret and
integrate the result correctly into patient care, is fundamental to patient safety and patient-related
outcomes.
The list given here is not intended as a complete record of either specialities or tests; these are
just examples of the most common tests.
Haematology FBC
White cell differential
PTT, INR, APTT, D-dimers
Fibrinogen
Pregnancy testing
Malaria screens
Blood transfusion ABO & Rh D Grouping and Antibody Screening
Antibody identification
Crossmatching blood
Direct antiglobulin test
Phenotyping
Clinical chemistry Urea and electrolytes (Na, K, Cl, Urea, Creatinine)
Liver function tests (albumin, bilirubin, alkaline phosphatase, GGT,
ALT, AST, total protein)
Ca, PO4, Mg
Amylase
Lipids (T. Chol, Tg, HDL Chol, LDL Chol)
Glucose
Uric acid
Immunology Anti-nuclear antibody (ANA)
Anti-smooth muscle antibody
Anti-mitochondrial
ANA
Anti-dsDNA
ANCA
Rheumatoid factor (RF)
C3, C4
Anti-CCP antibody
Coeliac disease: Anti-tTG Anti-EMA
Microbiology and Culture and sensitivity testing
Virology Blood cultures
Viral PCR (e.g. respiratory swabs)/viral serology
MRSA screening
PCR
Histopathology Fine needle aspiration cytology
Fluid cytology
Biopsies
Staging of cancer resections
Interoperative assessment
Immunohistochemistry
Molecular testing
Laboratory processes
It is a complex process.
It has multiple separate steps.
Numerous individuals are involved in it.
Each step is vulnerable to error and is a potential threat to patient safety.
For the purposes of analysing patient safety issues, these different processes can be divided into
three phases: pre-analytical, analytical, and post analytical.
The division into these categories does not attempt to suggest that one phase affects patients
more than another. The potential consequences are the same in all three.
Errors in laboratory medicine
Pre-analytical error
Up to 75% of all testing errors occur in the pre-analytical phase
This phase is the one most prone to error, as it involves the most steps and the most people.
The phase is also fragmented; the first part of the phase is performed outside of the laboratory,
while the second part is performed inside the laboratory
The pre-analytical phase sees a mixture of non-laboratory staff and laboratory staff that handles
the specimen between the time of order and the time of delivery to the laboratory.
Common causes of error in this phase are displayed in Box 36.1.
Although these areas are beyond the jurisdiction of the clinical laboratory itself, the credibility
of the lab is at stake because of these errors. The laboratories must bear the burden of the
inconsistencies or incorrect reporting that can ensue from these preanalytical errors.
Analytical error
The analytical phase of laboratory testing involves the preparation of the sample in the
laboratory, testing, interpretation, and verification of the result by a pathologist. Analytical errors
in this phase are estimated at 7%–13% (for examples, see Box 36.2).
Box 36.2 Errors that may occur at the analytic phase of testing
• sample mix up;
• incorrect processing prior to analysis;
• equipment malfunctions or failure in test processes;
• incorrect calibration or lack of maintenance;
• interpretation error.
Post-analytical error
The interpretation of the test is complete and, once verified, the results are released to the
requesting clinician for their interpretation. Patient safety may impact from errors or omissions in
the report provided by the laboratory (see Box 36.3):
Error reduction
A key component of education should be to ensure that the correct test is carried out on the
correct patient at the correct time and correctly.
• EQA participation;
• continual professional development;
• consultation with colleagues;
• multidisciplinary meetings;
• case reviews;
• competency assessement;
• calibration of measuring systems;
• internal controls;
• SOPS.
• synoptic reporting;
• consistent format;
• automatic alerts for critical values;
• electronic system to track report acknowledgment.
Critical values
Critical values are test results that may indicate a pathophysiological state that could be life-
threatening or of immediate clinical significance.
All laboratories should have systems in place to both identify and communicate critical values.
Having an appropriate system in place to cover the communication of results is an explicit
requirement of ISO 15189 from 2012.
While the importance of critical values is universally accepted, the scope of critical values is not
well defined.
The Royal College of Pathologists offers suggested tests and triggers, but recommends that
critical values should be defined according to local clinical needs and circumstances (Croal
2017).
This information should ideally be transmitted electronically, with read receipts if available, to
avoid verbal transcription errors. Any unnecessary verbal transmission of results should be
avoided if access to electronic means is possible.
Hence an electronic means of recording when results are urgently communicated should be in
place; and it should also record the name of the person to whom the result is communicated, the
name of the laboratory person communicating the result, and the date and time of the
communication.
The accuracy of laboratory results is vital to providing a safe, high-quality service. One method
of ensuring a high-quality service is participation in an external quality assessment (EQA)
scheme (for benefits, see Box 36.6). (WHO, 2009)
EQA allows for an objective measurement of a laboratory’s testing performance using an
external agency or facility.
EQA is an essential part of the lab’s quality management system.
It provides information that allows laboratories to assess and monitor the quality status of
internal procedures and processes, the suitability of the diagnostic systems, and the
accountability and competence of the staff.
It gives assurance to the laboratories themselves, to their users, and to the public that their work
is of an appropriate quality, is reliable, and is in line with the work of their peers nationally.
EQA participation is usually required for accreditation.
1. Proficiency testing—the external provider sends unknown samples for testing to a set of
laboratories, and the results of all laboratories are analysed, compared, and reported to
the laboratories.
2. Rechecking or retesting—slides that have been read are rechecked by a reference
laboratory; samples that have been analysed are retested, allowing for inter-laboratory
comparison.
3. On-site evaluation—usually done when it is difficult to conduct traditional proficiency
testing or to use the rechecking/retesting method.
Planning
A laboratory must have standard operating procedures (SOP) and policies on the quality
required. Quality manuals need to be developed and regularly updated. All aspects of the
laboratory service should be covered under standard operating procedures. User manuals should
be available online for consultation.
Control
Laboratory quality requires strict measurement over all parts of the process, as well as on the
outcomes. Regular user surveys and assessments of complaints with real-time feedback allow
laboratories to identify areas that require improvement. Failure to evolve puts patients potentially
at risk by either offering the wrong test or the not offering the right test at the right time. The risk
management system should assess:
errors, near misses and non-conformances;
trends in incidents.
Improvement
A non-conformance management programme should involve corrective and preventive action. A
safe laboratory will have a continuous improvement programme is in place that involves all
members of staff (see Box 36.7). This programme will aim at taking both corrective and
preventive action to maintain the standards, in line with corporate and accreditation
requirements.
Laboratory staff members have several roles outside the strict confines of the lab. These roles
play an active and essential part in maintaining patient safety. They include haemovigilance,
antimicrobial stewardship, multidisciplinary meetings, research, and forming ethics committees
and patient safety advisor groups.
Haemo-vigilance
Haemovigilance is defined by EC Directive 2002/98/EC as ‘organised surveillance procedures
relating to serious adverse or unexpected events or reactions in donors or recipients and the
epidemiological follow up of donors’.
There were 21 transfusion related deaths, 112 patients suffered major morbidity and there were
1671 near misses in the UK in 2017 (‘Annual SHOT report 2017’, 2018).
Errors account for 85.5% of all reported incidents (‘Annual SHOT report 2017’, 2018).
Antimicrobial stewardship
Antimicrobial resistance, which renders bacterial infections resistant to standard treatment, is a
growing concern globally.
Antimicrobial resistance increases the cost of healthcare through lengthier stays in hospital and
the need for more medical intervention.
Microbiology laboratories and clinical microbiologists should play a central role in securing the
provision of these services leading the development and provision of an antimicrobial
stewardship programme. (See Chapter 23, Sepsis and Antimicrobial Stewardship)
Summary box
• The role of the laboratory is to support the clinical staff in the diagnosis and treatment of
clinical conditions.
• Laboratories need to have safe processes in order to protect the staff in the laboratory;
they also need to provide error-free results in a timely manner, for both clinicians and
patients.
• Errors can take place during three phases: pre-analytical, analytical, and post-analytical.
• The application of safety theory to processes in the laboratory will assist by ensuring
reliability and safety at all the stages.
• The laboratory has an important role to play in haemo-vigilance and antimicrobial
stewardship.
References
Annual SHOT report 2017. SHOT: Serious Hazards of Transfusion. 12 July 2018.
https://www.shotuk.org/2017-annual-shot-report-published-12-july-2018.
Croal, B. The Communication of Critical and Unexpected Pathology Results. London: Royal
College of Pathologists, 2017.
Plebani, P J. Errors in clinical laboratories or errors in laboratory medicine? Clinical Chemistry
and Laboratory Medicine 44.6 (2006): 750–9.
World Health Organisation. Overview of external quality assessment (EQA) WHO Laboratory
Quality Management System Training Toolkit: Strengthening health security by
implementing the international health regulations. 2009. Content Sheet 10.
https://www.who.int/publications/m/item/overview-of-external-quality-assessment-eqa
Further reading
Badrick, T. et al. External quality assessment beyond the analytical phase: An Australian
perspective. Biochemia Medica 27.1 (2017): 73–80.
Bonini, P. et al. Errors in laboratory medicine. Journal of Clinical Chemistry 53 (2007):1338–42.
Hammerling, J. A. A review of medical errors in laboratory diagnostics and where we are today.
Laboratory Medicine 43.2 (2012): 41–4.
Lippi, G. and Guidi, G. C. Risk management in the preanalytical phase of laboratory testing.
Clinical Chemistry 45 (2007): 720–7.
Lippi, G. and Plebani, M. The importance of incident reporting in laboratory diagnostics.
Scandinavian Journal of Clinical and Laboratory Investigation 69.8 (2009): 811–14.
Medical Laboratories. Reduction of Error through Risk Management and Continual
Improvement. Online Browsing Platform, 2009.
https://www.iso.org/obp/ui/#iso:std:iso:ts:22367:ed-1:v1:en.
National Pathology Programme. Digital First: Clinical Transformation through Pathology
Innovation. 2004. https://www.england.nhs.uk/wp-content/uploads/2014/02/pathol-dig-
first.pdf.
Sandhu, P. K. et al. Effectiveness of laboratory practices to reduce specimen labeling errors at
the time of specimen collection in healthcare settings: A laboratory medicine best practices
(LMBP) systematic review. Journal of Applied Laboratory Medicine 2 (2017): 244–58.
Tang, D. et al. Patient safety issues in pathology: From mislabeled specimens to interpretation
errors. Vignettes in Patient Safety 3 (2018): 141–59. https://www.intechopen.com.
doi:10.5772/intechopen.79634.
Chapter 37
Patient safety in a pandemic
Key points
This chapter addresses patient safety issues and approaches during a pandemic. It explores
a system-wide approach, focusing on the following areas:
• public health measures in the community, in work environments, and in clinical
pathways for patients and healthcare workers (the suggested actions are derived from
Tartaglia 2020 and are based on experiences summarized by clinical risk managers);
• key human factors messages to assist in high-pressured environments;
• a compilation of ‘milestones’ and indicators for patient safety in a pandemic.
A pandemic is an infrequent event. Health systems need to be prepared for the eventuality of a
pandemic. This state of preparedness must be a constant, whether it be in terms of national plans,
local interventions, or the application of public health measures. Pandemics are VUCA events:
volatile, uncertain, complex, and ambiguous. They present challenges to the health system and
society; moreover, they constantly change and renew these challenges.
To be successful in responding to a VUCA event, healthcare systems need to:
place people first in all decision-making—and by ‘people’ we mean both citizens at large
and healthcare providers more specifically;
be creative in how they manage operations and work across boundaries and sectors;
ensure that there is strong teamwork and clear communication.
All this requires a special kind of leadership: compassionate, reflective, and possessed of
humility. In this chapter we provide key learning from the COVID-19 pandemic.
Why is it a challenge?
A pandemic is defined as an epidemic that stretches over a very wide area, runs across national
boundaries, and affects a very large number of people. In a pandemic it is a challenge to maintain
patient safety, that is, to ensure the absence of preventable harm to patients. To declare an
infection outbreak to be a pandemic, the infection in question needs to be caused by an emerging
pathogen to which the general population, including healthcare workers, is largely susceptible.
Depending on infectivity and virulence, a pandemic can cause multiple individuals to be
simultaneously affected, generating a massive influx of patients. This can result in hospital
overcrowding and staff overload on the one hand, staff shortage caused by illness on the other.
There may be limited but evolving knowledge of the pathogen, its transmission, clinical
manifestations, diagnostic work-up, and treatment. This can increase uncertainty and make the
field even more slippery for healthcare operators and management.
Given the exceptional characteristics of a pandemic, appropriate preparation and situational
awareness can be deficient. For example, the Influenza and COVID-19 pandemics, with their
characteristics of diffusion and severity, revealed the unequivocal need for personal protective
equipment (PPE).
Judging from the experience of pandemics over the past twenty years, the following measures
appear to work (Box 37.1):
An adequate approach to patient safety in such a context can only be systematic and have a
logical approach. It will look at three aspects:
Above all, as the pandemic involves more countries, the root cause of any adverse event is the
delayed recognition, and therefore the delayed declaration, initially of an epidemic, then of a
pandemic at the international level.
People
hand hygiene;
face masks;
respiratory etiquette.
Environmental
surface and object cleaning;
travel restrictions such as border closure, tourist restrictions, entry and exit screening at airports
and ports;
social distancing with an aim to reduce crowded spaces, for example by ensuring that employees
can work from home wherever possible:
• In many countries during the COVID-19 outbreak, this led governments to declare that
certain occupations have ‘keyworker status’, which allowed professionals in these
categories to continue work: delivery drivers, refuse workers, teachers for children of
keyworkers, supermarket employees, police officers, pharmacists, and other healthcare
professionals, and so on. Non-essential activities may be closed, for example, cafes and
nightclubs;
contact tracing, self-isolation of exposed persons, and quarantine of those infected:
• the length of time suggested for quarantine and self-isolation will depend on the
estimated period of infectivity of the pathogen.
These measures are aimed to delay and reduce the size of the peak (see Figure 37.1) and to slow
down transmission, so that the impact of the pandemic is mitigated and hospitals are not
oversaturated.
Figure 37.1 Flattening the curve.
Source: Anderson et al. 2020. Reproduced with permission of Elsevier
Cultural, socioeconomic, and political factors can affect or delay the application of PHMs—
with serious preventable harm to the community, lack of integration between health and political
authorities, inadequacy of national emergency task force (ETF), and delayed or omitted
decisions.
Environmental safety
Safer care in a safer environment involves the following measures:
Early and appropriate instructions for environment disinfection (detergents, contact time,
frequency) to cleaners and domestic staff will prevent in-hospital or clinic transmission.
Germicide deficiency can be avoided through galenic preparations.
A dedicated hospital or clinical area for infected patients is better than a separation between
clean and dirty pathways within the same clinical area.
Screening patients will identify suspected cases on admission to healthcare services, including
among those admitted for other reasons (e.g. surgery, coronary angioplasty, labour and delivery).
Reduction or suspension of non-urgent hospital admissions, routine outpatient clinic
appointments and routine surgical procedures is recommended.
Limit access and implement mandatory precautions for visitors (e.g. surgical masks, two-meter
distance between seats in waiting rooms). Restricted numbers of visitors and limited visiting
hours will reduce transmission. Healthcare facilities may be asked to limit visits, and a change of
clothes for visitors may be required in highly infectious pandemics.
Apply reliability principles of standardization of tasks to ensure effective care (e.g. hand-
hygiene; SEPSIS bundle; bundle for the prevention of ventilator-associated pneumonia or central
venous catheter infections).
Equipment for treating patients must be available and well functioning in care areas. Examples
are stock for pathology labs, gas analysers, pulse oximeters, mechanical ventilators, suction and
intravenous pumps, oxygen therapy.
Paediatrics
In children there may be differences in clinical presentation, and therefore different management
protocols.
Oncology
In patients with cancer and in other immunocompromised patients, the focus is on the safety of
the required procedures. Postponement of anti-neoplastic treatment should be evaluated on a
case-by-case basis; immune suppressants must not be suspended, but dose increases should be
postponed; a route of administration suitable for home treatment should be considered; steroids
can be continued cautiously. It is key to prevent infection with the pandemic-inducing pathogen,
therefore individual protective measures must be rigorously applied; visitors in therapy rooms or
hospital wards should be limited. These high-risk patients, in whom an infection with the
pathogen could prove fatal, are advised to observe longer periods of self-isolation; for example,
in the UK, the preliminary ‘shielding’ during the COVID-19 pandemic lasted 12 weeks.
Surgery
In special settings such as surgery (or morgue/autopsy), particular attention must be paid to
environment and operator safety, so as to avoid infection spreading. Bearing in mind that a
pandemic is often due to a new and unknown pathogen, autopsy investigation assumes great
importance: it helps us to understand the pathophysiology better and to address future treatment.
Most elective, non-cancer, and ‘non-urgent’ operations may need to be postponed in order to
prevent transmission and to increase ICU capacity and availability of equipment.
‘Cold sites’ may need to be considered; for example, in cases where elective procedures are
cancelled, specialist centres can act as cold sites for the admission and management of trauma
patients, covering a wider catchment area, to free up local hospital ITU capacity. Any trauma
patients who would normally present to the local hospitals could be diverted to such sites. This
also allows for specialist skills to be grouped into key sites.
Radiology
There may be increased demand for diagnostic imaging during a pandemic, or for complications
that arise from an advanced disease; for example, a CT pulmonary angiogram (CTPA) can
exclude pulmonary embolism in COVID-19-positive patients. Develop guidelines and pathways
that may guide clinicians, paying consideration to the appropriate transfer of infected patients
and to the cleaning time of equipment such as CT scanners between investigations.
The milestones of patient safety in a pandemic include the following rules and principles (Box
37.3):
The pandemic will have an impact on the delivery of healthcare to the wider population. These
are some of the measures to be considered.
The stress and mental well-being of healthcare workers, as well as their risk of infection, are
key factors to keep under observation.
Summary box
Plan:
• multidisciplinary task force;
Prevent:
• contact tracing and testing campaigns, to identify cases;
• epidemiological studies on the population to include periodic monitoring of the
epidemic’s evolution;
• vaccination of the population;
References
Anderson, R. M. et al. How will country-based mitigation measures influence the course of the
COVID-19 epidemic? Lancet l 395.10228 (2020): 931–40.
Tartaglia, R., Patient safety recommendations for COVID-19 epidemic outbreak. Global Clinical
Engineering Journal 2.3 (2020). doi: 10.31354/globalce.v2i.94.
Further reading
Clinical Human Factors Group. Key human factors messages when under pressure. ghfg, 30
March 2020. https://chfg.org/key-human-factors-messages-to-support-the-nhs.
Donaldson, L. et al. Textbook of Clinical Risk Management and Patient Safety. Springer, 2021.
Holden, R. J. et al. SEIPS 2.0: A human factors framework for studying and improving the work
of healthcare professionals and patients. Ergonomics 56.11 (2013): 1669–86.
https://doi:10.1080/00140139.2013.838643.
La Regina, M. et al. Responding to COVID-19: The experience from Italy and recommendations
for management and prevention. International Journal for Quality in Health Care 33.1
(2021). https://doi.org/10.1093/intqhc/mzaa057.
Nembhard, I. M., Burns, L. R., and Shortell, S. M. Responding to Covid-19: Lessons from
management research. NEJM Catalyst, 17 April 2020.
https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0111.
Pandit, M. Critical factors for successful management of VUCA times. BMJ Leader 5.2 (2020).
doi: 10.1136/leader-2020-000305.
Porta, M. A Dictionary of Epidemiology. 6th ed. Oxford: Oxford University Press, 2014.
Seghieri, C. et al. Looking for the right balance between human and economic costs during
COVID-19 outbreak. International Journal for Quality in Health Care 33.1 (2021). doi:
10.1093/intqhv/mzaa155.
Tartaglia, R. et al. COVID-19 pandemic: International survey of management strategies.
International Journal for Quality in Health Care 33.1 (2021). doi: 10.1093/intqhc/mzaa139.
WHO. Non-pharmaceutical public health measures for mitigating the risk and impact of
epidemic and pandemic influenza. WHO 2019. License: CC BY-NC-SA 3.0 IGO.
https://apps.who.int/iris/handle/10665/329439.
WHO. Patient safety. WHO 2021. https://www.who.int/patientsafety/en.
Chapter 38
Safety improvement tools
This chapter contains a list of practically useful safety improvement tools applicable in almost all
clinical settings. Many of these tools are referenced and demonstrated in other chapters. Tools
and resources that are more specific to areas of care or patient groups are contained within those
chapters.
International
World Health Organization
https://www.who.int/teams/integrated-health-services/patient-safety
OECD
https://www.oecd.org/health/patient-safety.htm
EU Patient Safety
https://www.oecd.org/health/patient-safety.htm
England
Patient Safety Learning
https://www.patientsafetylearning.org/
NHS England Patient Safety Programme
https://www.england.nhs.uk/patient-safety/patient-safety-improvement-programmes/
Northern Ireland
Safety and quality standards
https://www.health-ni.gov.uk/topics/safety-and-quality-standards
Scotland
NHS Scotland Improvement Hub
https://ihub.scot/improvement-resources/
Wales
Patient Safety Wales
https://du.nhs.wales/patient-safety-wales/
Ireland
National Quality and Patient Safety Directorate
https://www.hse.ie/eng/about/who/nqpsd/
USA
Institute for Healthcare Improvement
http://www.ihi.org/
Patient Safety Movement Foundation
https://patientsafetymovement.org
Australia
Clinical Excellence Commission NSW
https://www.cec.health.nsw.gov.au/
Canada
Health Excellence Canada
https://www.healthcareexcellence.ca/
BC Patient Safety and Quality Council
https://bcpsqc.ca/
Patient perspective
Notes Tables, figures, and boxes are indicated by t, f, and b following the page number
A
AARs (after-action reviews) 132
administration
medication safety 216
paediatric prescribing 228, 232
adverse drug reactions (ADRs)
antimicrobials 262
definition 214
potential 214
adverse events 161–176
case studies 173
definition 165
incident reports 167
investigation recommendations 172–173, 174, 175
just culture 170
management 166
operating theatres 322
patient & family role 170
reporting 114, 167
systems approach 168
taxonomy 165
after-action reviews (AARs) 132
Agency for Healthcare of Research and Quality (AHRQ) 15
AI see Appreciative Inquiry (AI) protocol
always events 298
AMB Score 316
ambulatory care 313–318
clinical challenges 314
communication & care transition 314
definition 314
investigations 314
pandemics 435
unit design 315
ambulatory care units
communication 317
governance & measurement 317
huddles 317
interventions 316
patient selections 316
process standardization 316–317
American Geriatrics Society 390–391
anaesthetists 327
analytical errors
external quality assessment 423
laboratories 418, 420
antenatal care
maternity care 352
multidisciplinary teams 410
antimicrobial-related adverse drug events 262
antimicrobial resistance (AMR) 236, 262
prevention & control 239
antimicrobials
consumption measurement 262
exposure 236
health economics 50
antimicrobial stewardship 251–263, 425
acute hospitals 256–259
challenges 253
definition 252
long-term care facilities 259
safety measures 262
Appreciative Inquiry (AI) protocol 158
learning from success 156
safe cultures 16
Ask Me 3 (Institute for Healthcare Improvement) 36–40
assumption bias 306
attitude 241
B
balancing measures, intensive care unit 384
Beers criteria 392
behavioural changes, healthcare-associated infections 241
best evidence, emergency department 309
Better Births framework 350–351
better health and well-being, maternity care 348
biomonitoring tracking 207
blood transfusions
health economics 49
laboratories 414
briefings, operating theatres 325
British Thoracic Society 316–317
C
CAM (Confusion Assessment Method) 390–391
care bundle (CB) 128–132, 134
delirium 391
maternity care 354
mobility 395
operating theatres 327
reliability 96
caregivers see second victim
care interfaces, medication safety 217
Care Opinion 116
Care Quality Commission (CQC) 354
care transition, ambulatory care 314
CAS (complex adaptive system) 102
catheter-associated urinary tract infection (CAUTI) 243
CAUTI (catheter-associated urinary tract infection) 243
CB see care bundle (CB)
CDI (Clostridioides difficile infection) 244, 245
CEA see cost-effectiveness analysis (CEA)
central line-associated bloodstream infections (CLABSIs) 241, 340, 374, 376
central venous catheter (CVC) 240–244
infection 241, 242, 243
'Check Back,' critical care 382
checks/checklists
emergency department 309
operating theatres 324
chief information officer (CIO) 209
chief medical information officers (CMIOs) 209
child health see paediatrics
chronic care, multidisciplinary teams 410
CIO (chief information officer) 209
CLABSIs (central line-associated bloodstream infections) 241, 340, 374, 376
climate of safety, operating theatres 325–326
clinical care, Zero Suicide initiative 370
clinical challenges, ambulatory care 314
clinical chemistry, laboratories 414
clinical coding databases 130
clinical complexity, maternity care 346
clinical decision support, paediatric prescribing 227
clinical incidents, leadership 25
clinical level, patient safety 122
clinical pathways, pandemics 433
clinical standards, maternity care 352
clinical teams 55–59
development methods 58
hierarchy 57
maternity care 346
safety measurements 58
second victim 194
theoretical basis of safety 57
training 57
clinician support, open disclosure 182
Clostridioides difficile infection (CDI) 244, 245
CMIOs (chief medical information officers) 209
cognition
emergency department 306
human factors and ergonomics 79
common language use 64
communication 61–68
ambulatory care 314, 317
barriers to 62
common language use 64
critical care 381, 382
critical interventions 67
diagnostic errors 282, 284–285
documentation 64, 66
handover implementation 64, 65
multidisciplinary teams 408
pandemics 431
primary care & general practice 291
technology use 66
Zero Suicide initiative 370
community care homes, pandemics 435
complex adaptive system (CAS) 102
complex systems 103
computerized provider order entry (CPOE) 204, 206
medication safety 218
paediatric prescribing 227, 228
prescribing process 216
computers
operating theatres 326–327
ordered entry systems 49
conclusions, remote consultation 293
condition-specific registries 36–40
Confusion Assessment Method (CAM) 390–391
consultation, remote 292, 293
controls 20
laboratories 424
conversation conduction 180
corcive measures, mental health 364–365
cost-effectiveness analysis (CEA) 44, 48
blood transfusions 49
definition 46
cost-effectiveness ratios 46
cost-effectiveness thresholds 46
COVID-19 pandemic 388, 400, 428
telehealth 208 see also pandemics
CPOE see computerized provider order entry (CPOE)
CQC (Care Quality Commission) 354
crew-resource management (CRM) 326
situational awareness 74
critical care 373–386
challenges 375
communication 381, 382
patient transport 381
preventable harms 376–377
critical incident management 8–9
critical interventions, communication 67
critical values, laboratories 421
CRM see crew-resource management (CRM)
crowding, emergency department 304
culture
operating theatres 322
promotion & enhancement 21
CVC see central venous catheter (CVC)
D
daily goals, critical care 382
data
clinical coding databases 130
harm data 130
maternity care 351
national-level data 120–121
patient safety measurement 115
debriefing
adverse events 166
learning from success 157
operating theatres 325
decision-making, shared 38
dedicated hospitals, pandemics 431–432
deep vein thrombosis (DVT) 316–317
Dekker, Sidney 170
delirium 390–391
care bundles 391
management 391
demographics, paediatrics 336
departments
diagnostic errors 282–283
learning from success 157
dependency, paediatrics 336
design
human factors and ergonomics 80
improvements of 82, 83, 84
operating theatres 326–327
people for 80
deterioration, paediatrics 338–339
development
paediatrics 336
safety systems 22
device-related infections 240–244
diabetes
multidisciplinary teams 410
new technologies 207
diagnosis
emergency department 306
primary care 290–291
diagnostic errors 277–286
key issues 278, 279
post-tests, reporting, future work 284–285
safety improvements 282–285
test delivery 282–283
differential epidemiology, paediatrics 336
disclosure see open disclosure
discrimination, mental health 365
disease tempo 294
disinfection 431–432
dispensing
medication safety 216
paediatric prescribing 227–228, 231
doctor tempo 294
documentation
adverse events 166
communication 64, 66
DVT (deep vein thrombosis) 316–317
E
early warning systems 274
Ebola pandemic 428
economics see health economics
ED see emergency department (ED)
education, mental health 368
effective maternity care 348
effective practice 97
efficiency thoroughness trade-off (ETTC) 104
EHRs see electronic health records (EHRs)
elective births, maternity care 352
electronic documentation 202
electronic health records (EHRs) 203, 206
prescribing process 216
electronic ordering 202
emergency department (ED) 89, 303–312
best evidence 309
case studies 310
checklists 309
cognitive biases 306
crowding 304
definition 304–305
high acuity 305
high inflow 305
individual impact 306
pandemics 435
pressures 305
situational awareness 308
specialist practitioners 308
staffing 305
system factors 307
time-related standards 309
trauma systems 312
triage & assessment 308
twelve-hour rates 121
Emergency Department Checklist (Bristol) 310
emergency hospitals readmissions 121
emergency task forces (ETFs) 430, 431
environment
ambulatory care units 315
critical care 375
honest environments 369
human factors and ergonomics 79
medical ward deterioration 268
mental health 367, 368
operating theatres 322
pandemics 430, 431–432, 436
environmental and human factors (HFE) 291
EQA see external quality assessment (EQA)
equipment
operating theatres 322
pandemics 433
ergonomics, operating theatres 326–327
errors
analytical errors see analytical errors
definition 165
diagnostic errors see diagnostic errors
diagnostic interpretation errors 284–285
diagnostic reporting errors 284–285
diagnostic transcribing errors 284–285
medication errors see medication errors
post-analytical errors see post-analytical errors
post-test diagnostic errors 284–285
pre-analytical see pre-analytical errors
pre-analytical errors see pre-analytical errors
reduction in laboratories 416
ETFs (emergency task forces) 430, 431
ETTC (efficiency thoroughness trade-off) 104
excellence 156
exnovation 156
experience-based design 41
external quality assessment (EQA) 422
benefits 422
performance problems 422
external stress, operating theatres 325–326
F
failure mode and effects analysis (FMEA) 26
falls 394–395
measure 395
medical ward deterioration 274
families, multidisciplinary teams 408
feedback, diagnostic errors 282, 284–285
'Fever in under 5s: Assessment and Initial Management' (NICE) 339–340
fishbone diagrams 164
5 Moments for Medication Safety (WHO) 36–40
5 WHYs 129
five key drivers, actions 351
five steps, operating theatres 325
flexible cultures 14
FMEA (failure mode and effects analysis) 26
foetal medicine 352
For Us (For Unity Safety) 347
4AT 390–391
four Ds, paediatrics 336
frailty
infections in older adults 401 see also long-term conditions
front line safety 125–138
integration & learning 132
maternity care 354
measurement & reporting 134
operation stability 131
past harm 129, 130
reliable processes 130–131
functional resonance analysis method (FRAM) 101, 106–107
future state design 144
G
gait assessment 394
general practice 287–302
cultural measures 298
focus areas 290–292
leadership 296
mitigation 296
pandemics 434
process measures 298–299
risk control 296
safety incidents 298–299
time 292–293, 294
geriatric emergency care 310
Glasgow Admission Prediction Score 316
Global Patient Safety Action Plan (WHO) 7
governance
ambulatory care units 317
maternity care 348
H
haematology 414
haemovigilance 425
HAIs see hospital-acquired infections (HAIs)
hand hygiene 240
handover implementation, communication 64, 65
harm data 130
harm reduction interventions, paediatrics 338
Harvard Medical Practice Study (1991) 4
HCAIs see healthcare-associated infections (HCAIs)
healthcare-associated infections (HCAIs) 235–249
behavioural changes 241
device-related infections 240–244
hand hygiene 240
outcome measures 248
prevention & control 239
process measures 248
Healthcare Safety Investigation Branch 173
healthcare workers, pandemics 438
health economics 43–53
antibiotic effectiveness 50
blood transfusions 49
computer-ordered entry systems 49
definition 46–47
nurse-to-patient ratios 50
quantification of health gains 47
safety vs., 52
Health Foundation 128–132
Health Information and Quality Authority (HIQA) 348, 354
'hello, my name is…,' 35
HFACS (Human Factors Analysis and Classification System) 80–81, 168
HFE see human factors and ergonomics (HFE)
HFE (environmental and human factors) 291
hierarchy, clinical teams 57
high acuity, emergency department 305
high inflow, emergency department 305
high-quality personalized care, mental health 368
high-reliability organizations (HROs) 8–9, 88, 90
characteristics of 90
HIQA (Health Information and Quality Authority) 348, 354
histopathology 414
honest environments 369
hospital-acquired infections (HAIs) 121
medical ward deterioration 274
paediatrics 340 see also antimicrobial stewardship; sepsis
hospital standardized mortality rate (HSMR) 120, 130
Hour-1 Bundle (2018) 256
HROs see high-reliability organizations (HROs)
HSMR (hospital standardized mortality rate) 120, 130
huddles
ambulatory care units 317
situational awareness 73
human factors
error rates 89
medical ward deterioration 269
Human Factors Analysis and Classification System (HFACS) 80–81, 168
human factors and ergonomics (HFE) 8–9, 77–86
applications of 80–81
definitions 78
domains of 79
incident analysis 80–81
principles 82
humble inquiry, safe cultures 16
I
ICER see Institute for Clinical and Economic Review (ICER)
ICNARC (Intensive Care National Audit & Research Centre) 384
ICU see intensive care unit (ICU)
illness severity, patient summary, action list, situation awareness and contingency planning and
synthesis by receiver (I-PASS) 64, 65
immunology laboratories 414
impact, emergency department 306
improvement collaboration, maternity care 355
improvement theory 139–149
case study 146
challenges 148
definition 140
future state design 144
implementation 144–145
patient viewpoint 143
people engagement 142–143
problem identification 142
system-wide integration 145
team-building 142–143
variation measures 143–144
work system 143
incident reporting 130
adverse events 167
incidents
analysis 80–81
definition 165
primary care & general practice 298–299
independent statutory authorities 354
individual responsibility 8–9
indwelling devices, infections 400
infections 400
frail older adults 401
indwelling devices 400
outcome measures in pandemics 438 see also hospital-acquired infections (HAIs); sepsis
information
maternity care 348
person-centred safety 36–40
information technology 201–211
challenges to introduction 204
computerized provider order entry 204
context 202
electronic documentation & ordering 202
electronic health records 203
interoperability 205
new technologies 206, 207
technology introduction 66
technology partners 209
telehealth 208
informed culture 14
innovation, maternity care 351
inpatient maternity care 352
in-patient multidisciplinary team rounds 408–410
Institute for Clinical and Economic Review (ICER) 47
definition 46
Institute for Healthcare Improvement (IHI)
Ask Me 3, 36–40
Global Trigger Tool 115
Institute of Medicine, To Err is Human (1999) 4
intelligent kindness 16
Intensive Care National Audit & Research Centre (ICNARC) 384
intensive care unit (ICU) 89
safety measures 384
sterile cockpit 146
International Federation of Emergency Medicine 304–305
interoperability 205
interpretation errors, diagnosis 284–285
intrapartum management 352
introduction, situation, background, assessment, recommendations (ISBAR) 268
investigations, adverse events 172–173, 174, 175
I-PASS (illness severity, patient summary, action list, situation awareness and contingency
planning and synthesis by receiver) 64, 65
Irish Histopathology National Quality Improvement Programme 424
ISBAR (introduction, situation, background, assessment, recommendations) 268
J
just cultures 14
adverse events 170
K
key actions, pandemics 436
key process reliability 282–283
Know Check Ask (HSE Ireland) 36–40
L
laboratories 413–426
analytical errors 418, 420
case study 424
control 424
critical values 421
disciplines 414
error reduction 416, 420
external quality assessment 422
improvement 424
learning 424
planning 424
post-analytical errors 418, 419, 420
pre-analytical errors 418, 420
processes 416–417
testing process 416–417
language use, common 64
leadership 20, 21
controls & measures 26
maternity care 348, 351
medication safety 215
operating theatres 324
organization development 26
primary care & general practice 296
safety planning 24–25
safety system development 22
transparency 19–29
learning cultures 14
maternity care 351
mental health 370
operating theatres 325–326
organizations 26
learning from success 151–160
advantages 152
failure vs., 152, 153
methods 156
practical approach 156, 157–158
reframing 158
learning system, diagnostic errors 282
legal considerations, open disclosure 180
literacy, medication safety 217
LMICs see low- and middle income countries (LMICs)
location
ambulatory care units 315
operating theatres 326–327
long-term conditions 387–403
low- and middle income countries (LMICs)
paediatric prescribing 226–227
technology introduction 66
M
machine learning 207
macro ergonomics 79
Manchester Patient Safety Assessment Framework (MapSaF) 15, 298
Maternity and Children Quality Improvement Collaboration (Scotland) 355
Maternity and Neonatal Safety Improvement Programme (MatNeoSIP) 355–356
maternity care 345–359
actions 351
care bundle 354, 355
clinical complexity 346
clinical standards 352
clinical teams 346
five key drivers 351
front line 354
improvement collaboration 355
independent statutory authorities 354
pandemics 433
safe care drivers 350–351
standards of care 348
Maternity Transformation Programme 350–351
MDT see multidisciplinary team (MDT)
measurement of patient safety 113–124
case study 122
challenges 118
clinical level 122
learning from 124
methods 114–115
metrics 120–121
organization/system level 121
reasons for 114
what is measured 118
medical complexity, maternity care 352
medical ward deterioration 265–276
assessment 268
definitions 266
early warning systems 274
falls 274
hospital-acquired infections 274
human factors 269
practical approaches 271
pressure ulcers 274
safety measurement 274
specific tools 275
staffing/environment 268
medication errors 374, 377, 378
adverse events 214
classification 215
costs 214
definition 214
paediatrics 338, 339 see also medication safety
medication prescribing
paediatrics see paediatric prescribing
primary care & general practice 290
process 216
reliability 96 see also polypharmacy
medication reconciliation 217
medication reviews 392, 393
medication safety 213–219, 392
administration 216
care interfaces 217
definition 214
dispensing 216
future of 218
health literacy 217
issues 214
leadership 215
measurement 217, 392
mental health 365
polypharmacy 217
prescribing process 216
primary care & general practice 290
terms & definitions 214 see also medication errors
Medication Without Harm initiative (WHO) 392
medicines reconciliation tool 298
mental health 361–371
autonomy vs. safety 364–365
diagnosis 364
education, training, and reviews 368
harm definition 364
high-quality personalized care 368
key issues 362
medication knowledge 365
open & honest environments 369
physical environment 368
prone restraint reduction 370
safety measurement 366
stigma & discrimination 365
talking therapies 365
microbiological laboratories 414
mitigation, primary care & general practice 296
mobility, care bundle 395
monitoring risk and improvement system safety (MoRISS) 298
Morse Fall Scale 394
mortality statistics 130
multidisciplinary team (MDT) 405–412
barriers to effectiveness 407
benefits 406
chronic care 410
members of 407
paediatrics 339
'my favourite aunt,' 35
N
National Early Warning Score 2 (NEWS2) 266, 268
medical ward deterioration 274
National Health Service (NHS)
Organization with a Memory (2000) 4
Patient Safety First Campaign 380–381
National Institute for Clinical Excellence (NICE), 'Fever in under 5s: Assessment and Initial
Management,' 339–340
national-level data 120–121
National Maternity Safety Strategy 350–351
National Mortality Case Record Review (NMCRR) 275
National Patient Safety Agency (2004) 269, 270
National Safety Standards for Invasive Procedures (NatSSIPs) 280
national systems, adverse event reporting 167
NCC MERP Index 215
near-miss definition 165
Never events 115, 130
primary care & general practice 299, 300
NEWS2 see National Early Warning Score 2 (NEWS2)
NHS see National Health Service (NHS)
NMCRR (National Mortality Case Record Review) 275
non-technical skills (NTS) 57
operating theatres 322
Norton scale 396
NTS see non-technical skills (NTS)
nurses
medication safety 216
patient ratios 50
Nursing Delerium Screening Scale 390–391
O
obstetrics see maternity care
office tempo 294
oncology, pandemics 434
on-site evaluation, laboratories 422
OPAT (out-patient parenteral antimicrobial therapy) 316–317
open disclosure 177–183
clinician support 182
conversation conduction 180
definition 178
follow-up 181
importance 179
legal considerations 180
pitfalls 182
preparation 180
open environment, mental health 369
operating room staff 327
operating theatres 319–331
care bundles 327
care study 320
design & ergonomics 326–327
five steps 325
interventions 324–327
people-related factors 325–326
safety measures 328
team-related factors 326
operation stability, front line safety 131
organizational human factors and ergonomics 79
organizations
ambulatory care units 315
critical care 375
development 20
learning from success 157
measurement of patient safety 121
mental health 367
pandemics 431, 436
transparency & learning 26
Organization with a Memory (NHS, 2000) 4
outcome measures
ambulatory care units 315
antimicrobial stewardship 262
healthcare-associated infections 248
intensive care unit 384
maternity care 355
operating theatres 328
sepsis safety 262
out-of-hours work 292
out-patient parenteral antimicrobial therapy (OPAT) 316–317
out-patients, pandemics 434
P
paediatric early warning score (PEWS) 268
paediatric prescribing 223–234
administration 228, 232
preparation & dispensing 227–228, 231
procurement 226, 230, 231
technology 227
paediatrics 333–343
deterioration recognition 338–339
emergency care 310
harm reduction interventions 338
hospital-acquired infections 340
medication harm 338, 339
pandemics 434
physiological changes 336
prescribing see paediatric prescribing
preventable harm 334
safety measurement 342
sepsis 339–340
Paediatric Trigger Tool 342
palliative care, pandemics 435
pandemics 427–439
ambulatory care 435
clinical pathways 433
community care homes 435
definition 428
emergency department 435
general practice 434
key actions 436
obstetrics 433
oncology 434
out-patients 434
paediatrics 434
palliative care 435
public health measures 430
radiology 434
safety measures 438
surgery 434
working of 429
work systems 430–433 see also COVID-19 pandemic
Parkinson's disease 394
patient flow, reliability 96
Patient Reported Experiences and Outcomes of Safety in Primary Care (PREOS-PC) 298
patients
ambulatory care units 316
autonomy in mental health 364–365
champions/representatives 35
critical care 375
critical care transport 381
experience surveys 35
improvement theory 143
information errors 282
leadership in person-centred safety 35
maternity care 348
medical records 36–40
mental health 367
multidisciplinary teams 408
operating theatres 322, 328
person-centred safety 39
reported methods 115, 116
reported outcome measures 35
safe cultures 16
screening in pandemics 431–432
Patient Safety First Campaign (NHS) 380–381
PCPs (primary-care physicians) 203
PDSA see plan, do, study, act (PDSA) cycles
peer-to-peer support 36–40
people
ambulatory care units 315
improvement theory 142–143
operating theatres 325–326
pandemics 430 see also person-centred safety
perinatal loss 352
peripheral venous catheter (PVC) infections 240–244
personal protective equipment (PPE) 428
pandemics 432, 433
person-centred safety 31–42
challenges of 34
definition 32
development 35
effectiveness 36–40
human factors and ergonomics 82
improvement methods 36
patient groups 39
shared decision-making 38
single patient co-design 37
systems approach 40
Teach Back 39
PEWS (paediatric early warning score) 268
PIER framework 350–351
plan, do, study, act (PDSA) cycles 384
improvement theory implementation 144–145
planning
laboratories 424
safety 24–25
pneumonia 400
polypharmacy 392
medication safety 217
seven-step bundle 393 see also medication prescribing
positive deviance, learning from success 156
post-analytical errors
external quality assessment 423
laboratories 418
postnatal care 352
post-test diagnostic errors 284–285
potential adverse drug reactions 214
PPE see personal protective equipment (PPE)
practitioners, learning from success 157
pre-analytical errors
external quality assessment 423
laboratories 418, 420
precipitating/predisposing factors, delirium 390
PREOS-PC (Patient Reported Experiences and Outcomes of Safety in Primary Care) 298
preparation
open disclosure 180
paediatric prescribing 227–228, 231
remote consultation 293
pre-pregnancy services 352
prescriptions see medication prescribing
PRESSURE 397b
pressure injuries 405–412
management 398
prevention measures 397b
risk factors 396b
skin care 397
stages 397b
pressure ulcers 377
medical ward deterioration 274
preventable harm
critical care 376–377
paediatrics 334
preventative harm, second victim support 194
primary care 287–302
cultural measures 298
focus areas 290–292
leadership 296
mitigation 296
process measures 298–299
risk control 296
safety incidents 298–299
time 292–293, 294
primary-care physicians (PCPs) 203
prioritization, diagnostic errors 282–283
problem identification, improvement theory 142
process measures
ambulatory care units 315, 316–317
antimicrobial stewardship 262
critical care 375
healthcare-associated infections 248
intensive care unit 384
maternity care 355
mental health 370
operating theatres 328
outcome measures in pandemics 438
pandemics 436
primary care & general practice 298
sepsis safety 262
procurement, paediatric prescribing 226, 230
proficiency testing, laboratories 422
Progress and Next Steps (National Maternity Safety Strategy) 350–351
promotion role, leadership 20
prone restraint reduction 370
provider factors, mental health 367
psychological safety 16
public health measures, pandemics 430
PVC (peripheral venous catheter) infections 240–244
Q
quality-adjusted life years (QALYs) 47
definition 46
quality improvement 157
quality of care 6–7
R
radiology, pandemics 434
RAG (resilient assessment grid) 101, 106–107
randomized control trials (RCTs) 253
RCA see root cause analysis (RCA)
RCOG (Royal College of Obstetricians and Gynaecologists) 352
rechecking, laboratories 422
referrers, diagnostic errors 282, 284–285
reframing, learning from success 158
reliability 87–99
concepts of 95
definitions 88, 89
design for 95
effective practice 97
high-reliability 90
importance 88
measures 92
medication prescribing 96
patient flow 96
practical actions 96–97
theory into practice 94
theory of 90
reliability matrix 130–131, 134, 135
reliable processes, front line safety 130–131
remote consultation 292, 293
reporting culture 14
reporting diagnostic errors 284–285
required tasks, pandemics 432
resilience, Safety-II 104, 106–107
resilience theory 8–9
resilient assessment grid (RAG) 101, 106–107
resilient healthcare 156
resources, maternity care 348
retesting, laboratories 422
reviews
mental health 368
retrospective medical records 115
risk factors
falls 391
primary care & general practice 296
risk management 8–9
leadership 25
risk registers 130
room temperature, operating theatres 326–327
root cause analysis (RCA) 102, 129, 168
adverse events 162
Royal College of Obstetricians and Gynaecologists (RCOG) 352
run chart 134, 135
S
safe culture 13–18
components of 14
development of 16–17
measurement of 15
practices of 16
SAFER guidelines 210–211
safety briefs, critical care 382
safety checklists, operating theatres 324–325
safety cross 134, 135
Safety-I 104
Safety-II vs., 105
Safety-II
learning from success 156
resilience 104, 106–107
Safety-I vs., 105
safety improvement tools 441–443
safety management systems 20
safety team projects 157
safety thermometer 130
Saving Babies Lives (SBLCB) 354, 355
SBAR see situation, background, assessment, and recommen dation (SBAR)
scheduling, diagnostic errors 282–283
Schwartz rounds 58
Scottish Intensive Care Society Audit Group 384
Scottish Patient Safety Programme (SPSP) 122, 380–381
Scott's three-tiered emotional support system 195
SEA (significant event analysis) 299
second victim 185–197
background 186
clinical team support 194, 195
definition 186
feelings of 188
long-term impact 192
support between 196
symptoms 188, 189, 190
self-care, maternity care 348
self-efficacy, healthcare-associated infections 241
sensor activation reminder system 207
sepsis 251–263
challenges 253
definition 252
paediatrics 339–340
safety measures 262
working methods 256 see also infections
seven-step bundle, polypharmacy 393
Seven Steps to Patient Safety (2004) (National Patient Safety Agency) 269, 270
shared decision-making 38
shared medical review 36–40
SHMI (summary hospital mortality indicator) 130
significant event analysis (SEA) 299
sign in/out, operating theatres 325
simulations, technology introduction 66
situational awareness 69–76
clinical example 73
crew resource management 74
definition 70
emergency department 308
huddles 73
operating theatres 324
theoretical basis 72
working methods 72
situation, background, assessment, and recommendation (SBAR) 64, 65
critical care 382
size, operating theatres 326–327
skill mix, pandemics 432
SKIN bundle 377
skin care, pressure injuries 397
SMART, improvement theory 144–145
social influence, healthcare-associated infections 241
SOPs (standard operating procedures) 26
SPC (statistical process control) chart 134, 136, 143–144
specialist practitioners 308
SPSP (Scottish Patient Safety Programme) 122, 380–381
SSI (surgical site infection) 245, 246, 327
SSKIN care bundle 396, 396b
staff
critical care 375
emergency department 305
medical ward deterioration 268
operating theatres 322
standardization, reliability 96
standard operating procedures (SOPs) 26
standards of care, maternity care 348
Stanford/Harris study (2018) 203
statistical process control (SPC) chart 134, 136, 143–144
'Stay smart, then focus,' 256–259
sterile cockpit, intensive care unit 146
stigma, mental health 365
STOPP/START tools 392
stroke, falls 394
success, learning from see learning from success
summary hospital mortality indicator (SHMI) 130
surgeons 327
surgery
pandemics 434
safety checklist 73
teams 327
surgical site infection (SSI) 245, 246, 327
system factors
adverse events 168
emergency department 307
measurement of patient safety 121
person-centred safety 40
system promotion, leadership 24
Systems Engineering Initiative for Patient Safety (SEIPS) 82, 83, 84, 85, 168
pandemics 430–433
Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 408
operating theatres 322, 323
patient transport 381
Systems Engineering Initiative for Patient Safety (SEIPS) 3.0, 408–410
systems organization 82
systems theory 8–9
system tempo 294
system-wide integration 145
T
Take 2 (CEC, NSW) 36–40
take 5/patient/personal stories 35
talking therapies, mental health 365
tasks
ambulatory care units 315
operating theatres 322
pandemics 436
Teach Back 39
team-building 142–143
teams
diagnostic errors 282–283
learning from success 157
maternity care 351
operating theatres 326, 328
pandemics 431, 432
technology
communication 66
critical care 375
operating theatres 326–327
paediatric prescribing 227
pandemics 436
telehealth 208
test delivery, diagnostic errors 282–283
testing process, laboratories 416–417
thalidomide 4
time out, operating theatres 325
time-related standards, emergency department 309
tiredness, operating theatres 325–326
To Err is Human (1999) (Institute of Medicine) 4
tools
critical care 375
operating theatres 322
pandemics 436
training
clinical teams 57
mental health 368
technology introduction (WHO) 66
transcribing diagnostic errors 284–285
transparency
leadership 19–29
organizations 26
safe cultures 16
trauma systems, emergency department 312
triage, emergency department 308
trigger tool review, primary care & general practice 298
trigger tools 130
U
UC see urinary catheters (UC) infections
UK CEMACH, 'Why Children Die' (2007) 334
ulcers see pressure ulcers
uninfected individuals, pandemic outcome measures 438
unit design, ambulatory care 315
unprofessional behaviour 306
urinary catheters (UC) infections 240–244
care bundles 244
V
VAP see ventilator-associated pneumonia (VAP)
variation measures
improvement theory 143–144
primary care & general practice 292
ventilator-associated pneumonia (VAP) 243–244, 374, 376
care bundle 244
ventilator support infections 240–244
Vincent framework 128–132
viral respiratory tract infections 260
virology laboratories 414
virtual reality 207
VULCA events (volatile, uncertain, complex, and ambiguous) 428
Vulnerable Women, maternity care 352
W
WAD (work-as- done) 103
WAI (work-as-imagined) 103
ward staff 327
Waterlow Scale 396
'what matters to you?,' 35
WHO see World Health Organization (WHO)
'Why Children Die' (2007) (UK CEMACH) 334
work-as-done (WAD) 103
work-as-imagined (WAI) 103
workforce, maternity care 348
work systems
improvement theory 143
pandemics 430–433
World Health Organization (WHO)
adverse events taxonomy 165
critical care 380–381
Global Patient Safety Action Plan 7
hand hygiene 240
medication error costs 214
Medication Without Harm initiative 392
operating theatre checklists 324–325
paediatric mortality 334
principles & strategy 7
surgical safety checklist 73
technology introduction 66
written handovers, critical care 382
Y
Yorkshire Contributory Factors Framework 168
Z
Zero Suicide initiative 366, 370